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resumo 
 
 
Os mecanismos de biogénese, distribuição apical e secreção regulada de 
enzimas digestivas dos grânulos de zimogénio são, atualmente, pouco 
conhecidos. De modo a esclarecer e descrever estes processos de elevada 
importância biológica e clínica, é necessária uma melhor compreensão dos 
componentes da membrana granular e as funções e interações destes. Neste 
trabalho, através de uma abordagem proteómica, foi possível identificar novas 
proteínas granulares previamente associadas ao transporte vesicular sináptico. 
Para estudar as funções destas proteínas na génese e secreção de grânulos, 
foram realizados estudos de sobre-expressão, assim como estudos 
bioquímicos (1D, 2D, and LC-MS/MS) e morfológicos, utilizando céluas de 
mamífero. Entre as proteínas descobertas, cinco foram selecionadas e 
analisadas: RMCP-1, Piccolo, Synaptojanin-1, APP e ZG16p. Destas 
proteínas, confirmou-se a presença da  RMCP-1 e APP nos grânulos de 
zimogénio. Interessantamente, o lectin ZG16p da secreção pâncreatico, 
encontra-se expressa no cérebro de rato, estando localizada nos terminais 
pós-sinápticos e em grânulos de RNA, indicando uma possível função desta 
proteína na formação das vesículas sinápticas. 
Finalmente, demonstrei que a formação de grânulos de zimogénio pode ser 
modulada, no modelo de células pancreáticas AR42J, pelas condições de 
cultura. Em contraste com as proteínas de carga neuroendocrinas, a sobre-
expressão de proteínas de carga ou da membrana dos grânulos de zimogénio 
não foi suficiente para induzir a formação de grânulos ou de estruturas 
granulares em células constitutivamente secretoras, indicando diferenças na 
biogénese de grânulos neuroendócrinos e exócrinos. 
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abstract 
 
The mechanisms of secretory granule biogenesis, apical sorting and regulated 
secretion of digestive enzymes in pancreatic acinar cells are not yet well 
understood. In order to shed light on these biologically and clinically important 
processes, a better molecular understanding of the components of the granule 
membrane, their functions and interactions is required. Using a proteomics-
based approach, novel granule proteins were identified, which have been 
previously described to be involved in synaptic vesicle biogenesis and 
trafficking. To elucidate the yet unknown functions of these proteins in zymogen 
granule biogenesis and secretion, overexpression studies as well as 
biochemical (1D, 2D, and LC-MS/MS) and morphological methods were 
applied to mammalian cells. Five proteins identified were selected for further 
evaluation: RMCP-1, Piccolo, Synaptojanin-1, APP and ZG16p. While RMCP-1 
and APP were confirmed to be new zymogen granule proteins, the existence of 
Synaptojanin-1 and Piccolo in ZGs could not be verified. Interestingly, the 
pancreatic secretory lectin ZG16p was demonstrated to be expressed in rat 
brain, localizing to post-synapses and RNA granules suggesting a potential 
function in synaptic vesicle formation. 
I also demonstrated that ZG formation in AR42J cells, a pancreatic model 
system, can be modulated by altering the growth conditions in cell culture. In 
contrast to neuroendocrine cargo proteins, overexpression of ZG cargo and 
membrane proteins was not sufficient to induce ZG formation or granule-like 
structures in constitutively secreting cells pointing to differences in 
neuroendocrine and exocrine granule biogenesis. 
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Chapter 1   INTRODUCTION 
 
1.1 The Pancreas as a Model for Exocrine Secretion 
 
The pancreas is a composite gland of the digestive and endocrine system of vertebrates. 
The endocrine cells are grouped in the islets of Langerhans occupying approximately 1.5% of the 
pancreatic tissue being surrounded by the exocrine cells (Figure 1). The endocrine cells produce 
hormones (e.g. insulin, glucagon and somatostatin) and the pancreatic peptide, which are 
secreted upon stimuli directly into the blood stream, influencing carbohydrate metabolism 
(Junqueira, Carneiro 1996). The exocrine pancreas, producing mainly digestive enzymes, is 
structured in lobules which consist of several acinar units of around 20-30 exocrine cells. Attached 
to a basement membrane, the polarized acinar cells surround the acinar lumen with their apical 
pole (Figure 1 and Figure 2). As the acinar cells accommodate the typical inventory of secretory 
cells, the pancreas served as a model to unravel the role of individual intracellular compartments 
in the secretory pathway (Palade 1975). In particular, acinar cells harbor a constitutive vesicular 
secretion system directed to both the basal and the apical cellular membrane and a regulated 
secretion system for the controlled secretion of the digestive enzymes (Burgoyne and Morgan 
2003). The basolateral membrane, facing neighboring cells, is responsible for intercellular 
communication while the apical membrane in acinar cells is responsible for the regulated 
secretion of digestive enzymes (Barthel, Nickel et al. 1995; Nelson and Yeaman 2001). Thus, to 
discriminate between proteins destined for the individual secretion systems acinar cells possess 
elaborated sorting systems to ensure the correct packaging of individual constituents into the 
proper vesicles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A) Human pancreas attached to the duodenum, 
showing the pancreatic duct system in (yellow). 
(B) Lobules of the pancreas showing acinar units 
surrounding an islet of Langerhans (IL). (C) Acinar 
units consistent of acinar cells surrounding a 
lumen.  A single acinar cell is marked with a green 
arrow and the ZG at the apical pole of this acinar 
cell are marked with a red arrow. (Taschenbuch 
der Histologie, Georg Thieme Verlag 2009) 
Figure 1: Human pancreas. 
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Like most secreted proteins the digestive enzymes in acinar cells are synthesized at the strongly 
developed rough endoplasmic reticulum (rER), pass through the prominent Golgi apparatus and 
are finally packaged into secretory vesicles termed zymogen granules (ZG) (Figure 3). The ZG 
contain around 15 to 20 different inactive pro-enzymes with a molecular mass between 13-90 
kDa. These hydrolytic enzymes are termed zymogens and can be divided into five functional 
groups: lipases (pancreatic lipase, pro-phospholipase A2), glycosidases (α-Amylase), endo- and 
exoproteases (Trypsinogen 1-4, Carboxypeptidase A-D, Chymotrypsinogen 1 and 2, pro-Elastase 
1), RNase and DNase. Consequently, acinar cells are highly specialized in the production, sorting 
and packaging of digestive enzymes and isoenzymes, which are packaged and stored in a 
condensed and inactive form in relatively large (~1 µm in diameter, Figure 2) granules (Scheele 
1993; Borgonovo, Ouwendijk et al. 2006; Dikeakos and Reudelhuber 2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
When required, the zymogens are secreted upon a stimulus via cholinergic neurons of the 
parasympatic system and the gastrointestinal hormones cholecystokinin (CCK), or secretin 
(Jamieson and Palade 1971; Williams 2001; Williams, Chen et al. 2009). In pancreatic acinar cells 
CCK activates multiple signaling pathways through the G protein-coupled receptor, CCK1 
(Schnefel, Profrock et al. 1990; Yule, Baker et al. 1999). Activation of CCK1 induces conformational 
changes in the α-subunit of the associated heterotrimeric G protein thus promoting the exchange 
of GDP for GTP. GTP-bound Gα dissociates from the complex and activates downstream effectors 
which stimulate phospholipase C and adenylate cyclase (Sabbatini 2010, Graziano 1987). Finally, 
phosphoplipase catalyzes the formation of inositol-1, 4, 5-trisphosphate causing an increase in 
intracellular Ca
2+
 levels (Sabbatini, Bi et al. 2010). Synaptotagmin, which is proposed to act as a 
clamp, preventing the fusion of docked vesicles and also zymogen granules in the absence of 
relevant stimuli, ensures that secretion does not occur spontaneously (Poo, Dan et al. 1995; 
Falkowski, Thomas et al. 2011). Synaptotagmin does that via the inhibition of membrane fusion 
through an interaction with the SNARE complex (Falkowski, Thomas et al. 2010; Falkowski, 
Thomas et al. 2011). It is proposed that, (among other factors) upon Ca
2+
 binding, Synaptotagmin 
dissociates from the SNARE complex, allowing SNAP/NSF interaction to lead to membrane fusion 
triggering exocytosis (Popov and Poo 1993; Morimoto, Popov et al. 1995).  
(A) Electron micrograph of ZGs in the apical region of pancreatic acinar cells 
surrounding an acinar lumen (L). (B) Electron micrograph of a crude ZG fraction 
isolated from rat pancreas. 
Figure 2: Ultrastructure of zymogen granules. 
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Proteins secreted at the apical membrane enter the pancreatic duct system and are 
conveyed to the intestinal lumen. Solubilized in an aqueous, bicarbonate solution secreted by 
pancreatic duct cells, the enzymes reach the duodenum, where the gastric acid is neutralized by 
the alkaline secret thus creating an environment allowing effective enzyme activation. First, 
enterokinase cleaves Trypsinogen into active Trypsin which again converts all remaining enzyme 
precursors into their active forms thereby priming the break down of carbohydrates, proteins and 
lipids in the chyme to ensure nutrient absorption by the enterocytes of the small intestine. The 
physiological importance of this secretion process is illustrated by fact, that along with 
hepatocytes, the pancreatic acinar cells exhibit the highest rate of protein synthesis among all 
cells in higher organisms. In the pancreatic acinar cell of the exocrine pancreas, more than 90% of 
the synthesized proteins are targeted to the secretory pathway (Figure 3) (Scheele, Palade et al. 
1978). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The way a protein takes from the rER (blue line, with dots representing ribosomes) through the Golgi 
complex (blue filled structure) where it is packaged in vesicles and sent to the plasma membrane, is called 
secretory pathway. A protein can be secreted constitutively (light blue vesicles) but sorted to a specific 
membrane compartment (apical or basolateral), here indicated by the arrows pointing towards both types 
of membranes, or it is destined for regulated secretion. In this case, proteins are sorted into condensing 
vacuoles (yellow) which through a maturation process of selective aggregation bud off vesicles with remote 
proteins not destined for regulated secretion (constitutive-like secretion, little yellow vesicle) in a clathrin-
dependent manner. On its way to the apical membrane, the secretory granule matures to a large dense 
core granule (red vesicles, ZG) and is stored there until secretion upon an external stimulus. Upon 
stimulation and increase in Ca
2+
, a ZG fuses with the plasma membrane. Other ZG may fuse with the first 
one to discharge their content (compound exocytosis). Rejected proteins are sent to late endosomes (big 
greenish vesicle) from where they can be transported towards different locations e.g. lysosomes (big brown 
vesicle), or back to the Golgi complex (small greenish vesicles), depending on the protein itself. Membranes 
can then be recycled via clathrin-dependent endocytosis (little dark green vesicles) from both membrane 
compartments and are sent back to the Golgi via early endosomes (oval dark green vesicle). 
Figure 3: Secretory pathways, exocytosis and endocytosis in eukaryotic cells 
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Untimely, pancreatitis a severe and painful inflammation disorder can arise by the 
activation of digestive enzymes emerging from the pancreatic acinar cells thereby leading to an 
autodigestion of the organ and eventually surrounding tissue. Pancreatitis has a mortality rate of 
around 5% in milder versions which, however, can rise to 70% for severe inflammations. 
Moreover, chronic pancreatitis promotes the development of pancreatic cancer which is one of 
the most aggressive forms with survival rates between 25% when discovered at an early stage and 
6%, depending on the disease state at the time of diagnosis. Missorting to lysosomes or the 
basolateral membrane are other reasons for pancreatic injury (Gaisano and Gorelick 2009; Husain 
and Thrower 2009) such as pancreatitis. Thus, understanding how ZG packaging and secretion is 
controlled and regulated may be a prerequisite to fully understand the etiology of this disorder 
and to improve and develop new treatments, or to discover and define risk factors which can be 
explored for diagnosis. 
 
 
1.2 Protein Sorting: From the TGN to Zymogen Granules 
 
Proteins following the secretory pathway contain a specific ER-sorting signal at the N-
terminus of the peptide chain, which is the first part of the protein to be synthesized. Leaving the 
ribosome, this short sequence is recognized by a protein complex called signal recognition particle 
(SRP) which then binds to a SRP receptor in the rER membrane by hydrolyzing GTP to GDP. This 
whole complex transports the growing protein chain to a membrane channel in the rER called 
translocon. At the translocon, the peptide is fed into the rER lumen where the signal sequence is 
cleaved and post-translational modifications (e.g. formation of disulfide bonds, addition and 
processing of carbohydrates, folding) are initiated and later completed in the Golgi complex. The 
sorting of proteins to their destined vesicles takes place at the Trans-Golgi-Network (TGN) 
according to sorting signals contained in the protein sequence; e.g., the majority of lysosomal 
proteins are recognized by specific signal patches at the proteins surface and subsequently 
marked by fusion of mannose 6-phosphate (M6P) residues, allowing their recognition by M6P 
receptors in the Golgi complex and transport to the endosomal/lysosomal compartment through 
the involvement of clathrin (Olson, Sun et al. 2010). Others lysosomal proteins are recognized by 
alternative receptors like LIMP-2 or Sortilin, and lysosomal transmembrane proteins require a 
specific cytosolic sorting signal (Gough, Zweifel et al. 1999; Braulke and Bonifacino 2009).  
The sorting of zymogen proteins into secretory granules diverges from such a common 
scheme: Sorting starts for most proteins in the TGN through a selective aggregation at a slightly 
acidic pH (6.5) (Leblond, Viau et al. 1993; Colomer, Kicska et al. 1996; Castle and Castle 1998; 
Dartsch, Kleene et al. 1998) and high Ca
2+
 levels (Siekevitz and Palade 1966; Chanat and Huttner 
1991; Freedman and Scheele 1993) while a few proteins already form complexes in the ER lumen 
(Tooze, Kern et al. 1989; Kleene, Kastner et al. 1999). It is assumed that the so-formed dense core 
aggregates associate to specific TGN membrane domains. The aggregates exhibit a distinct 
protein composition and contain certain zymogens in association with non-enzymatic proteins, 
which have been proposed to act as “helper” proteins in complex formation, aggregation and/or 
sorting to the membrane (Kleene, Kastner et al. 1999; Kleene, Classen et al. 2000). While the 
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selective aggregation is well documented, the interaction with the TGN/ZG membrane mediating 
the sorting of regulated secretory proteins is poorly understood at the molecular level. In fact, at 
present neither a sorting signal, nor a sorting receptor has been identified. Two models, an active 
one known as „Sorting by entry“ and a passive one known as „Sorting by retention“, are discussed 
but could as well complement each other (Tooze 1998; Borgonovo, Ouwendijk et al. 2006). In the 
active „Sorting by entry“ model, membrane binding of aggregated secretory proteins is assumed 
to depend on a “sorting receptor” within the TGN, so that the entry into forming granules is 
restricted to receptor-mediated trafficking (Figure 4). In the passive „sorting by retention“ model 
the sorting event is the formation of the aggregates itself. Here, the ZG present the sorting site to 
which also non-secretory proteins can enter (Figure 4). Non-regulated secreted proteins are then 
selectively removed from the immature secretory granules (condensing vacuole, CV) through the 
constriction of small clathrin-coated vesicles (constitutively-like secretion), which leads to 
zymogen granule (ZG) maturation (Castle 1990; Arvan and Castle 1998; Dahan, Anderson et al. 
2005). In addition, it was shown that a proper assembly of lipid microdomains and cholesterol 
biosynthesis are crucial for the ZG formation at the TGN (Schmidt, Schrader et al. 2001; Gondre-
Lewis, Petrache et al. 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3 Sorting and Packaging of Zymogens with the Help of a Submembranous 
Matrix 
 
As mentioned above, two hypotheses for the sorting of zymogens into ZG are currently 
discussed: the active “Sorting by entry“ and the passive “Sorting by retention” model. To clarify 
this issue more information on the interaction between aggregated zymogens and the 
membranes of the TGN/ZGM is required. Receptors for some major zymogens were postulated 
(e.g. Amylase) but have yet not been identified. As a consequence, the aggregated secretory 
In the active “Sorting by entry” model, aggregated proteins are sorted in the 
TGN and bind to the ZGM via a specific sorting receptor. In the passive 
“Sorting by retention” model the ZG present the sorting site in which non-
secretory proteins can enter and are selectively removed by constriction of 
clathrin-coated secretory vesicles (constitutive-like secretion). (Figure taken 
from Tooze et al. 1998 and modified) 
Figure 4: Protein sorting models. 
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proteins may more likely interact with specialized membrane domains or submembranous 
structures instead with receptors specific for individual enzymes.  A network-like structure on the 
luminal side of the ZGM was already observed by freeze-fracture and deep-etching studies 
(Cabana, Hugon et al. 1981). Since around 90% of sulfated proteoglycans were found associated 
with the ZGM and could be released by alkaline sodium carbonate treatment, Scheele et al (1994) 
postulated the existence of a submembranous matrix at the luminal surface of the ZG. Later 
studies from Dartsch and colleagues demonstrated that zymogen granule content (ZGC) proteins 
condense upon an acidic pH of 5.9 and bind to ZG membranes in a condensation-sorting assay 
(Dartsch, Kleene et al. 1998). More recent findings indicate that membranous or submembranous 
proteoglycans indeed interact with the zymogens via electrostatic interactions: Muclin, a strongly 
glycosylated and sulfated membrane protein, was suggested as a potential sorting receptor for 
aggregated zymogens in ZG (De Lisle 2005). Most likely, muclin binding is mediated via 
interactions between its negatively charged sulfate groups and positively charged patches on the 
zymogens in the TGN (Boulatnikov and De Lisle 2004). Moreover, negatively charged 
proteoglycans in secretory granules of haematopoietic and mast cells have been shown to be 
involved in the binding and sorting of small positively charged molecules, such as histamine 
(Brion, Miller et al. 1992; Grimes and Kelly 1992; Castle and Castle 1998) and proteases 
(Lutzelschwab, Pejler et al. 1997; Huang, Sali et al. 1998), and proteoglycans were found 
aggregated to the secretory proteins after exocytosis in the pancreatic duct system (Tartakoff, 
Jamieson et al. 1975; Reggio and Palade 1978). Furthermore, alterations in the glycosylation and 
sulfation lead to problems in proper zymogen condensation and packaging (De Lisle 2002). Thus, a 
submembranous matrix was hypothesized to be essential for the shape and stability of ZG 
(Schrader 2004), mediating protein sorting, packaging and ZG biogenesis (Matsumoto, Sali et al. 
1995; Forsberg and Kjellen 2001). 
To fully understand how the export proteins are selected and discriminated from Golgi-
resident proteins it is indispensable to identify the molecular components of the submembranous 
matrix and characterize their linkage to the granule-surrounding membrane. Peripheral 
membrane proteins identified in ZG are: the secretory lectin ZG16p, ZG29p (Kleene, Zdzieblo et al. 
1999), Syncollin (Kalus, Hodel et al. 2002), the serpin ZG46p (Chen, Cronshagen et al. 1997) and 
GP3, a glycoprotein which is secreted into the pancreatic juice (Wagner, Wishart et al. 1994). In a 
condensation-sorting assay these components have been identified as sulfated proteoglycans and 
glycin-rich glycoproteins, which in vitro are able to link aggregated zymogens to the ZGM 
(Schmidt, Dartsch et al. 2000; Schmidt, Schrader et al. 2001). In a recent proteomics study, the 
proteoglycans glypican-4-heparansulfate-proteoglycan, proteoglycan-2 and Syndecan 4 were 
identified in a ZG fraction (Rindler, Xu et al. 2007). Sulfated proteoglycans were also found in 
many other cellular compartments (endosomes, lysosomes and the nucleus) but especially in 
storage granules of immunosecretory cells (Gallagher, Hall et al. 1986; Kolset and Gallagher 1990; 
Prydz and Dalen 2000). (Glycosylphosphatidylinositol) GPI- anchored membrane proteins like e.g. 
GP2 were found to be associated to a scaffold of sulfated proteoglycans (Kleene, Dartsch et al. 
1999; Schmidt, Dartsch et al. 2000; Schmidt, Schrader et al. 2001). The GPI-anchor is supposed to 
integrate into lipid microdomains of the ZGM (Figure 5, Schmidt, Schrader et al. 2001). It was 
found that the submembranous matrix is associated with lipid microdomains, which are rich in 
cholesterol and sphingolipids (Schmidt, Schrader et al. 2001; Kalus, Hodel et al. 2002). Apparently, 
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the depletion of cholesterol leads to a disturbance in lipid microdomain formation which in turn 
inhibits granule formation (Schmidt, Schrader et al. 2001) and is leading to a miss-sorting of 
zymogens into the constitutive secretion pathway (Schmidt, Schrader et al. 2001; Kalus, Hodel et 
al. 2002). These findings were supported by a study in a mouse model with a cholesterol synthesis 
deficiency leading to a strong reduction in the number of secretory granules in the pancreas 
(Gondre-Lewis, Petrache et al. 2006). The few remaining granules, however, had an abnormal 
morphology and a reduced regulated secretion which could be restored through the addition of 
exogenous cholesterol. Further, the insertion of cholesterol precursors in artificial membranes led 
to a decreased membrane curvature, emphasizing the importance of cholesterol in granule 
biogenesis (Gondre-Lewis, Petrache et al. 2006). 
In summary, there is increasing evidence that the submembranous matrix is involved in 
the sorting of zymogens in the TGN due to electrostatic interactions with the proteins to be 
exported and may act as a mechanic support for the generally formation of membrane curvature 
at the TGN thereby stabilizing the granule structure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4 Zymogen Granule Exocytosis 
 
Mature ZG are transported along microtubules towards the apical plasma membrane and 
then transferred to a subapical actin network guiding to the fusion site (Ishihara, Sakurai et al. 
2000; Ueda, Ohnishi et al. 2000; Valentijn, Valentijn et al. 2000). This step requires dynein, 
Lipid microdomains (yellow) in the ZGM and associated components like the GPI-anchored glycoprotein GP2 
(black ovals), may be involved in the binding of a submembranous protein matrix (red) composed of 
proteoglycans, glycoproteins and lectins (e.g., ZG16p in light blue). Additional components are the SNARE 
proteins syntaxin 3 and synaptobrevin 2. Syncollin binds to membranes in a cholesterol-dependent manner 
and forms homo-oligomers. A hypothetical ‘core’ domain containing highly-ordered lipids is indicated.  
Figure 5: Submembranous matrix model (Kalus et al 2002, Schrader 2004) 
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dynactin and myosin motor proteins that were recently identified by proteomics studies of 
zymogen granule membrane (ZGM) fractions (Chen, Walker et al. 2006; Rindler, Xu et al. 2007). 
Until a hormonal or neuronal stimulus leads to an increase of intracellular Ca
2+
 concentrations 
which triggers the exocytosis of the ZG content into the pancreatic duct system (Williams 2001; 
Williams, Chen et al. 2009), the ZGs are stored underneath the apical plasma membrane. Despite 
intensive studies, the exact mechanism for ZG exocytosis is not yet clear since e.g. no Ca
2+
 sensor 
has been identified. However, some information about proteins mediating the ZG fusion with the 
plasma membrane starts to emerge (Wasle and Edwardson 2002; Williams, Chen et al. 2009; 
Falkowski, Thomas et al. 2011). Several soluble N-ethylmaleimide-sensitive factor-activating 
protein receptor (SNARE) proteins, as well as Rab GTPases and aquaporins are suggested to be 
involved in granule docking, priming, swelling and exocytosis (Chen, Edwards et al. 2002; Cho, 
Sattar et al. 2002; Riedel, Antonin et al. 2002; Chen, Li et al. 2004; Faust, Gomez-Lazaro et al. 
2008; Williams, Chen et al. 2009; Gomez-Lazaro, Rinn et al. 2010). Partially, the localization of 
these proteins to ZG was confirmed in recent proteomic studies (Chen, Walker et al. 2006; 
Rindler, Xu et al. 2007; Chen, Ulintz et al. 2008) but further functional evaluation is required to 
clarify the role in the excretion process. It was proposed that the ZG membrane connects and 
fuses temporally to specific plasma membrane structures called “Porosomes” (Jeftinija 2006) and 
that the ZG release their content upon an increase of intra-vesicular pressure after vesicle 
swelling (Cho, Sattar et al. 2002; Kelly, Abu-Hamdah et al. 2005; Sugiya, Matsuki-Fukushima et al. 
2008). Furthermore, in a process called compound exocytosis, granules with a more basal location 
may fuse with more apically positioned granules that are intermittently in contact with the 
plasma membrane (Thorn, Fogarty et al. 2004; Pickett and Edwardson 2006). This homotypic 
fusion is supposed to be mediated by the SNARE protein Syntaxin 3 on the ZG membrane 
(Hansen, Antonin et al. 1999). The fusion of ZG with the plasma membrane is transmitted by an 
actin meshwork and lasts several minutes (Nemoto, Kojima et al. 2004; Thorn, Fogarty et al. 
2004). ZG membranes are then recycled in two steps: first by constriction of patches from the 
primary ZG fused to the plasma membrane (Thorn, Fogarty et al. 2004) and then by endocytosis 
of integrated ZGM material in the plasma membrane through clathrin-coated vesicles.  
 
 
1.5 Biogenesis and Secretion of Secretory Granules in (Neuro)Endocrine Cells 
 
In (neuro)endocrine cells, regulated secretory proteins (RSP) can be divided into soluble, 
aggregating proteins and membrane-bound proteins (Pimplikar and Huttner 1992; Yoo 1993) 
which are packed in secretory granules (SG). The accepted model of SG biogenesis comprises four 
distinct steps ultimately leading to the formation of mature secretory granules (MSGs). These are 
(1) aggregation of the RSP and its sorting at the TGN membrane, (2) budding from the TGN, (3) 
homotypic fusion of immature SGs, and (4) remodeling of the immature SG membrane and 
contents as depicted in Figure 6, (Tooze, Martens et al. 2001; Inomoto, Umemura et al. 2007). The 
interaction of the soluble RSPs with specialized membrane domains of the TGN and membrane 
bound RSPs induces an association into oligomers which subsequently leads to the formation of 
immature secretory granules (ISG) at the TGN (Arvan and Castle 1998; Tooze 1998). Like in ZG 
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maturation this aggregation process is pH-dependent (secretory granules provide a pH of 5.5) and 
occurs in a calcium-dependent manner (Ozawa and Takata 1995; Yoo 1995). In contrast to ZG, 
however, a submembranous matrix based on a proteoglycan scaffold seems to lack in secretory 
granules. Instead, several different sorting domains were identified on cargo proteins. Granins 
(chromogranins and secretogranins) are regulated secretory proteins ubiquitously found in the 
cores of amine-, peptide hormones and neurotransmitter dense-core secretory granules (Huttner, 
Gerdes et al. 1991). It is assumed that these acidic proteins support the formation of aggregates 
and assist in the sorting of pro-hormones (Huttner and Natori 1995). Granins exist as membrane 
bound forms, interacting with soluble proteins probably as “nucleation receptors” during 
aggregation (Tooze, Martens et al. 2001). In addition, it was also demonstrated that 
overexpression of CgA and B as well as of Secretogranin II and POMC induces the formation of 
granule-like dens-core structures in non-(neuro)endocrine cells such as COS-1 and COS-7 (Kim, 
Tao-Cheng et al. 2001; Huh, Jeon et al. 2003; Beuret, Stettler et al. 2004; Inomoto, Umemura et al. 
2007; Stettler, Beuret et al. 2009). For chromogranin A (CgA) and B (CgB) and for the pro-
opiomelanocortin (POMC), a disulfide-bonded loop at the N-terminus has been identified as a 
signal for sorting into ISGs (Chanat, Weiss et al. 1993; Cool, Fenger et al. 1995; Kromer, Glombik et 
al. 1998). Disruption of these loops leads to mistargeting into the constitutive pathway as was 
described for CgB (Chanat, Weiss et al. 1993). The capacity of granins to sort proteins by their 
incorporation into aggregates is supporting the model of “Sorting by entry”, previously explained 
in section 1.2.  
SGPs such as CBP-E or Secretogranin III bind to cholesterol-rich membrane domains at the 
TGN/SG. Both proteins were shown to function as sorting receptors for peptide hormones (Loh, 
Snell et al. 1997; Rindler 1998; Han, Suda et al. 2008; Takeuchi and Hosaka 2008), via recruition of 
granins to the SG membrane (Cool, Normant et al. 1997; Normant and Loh 1998; Park, Koshimizu 
et al. 2009; Hosaka and Watanabe 2010). Based on these informations, it was suggested that 
neuroendocrine cells combine “Sorting by entry” and “Sorting by retention”-like mechanisms for 
the sorting of peptide hormones and the biogenesis of secretory granules (Takeuchi and Hosaka 
2008).  
Besides the role of cholesterol rich membrane domains and lipid microdomains as anchor 
regions for SG membrane receptors, these domains were also shown to be involved in membrane 
curvature, budding, fission and apical targeting (Ikonen and Simons 1998; Thiele and Huttner 
1998; Huttner and Zimmerberg 2001; Tooze, Martens et al. 2001). It was demonstrated that the 
depletion of cholesterol by lovastatin inhibits the formation of POMC containing ISGs and 
constitutive vesicles from the TGN (Wang, Thiele et al. 2000). At present, it is still not clear if SG 
possess only a single or multiple types of lipid microdomains. However, findings of Blazquez and 
Thiele (2000) point to the existence of multiple lipid domains as they demonstrated that the pro-
hormone convertase 2 associated with detergent-insoluble rafts together with the granule 
protein GPIII (Palmer and Christie 1992), whereas CgA did not. Additionally, different sorting 
domains have been identified on several RSPs such as on the pro-peptide somostatin (Stoller and 
Shields 1989) and PC5-A (De Bie, Marcinkiewicz et al. 1996) but no common structural sorting 
motif emerged from these studies.  
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In contrast to ZGs, SGs fuse homotypically with each other to mature after leaving the 
TGN. The (t)-SNARE (soluble N-ethylmaleimide-sensitive-factor attachment receptor) protein 
Syntaxin 6 (Syn6) was identified as a component of the core machinery of the homotypic fusion of 
ISG (Wendler, Page et al. 2001) but is not incorporated into mature SGs. Interestingly, Syn6 
associates to the (t)-SNAREs SNAP25, SNAP29/GS32 and also to the (v)-SNARE VAMP4, but none 
of these proteins were found to be involved in the homotypic fusion process. These findings 
rather point to a fusion mediated by forming t-t SNARE interactions between Syn6 molecules on 
the opposing vesicles (Wendler, Page et al. 2001). Other proteins found to be involved in this 
process are Rab3D (Riedel, Antonin et al. 2002) and Synaptotagmin IV (Syt-IV) (Ahras, Otto et al. 
2006). It was found that the cytoplasmic domain of Syt-IV binds specifically to Syn6 on ISGs but 
not to MSGs, inhibiting homotypic fusion. Moreover, the depletion of Syt-IV prevents the 
activation of PC2 thus reducing the processing of secretogranin II (Ahras, Otto et al. 2006). The 
next step of SG maturation is the formation of clathrin-coated vesicles (CCVs) from immature SGs 
(A) Formation, homotypic fusion, maturation/remodelling and exocytosis of secretory granules in 
neuroendocrine cells. In neuroendocrine cells immature secretory granules (ISG) mature (MSG) through 
“homotypic fusion” (2) and removal of clathrin coated vesicles (CCV) containing non-regulated secretory 
proteins. (B) Formation, maturation/remodelling and exocytosis of secretory granules in the acinar cells of 
the exocrine pancreas. In exocrine cells maturation of ISG to MSG occurs only through constriction of CCV. 
The sorting and association of the regulated secretory proteins (RSP) succeeds most likely over a 
submembranous matrix (dark gray line). In both cell types, „lipid rafts“(black lines) participate in the sorting 
of the RSP, the transport of secretory granules (by binding to the cytoskeleton (3)) and in the fusion with 
the plasma membrane (4). (Taken from Schrader 2004) 
Figure 6: Biogenesis of secretory granules in neuroendocrine and exocrine cells. 
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(ISGs) to remove non-secretory proteins. The clathrin adaptor GGA (Golgi-associated-gamma-ear-
containing, ADP-ribosylation factor-binding protein) was found to be essential for the budding of 
CCVs from ISGs (Kakhlon, Sakya et al. 2006). Its depletion resulted in the retention of VAMP4 and 
Syn6 in MSGs and led to the inhibition of the autocatalysis of PC2 and as well prevented the 
processing of secretogranin II to its product p18.  
As a result of the two maturation steps (homotypic fusion and CCV budding), highly 
ordered dense core granules are formed, which are much smaller than ZG but larger than the 
initial ISGs. The MSGs are finally transported along microtubules towards the apical cell 
membrane. MSGs are than stored to fuse with the apical plasma membrane via exocytosis, 
(Figure 6 A), upon a Ca
2+
 or secretagogeous stimulus (Wendler, Page et al. 2001).  
 
 
1.6 ZGM Associated Proteins 
 
A group of proteins identified in ZG (which include the glycoprotein GP2, the lipase GP3, 
the lectin ZG16p, Syncollin, Syntaxin 3 and supposedly also Synaptobrevin 2) interact with lipid 
microdomains in the ZGM on the submembranous granule matrix. The major ZGM protein GP2 
binds to the ZG membrane with the help of its GPI-anker, as shown in Figure 5, but also a soluble 
form was identified (Rindler and Hoops 1990; Fukuoka, Freedman et al. 1992). Although until now 
no essential function for GP2 in ZG biogenesis could be confirmed (Dittie and Kern 1992; Schmidt, 
Schrader et al. 2001; Yu, Michie et al. 2004), a new role in host defense by binding bacterial 
fimbriae has recently been proposed (Yu and Lowe 2009). GP2 was also identified as a transcytotic 
receptor on M cells for type-I-piliated bacteria in the process of mucosal immune response (Hase, 
Kawano et al. 2009). The GP2 homologue uromodulin/Tamm Horsfall protein was also identified 
as a possible soluble receptor for bacteria in order to remove them from the urogenital system 
(Bates, Raffi et al. 2004; Mo, Zhu et al. 2004). Similar to GP2, also Syncollin, another membrane-
bound ZG protein, was identified in pancreatic juice in a soluble form (Kalus, Hodel et al. 2002; 
Gronborg, Bunkenborg et al. 2004). Even though Syncollins` function is not yet known, it may be 
required for sorting/packaging of zymogens as well as for granule formation, since it is part of the 
submembranous matrix. It was hypothesized that Syncollin might be involved in signal 
transduction processes across the granule membrane and thus in the regulation of granule 
maturation (e.g. via membrane pores) and/or exocytosis of secretory proteins via lipid 
microdomains (Schrader 2004). 
 
The Zymogen Granule Protein ZG16p 
The secretory lectin ZG16p is a 16 kDa protein that belongs to the Jacalin lectin family due 
to its sequence similarities to the carbohydrate recognition domain of the plant lectin Jacalin from 
jack fruit (which specifically binds to Galβ1-3GalNAc) (Cronshagen, Voland et al. 1994; Kleene, 
Dartsch et al. 1999; Kanagawa, Satoh et al. 2011). Lectins are carbohydrate binding proteins with 
a high specificity to individual or groups of mono- or oligosaccharides (Barondes 1988; Gabius, 
Andre et al. 2002). In animals, lectins play important roles in cell adhesion, maintenance of 
12 
 
membrane polarization, the recognition of pathogens (innate immune system), glycoprotein 
synthesis and in various protein trafficking/sorting processes (Dodd and Drickamer 2001; 
Delacour, Koch et al. 2008; Pearse and Hebert 2010; Svajger, Anderluh et al. 2010; Tanne and 
Neyrolles 2010; Butterfield and Owen 2011).  
Figure 7 shows a phylogenetic tree, compiled of the ZG16 sequences available at the ncbi 
protein database. For a better overview, the tree was partially organized in subgroups such as 
primates or rodents. Branches marked in green represent ZG16p homologues in various species 
including mammals, reptiles and fishes. The blue branch represents the least related sequence 
shown in this tree coming from the green sulfur bacteria (prosthecochloris aestuarii). The gray 
branches illustrate the distribution of the ZG16p homologue PAUF/ZG16b. ZG16b/PAUF is to 30% 
identical to ZG16p; 18% of the amino acids are conserved substitutes and around 14% are 
functionally conserved amino acids (see alignment in Appendix, Rinn, Aroso et al. 2011). In 
humans, the paralog ZG16b/PAUF (Pancreatic Adenocarcinoma Up-regulated Factor) was recently 
reported to play a role in gene regulation and cancer metastasis (Kim, Lee et al. 2009; Lee, Kim et 
al. 2010). 
A multiple sequence alignment restricted to mammalian sequences reveals that ZG16p is 
highly conserved among mammals: 70% of the amino acids are homologue, 25% are  identical and 
only 5% of the amino acids do not relate to each other (Figure 8). ZG16p shares sequence 
homologies, specifically at the C-terminus, with two secretory proteins from other exocrine 
glands, prostatic spermine binding protein and common salivary protein 1, possibly belonging to a 
group of evolutionary related proteins (Cronshagen, Voland et al. 1994).  
For the human proteins ZG16p and ZG16bp, the crystal structure was recently resolved 
(Kanagawa, Satoh et al. 2011): both proteins harbor a β-prism fold of 3 β-sheets, each consisting 
of 3-4 β-strands forming three Greek motifs similar to jacalin related mannose-binding type 
lectins (Kanagawa, Satoh et al. 2011). The N-terminal parts of ZG16p and ZG16bp contain each an 
ER-targeting signal. Kanagawa et al. (2011) suggested that the sugar-binding capacity of ZG16p 
originates from three different loops (GG-loop, recognition loop, and binding loop) all situated on 
top of the β-prism fold which act together as one motif (Figure 9). This motif is well conserved 
and is shared by all mannose-binding-type Jacalin-related lectins (Kanagawa, Satoh et al. 2011). In 
addition, a positively charged basic patch of lysine and arginine residues, which may bind sulfated 
groups of GAGs, is located around the putative sugar-binding site of ZG16p and ZG16bp. ZG16p 
has also been found to associate with cholesterol-glycosphingolipid-enriched microdomains in the 
ZGM together with GP2 and sulfated proteoglycans (Schmidt, Schrader et al. 2001). In addition, a 
tightly membrane-associated form of about 32 kDa, presumably a dimer, has been identified 
(Kleene, Dartsch et al. 1999; Kalus, Hodel et al. 2002). However, the ZGM association of ZG16p 
was not influenced in GP2 knock-out mice (Yu, Michie et al. 2004). Pretreatment of ZGM with 
anti-ZG16p antibody or with chondroitinase ABC in an in vitro condensation-sorting assay 
(Dartsch, Kleene et al. 1998) inhibited the binding of aggregated content proteins to the 
membrane by about 40-50% whereas pretreatment with anti-Amylase antibody had no significant 
effect (Kleene, Dartsch et al. 1999). Competition experiments with mono- and disaccharides 
showed that the addition of 10 mM galactose had only a weak inhibitory effect on condensation-
sorting (Kleene, Dartsch et al. 1999). 
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Thévenod and co-workers proposed an additional function of ZG16p in the regulation of a 
K
+
 conductance in ZG (Braun and Thevenod 2000). They suggested a regulatory role for ZG16p in 
the direct coupling between granule fusion to the plasma membrane and the activation of 
channels in the ZGM (Thevenod 2002). It was already proposed that anion-cation channels might 
promote a “flushing out” of the granule content (i.e., enzymes or mucins) during exocytosis in 
pancreatic acinar cells and in intestinal goblet cells (De Lisle and Hopfer 1986; Guo, Merlin et al. 
1997). In fact, goblet cells use two types of secretion (apocrine and merocrine), depending on the 
type of stimuli they receive. Mucus secretion occurs by fusion of secretory vesicles to the plasma 
membrane causing the release of the mucins (merocrine) through an exchange of Ca
2+
 for Na
+ 
and 
a cellular volume increase up to 600 fold (Perez-Vilar 2007; Rogers 2007). It is speculated that a 
similar mechanism may take place after an initial, fusion pore-mediated granule swelling by the 
granule matrix, including ZG16p (Thevenod, Anderie et al. 1994; Thevenod 2002). Furthermore, it 
was found that the expression of ZG16 mRNA in the rat pancreas is only moderately affected by a 
hormonal treatment with cholecystokinin (CCK) or cerulein (Cronshagen, Voland et al. 1994). Both 
peptide hormones are known to evoke a complete release of ZG and to upregulate expression and 
transport of zymogens (Wang and Cui 2007). On the other hand, a repeated treatment of mice 
with supraphysiological doses of CCK over 2 weeks, causing pancreatitis, led to a short term down 
regulation of ZG16 mRNA in the pancreas (Neuschwander-Tetri, Fimmel et al. 2004). In 
dexamethasone-treated AR42J cells, a pancreatic model system, a strong upregulation of the 
ZG16 mRNA was observed already after 24 hours (Cronshagen, Voland et al. 1994). Additionally, 
an immunohistochemical staining and northern blot analysis of several rat organs revealed the 
presence in duodenum and colon, where ZG16p was found to localize to mucus-producing goblet 
cells (Cronshagen, Voland et al. 1994). In a study involving biomaterial patches sutured onto rat 
stomach, ZG16p mRNA was found to be slightly upregulated (together with Amylase and lipase 
The alignment was compiled using Clustal X2, and Genedoc was used for the graphical layout. Selected 
sequences for human, rat, mouse, chimpanzee, rhesus monkey, opossum cattle dog and horse were aligned 
with each other. The selected sequences show a 70% homology with each other (black highlighted amino 
acids) and from the remaining 30%, 25% are highly conserved (amino acids highlighted in gray). 
Figure 8: ZG16p is highly conserved in mammals. 
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mRNA) already under control conditions (surgery without implant) and to a higher extent with 
implant (Lobler, Sass et al. 2002). In a study about differentially expressed genes in the rat ileum 
used for bladder augmentation, ZG16 was found in a cDNA microarray to be transiently increased 
compared to normal ileum after 1 and 3 months post-surgery (Miyake, Hara et al. 2004). By RT-
PCR and immunoblotting, ZG16p was shown to be expressed in human liver and to be down 
regulated in hepatocellular carcinoma. Down-regulation appears to be a consequence of the 
hepatic cancer rather than the cause (Zhou, Cao et al. 2007). Overexpression of ZG16p in some 
hepatoma cell lines inhibited cell proliferation or cell cycle progression (Zhou, Cao et al. 2007). In 
a study on hepatotoxicity of pharmaceutical xenobiotics, rat ZG16 mRNA level doubled under the 
influence of the hepatotoxic substance ANIT (α-napthylisothiocyanate) (Jessen, Mullins et al. 
2003). Finally, in a rat cDNA hybridization array, ZG16 was found to be 3 times upregulated after a 
post commissural fornix transfection, during axonal regeneration, being associated to axonal 
regeneration failure (Kury, Abankwa et al. 2004). Another study found the ZG16 gene located in 
an area of chromosomal microduplication (16p11.2), which has been related to several clinical 
conditions, like childhood neurodevelopmental disorders, mental retardation, schizophrenia and 
others (Bedoyan, Kumar et al. 2010). Very recently, human ZG16p was demonstrated to bind to 
pathogenic Candida and Malassezia species heavily coated with mannan. Since ZG16p was 
detected in mucus-producing cells such as serosanguineous acinar cells of the parotid gland, 
acinar cells of the pancreas, and goblet cells of the intestine, which are involved in self-defense 
against invading pathogens, these observation imply a role of ZG16p in the recognition of 
pathogenic fungi through unique specificity to polyvalent mannose, which is a key signature of 
non-self microorganisms in the digestive system (Tateno, Yabe et al. 2011). Remarkably, two 
other structurally different C-type lectins - PSP (Pancreatic Stone Protein) and PAP (Pancreatitis 
associated Protein) - found in ZG (and pancreatic sections) exert anti-inflammatory, anti-
apoptotic, proliferative, and antibacterial effects (Iovanna and Dagorn 2005; Moniaux, Song et al. 
2011). Thus, ZG16p may as well be involved in other cellular functions potentially depending on 
its sugar-binding lectin domain.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
with sugar binding motifs 
adapted from Kanagawa et al 
2011 
Figure 9: ZG16p protein structure 
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1.7 The Importance of Proteomics Studies for the Architecture of ZG 
 
Zymogen granules are well-suited for subcellular (and suborganellar) proteomics, as they 
are abundant organelles of the exocrine pancreas, which can be easily isolated and purified, 
owing to their large size and density. In addition, their isolation yields large quantities of 
organelles and proteins (Gomez-Lazaro, Rinn et al. 2010). Furthermore, intact ZGs can be lysed 
and further separated into a ZG content (ZGC) and ZGM fraction. The ZGM can then be further 
separated in fractions enriched in peripheral or integral membrane proteins.  
Through several different proteomics approaches such as 2D-SDS PAGE, doubled-SDS-
PAGE and Shot gun-LC-MS/MS, more and more putative ZGM and ZGM associated proteins have 
been identified. Chen et al. (2006) applied an experimental approach combining either 2D-SDS 
PAGE or 2D-liquid chromatography with tandem mass-spectrometry to identify further ZGM 
proteins. To increase the probability to identify new integral ZG membrane proteins, the 
membranes were treated with potassium bromide and carbonate. However, neither treatment 
allowed the identification of hitherto unknown integral membrane proteins; rather ZG content 
proteins such as Amylase, enzymes of the lipid metabolism and peripheral ZGM proteins (e.g. 
Syncollin) were detected (Chen, Walker et al. 2006). These data were partially confirmed by 
another LC-MS/MS study, where a similar set of proteins was identified as lipid-microdomain 
associated proteins (Berkane, Nguyen et al. 2007). Rindler et al (2007) analyzed individual ZG 
subfractions in a LC-MS/MS approach in order to gain information on the suborganellar 
distribution of individual ZG proteins thus intending a reconstruction of the ZG architecture. Chen 
et al (2008) improved this assignment of proteins to individual ZG subfractions by a quantitative 
MS-approach using the isobaric tag for relative and absolute quantification (iTRAQ) method (Chen 
and Andrews 2008). With this subtractive proteomic method, protein quantities in individual 
fractions can be compared enabling to discriminate between enriched proteins and 
contaminations from other fractions. Comparing normally isolated subfractions with samples 
digested by trypsin before organelle lysis even enabled to partially distinguish between cytosolic 
and luminal attached proteins (Chen and Andrews 2008; Chen and Andrews 2009).  
These recent proteomics studies generated a huge list of new candidate ZG proteins 
including GTP-binding and transmembrane proteins, ion channels and transport proteins. Up to 
now only a very small percentage was confirmed by alternative methods (e.g. Carboxypeptidase 
D, SCAMP 1, Tm63A, Pantophysin, PpiB and Chymase) (Rindler, Xu et al. 2007; Chen and Andrews 
2008; Faust, Gomez-Lazaro et al. 2008; Borta, Aroso et al. 2010). Especially the number of small 
GTPases associated to ZG largely increased (from the previously known eight to approximately 
twenty three) implying their involvement in ZG biogenesis, trafficking and secretion (Gomez-
Lazaro, Rinn et al. 2010). Small G-proteins are supposed to regulate each of the four major steps 
involved in membrane trafficking: vesicle/granule budding, delivery, tethering and final fusion 
with the target membrane. The majority of the newly identified small G-proteins have not been 
subjected to further functional studies, but some have been validated by immunodetection. 
Functional studies (including expression of mutated proteins, knockdown by siRNA and 
generation of knockout mice) have so far been performed on Rab3D, Rab27B, Rab8A and Rap1 
(reviewed in, Williams, Chen et al. 2009). Rab8A is the only Rab protein so far implicated to act in 
an early stage of ZG formation (Faust, Gomez-Lazaro et al. 2008). 
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Furthermore, several integral membrane proteins of ZG have been recently identified in 
proteomics studies (Chen, Walker et al. 2006; Rindler, Xu et al. 2007; Chen and Andrews 2008), 
but neither a confirmation nor a clear proof of function for most of them has been provided yet.  
The integral membrane associated protein-1 (ITMAP) was one of the first integral membrane 
proteins discovered in ZG by proteomics. It could be demonstrated that ITMAP-1 deficient mice 
have an increased severity of secretagogue- and diet-induced pancreatitis. Moreover, an effect of 
ITMAP on trypsin activation was confirmed but no influence on ZG size, appearance or 
composition could be observed (Imamura, Asada et al. 2002). Other proteins of the ZGM include 
proton pumps, transporters and channels (Jamieson and Palade 1971; Zachowski, Henry et al. 
1989; Roussa, Alper et al. 2001; Cho, Sattar et al. 2002; Kelly, Abu-Hamdah et al. 2005; Lee, 
Torchalski et al. 2008). Intriguingly, many of these proteins are already known to participate in 
(neuro)endocrine secretion systems (Table 5.0). As depicted, ongoing proteome and functional 
studies are gradually improving our understanding of the role of individual components of the ZG 
membrane and submembranous matrix in the process of granule biogenesis; however, our 
current knowledge remains still fragmentary and new key players have to be identified in order to 
fill the gaps in the current models on ZG biogenesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
In this model several ZGM proteins 
are shown which are as well 
known from synaptic vesicles of 
the neuroendocrine system, such 
as, Presinilin, APP, Pantophysin 
and myosin. (Figure taken from 
Chen and Ulintz 2008) 
Figure 10: Molecular topology of 
pancreatic ZGM proteins. 
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Chapter 2  Objectives  
 
Hitherto very few membrane and membrane-associated proteins of the ZG from the 
acinar cells of the exocrine pancreas have been identified and characterized. However, especially 
these proteins may contribute to the generation of a submembranous matrix, composed of high 
molecular weight components (e.g. a proteoglycan scaffold and associated (glyco)proteins) which 
fulfills crucial functions during the sorting and packaging of secretory proteins. Furthermore, 
these components might as well have a central function in the regulation of apical exocytosis and 
membrane fusion and in signal transduction. Disturbances in these regulated processes (incorrect 
compartmentalization, premature activation of the zymogens, incorrect transport, uncontrolled 
and unspecific fusions) can cause pathological changes of the pancreas, including necrosis and 
fibrosis, e.g. during acute pancreatitis (Adler, Rohr et al. 1982; Raraty, Ward et al. 2000; Gomez-
Lazaro, Rinn et al. 2010). Hence, the identification and molecular characterization of these 
components is highly relevant for both, basic cell biology and clinical research.  
The perpetually growing sensitivity of mass spectrometric equipment will increase the 
potential to identify more and more low-abundance proteins of the ZG. However, in parallel the 
probability for the detection of contaminating proteins from other cellular compartments or false 
positives will rise with even higher frequency. Thus, techniques for protein localization 
complementing proteome studies will grow more and more inevitable to discriminate between 
actual constituents of the ZG and contaminants (Gomez-Lazaro, Rinn et al. 2010).  
In this context, this thesis is designed to identify new low abundant constituent of the ZG 
and to verify their localization in pancreatic tissue but also in other secreting cell types. As some 
ZGM and peripheral proteins are already known from (neuro)endocrine secretion systems, 
implying a functional overlap in secretory vesicle biogenesis in both endocrine and exocrine 
systems, reciprocally ZG proteins will be also monitored in other secreting tissues. 
Complementing each other, both immunoblotting with marker proteins typical for the ZG and 
other cellular organelles such as Golgi, mitochondria, ER, peroxisomes and lysosomes (Faust, 
Gomez-Lazaro et al. 2008; Borta, Aroso et al. 2010) as well as  immunofluorescence 
(quantification of co-localization by pixel-by-pixel analysis of confocal images) and 
immunoelectron microscopy will be used for these purposes (Figure 2). Moreover, only functional 
information will enable to discriminate proteins involved in biogenesis from purely secreted 
granule content. AR42J cells originally derived from the acinar cells of a rat pancreatic tumor 
(Longnecker, Lilja et al. 1979) can be used as a model for granule biogenesis and trafficking 
studies. Treatment of AR42J cells with the synthetic glucocorticoid dexamethasone induces their 
differentiation into exocrine, acinar-like cells, with de novo formation of electron-opaque 
secretory granules containing the major pancreatic zymogens and exhibiting a regulated secretory 
state (Logsdon, Moessner et al. 1985). However, AR42J cell still only express an incomplete 
assembly of known granule proteins which could certainly alter the mechanisms of granule 
formation. In this respect, a careful adjustment of culture conditions could offer a possibility to 
improve the value of this model system. 
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Specific aims/tasks of the thesis: 
 
1. Identification of new ZG matrix constituents of the rat exocrine pancreas: To accomplish 
this task a combination of 1D- and 2D-gel electrophoresis and approaches were applied in 
order to separate peripheral membrane fractions of the ZG. For protein identification, spots 
were cut out and analyzed by MALDI-TOF/TOF mass spectrometry. 
2. Validation of new, low abundant ZGM protein candidates identified in the proteomics 
approach. Protein candidates for the ZGM with a known distribution in other secretion 
systems were selected for validation. Immunoblotting and immunofluorescence 
experiments with pancreatic tissue and cell cultures were used to verify expression and 
subcellular localization in ZG granules. 
3. Assessment of the presence of ZGM proteins in neuroendocrine secretion systems using 
the example of ZG16p. Reciprocal to the existence of neuroendocrine vesicle constituents 
in ZG, granule proteins may play a role in neuroendocrine tissue. As an example to test this 
assumption, ZG16 was localized in different brain sections by RT-PCR, immunoblotting and 
immunofluorescence. 
4. Optimization of the AR42J cell culture system as a model to study ZG biogenesis. Panserin 
is a growth factor and serum-free medium for the culture of adherent mammalian cells. 
Thus, it may be applied to study exogenous regulation of granule formation by defined 
supplementation of the medium. The influence of Panserin on AR42J differentiation and 
granule formation was studied by morphological and biochemical methods. 
5. Analysis of the influence of selected ZG constituents on the biogenesis of granules in the 
AR42J model system. Several zymogens and ZG membrane proteins were expressed in 
non-stimulated AR42J cells and in constitutively-secreting COS-7 cells. Their influence on 
granule formation was studied by immunofluorescence microscopy. 
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Chapter 3   MATERIALS & METHODS 
 
3.1 Equipment 
 
Cell Culture 
- Electro Cell Manipulator ECM 630 (BTX Harvard Apparatus, Holliston, USA) 
Centrifuges 
- Ultra Centrifuge - Optima
TM
 LE 80K Ultracentrifuge (Beckman Coulter, Fullerton/USA) with 
a Rotor Type 80 Ti (Beckman Coulter, Ireland) 
- High Speed Centrifuge - Avanti
TM
 J-25I (Beckman Coulter, Ireland) with a fixed angle rotor 
JA 25.50 (USA) 
Electrophoresis and blotting equipment 
- Horizontal PerfectBlue Gel System Mini M and Maxi S (Peqlab Biotechnology, Erlangen, 
Germany) 
- Hoefer SE 600 Ruby gel chamber (Amersham Biosciences, Uppsala, Sweden)  
- Slap mini gel chamber (Keutz, Reiskirchen, Germany) 
- Electrophoresis Power supplies: EPS 2A200 and EPS 601 (Amersham Biosciences, Uppsala, 
Sweden) 
- Trans-blot SD Semidry transfer cell (Bio-Rad, Munich, Germany) 
- Hoefer TE22 Mini Tank blot system (Amersham Biosciences, Uppsala, Sweden) 
- Hoefer TE42 Standard Transfer Tank (Amersham Biosciences, Uppsala, Sweden) 
- Ettan IPGphor (GE Healthcare, San Francisco, USA) 
Optical Equipment and Microscopes 
- Calibrated Imaging Densitometer GS-710 (Bio-Rad, Munich, Germany) 
- Leica DMIL microscope (Leitz, Wetzlar, Germany; cell culture) 
- Olympus IX81 microscope; PlanApo 100X/1.40 objective (Olympus Optical Co. GmbH, 
Hamburg, Germany) 
1. Camera F-View II CCD and Soft Imaging software (Soft Imaging Systems, Münster, 
Germany) 
- Zeiss LSM 510; Plan-Apochromat 63× or 100×/1.4 oil objective (Carl Zeiss, Oberkochen, 
Germany) 
1. Zeiss LSM Image Browser version 4.2.0.121 (Carl Zeiss MicroImaging GmbH 1997-
2006, Germany) 
- Nanodrop (Nanodrop ND 1000 (Peqlab Biotechnology, Erlangen, Germany)  
- Photometer Ultraspec 100 pro (Amersham Biosciences, Uppsala, Sweden) 
Other Equipment 
- Thermo Cycler MyCycler (Bio-Rad, Munich, Germany) 
- LC – MS/MS - Dionex 3000 Ultimate nano LC and a Waters 2690 HPLC with an integrated 
LcPackings Probot auto sampler. The Probot can spot the eluent directly onto a MALDI 
target plate, for MALDI MS/MS analysis. 
22 
 
1. Zorbax 300SB-C18 capillary analytical column with 3.5 μm particle size, 150 mm × 
75 μm (Agilent Technologies)  
2. Zorbax 300SB-C18 trapping column with 5 µm particle size, 5x0.3 mm (Agilent 
Technologies) 
- MALDI-TOF/TOF mass spectrometer (4800 Proteomics Analyzer, Applied Biosystems, 
Europe) 
- Homogenizer (IKA, Jellowline OST 20 digital, Germany) 
Most used Software Tools 
- Digital images were optimized for contrast and brightness using IrfanView Version 4.23 
(Irfan Skiljan, Vienna University of Technology, Austria) 
- Programs used for cloning: SECentral Clone Manager 5 (Ed-Sci-Software, NC, USA), 
OligoCalc 3.26, NCBI Primer-BLAST, NEB Cutter 
- Programs used for sequence analysis: Chromas Lite 2.01 (Technelysium Pty Ltd, Brisbane, 
Australia), Sequence Alignment LaLIGN (Myers and Miller, CABIOS (1989) 4:11-17),  
- Clustal W2 and Clustal X2 (Multiple Sequence Alignment, EMBL-EBI) 
- BLAST pair wise alignments for proteins (BLASTP 2.2.25+, NCBI) (compilation of 
Phylogenetic trees) 
  
23 
 
3.2 Chemicals & Reagents 
 
Table 3-1 Chemicals 
Company Country Chemical 
Applied Biosystems  Foster City, CA, USA α-Cyano-4-hydroxycinnamic acid 
AppliChem Darmstadt, Germany Coomassie G250 
Bio Rad München, Germany Protein Assay-Dye Reagent 
Concentrate 
Fluka Steinheim, Germany 
 
 
 
 
Buchs, Switzerland 
Ethidiumbromid 
Glucose (D+) 
Glutaraldehyde solution 70 % 
Luminol 
N-propyl gallate 
MES 
Sodium acetate 
Trifluoroacetic acid (TFA) 
Kodak  Developer 
Fixer 
Merck-Schuchardt 
 
 
 
 
 
 
Calbiochem/Merck 
Darmstadt, Germany 
 
 
 
 
 
Hohenheim, Germany 
Darmstadt, Germany 
Chloroform 
Ethanol por analysis 
Hydrogen peroxide 30 % solution 
Isopropanol p. a. (2-propanol) 
Methanol 
Tetramethylethylene diamine 
Aceton 
Mowiol 4-88 reagent 
Olympus Japan Immerson oil type F 
Peqlab Erlangen, Germany TriFast 
Polysciences Eppelheim, Germany Hoechst dye 33258  
Promega Madison, Wisconsin, USA Sequence grade modified porcine 
Trypsin 
Riedel Seelze, Germany HPLC-grade acetonitrile 
Roth Karlsruhe, Germany Acrylamide (Rotiphorese Gel 30) 
Agarose NEEO 
BSA fraction V 
Glycerol 
Magnesium sulfate 
Ponceau S 
Potassium acetate 
Silver nitrate 
Trichloroacetic acid solution 20 %  
Tris – base 
Sigma – Aldrich Steinheim, Germany Ammoniumperoxodisulfat  
β-Mercaptoethanol 
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Boric acid  
Bromophenol blue 
Diethylpyrocarbonat (DEPC) 
Dimethyl sulfoxide 
Dithiothreitol 
Ethylendiamintetraacetic (EDTA) 
Formamide 
Glycine 
HEPES sodium salt 
MES monohydrate 
MOPS sodium salt 
para-Formaldehyde 
p-Coumaric acid 
Potassium carbonate 
Potassium chloride  
Potassium phosphate monobasic 
Potassium phosphate dibasic 
Sodium azid 
Sodium bicarbonate  
Sodium chloride 
Sodium deoxycholate monohydrate 
Sodium dodecyl sulfate (SDS) 
Sodium phosphate dibasic 
Sodium phosphate monobasic  
Sodium thiosulfate solution 
Sucrose 
Triton X – 100 
 
 
Table 3-2 Medium & Supplements 
Medium & Supplements Company City, Country 
DMEM High Glucose,  
Fetal Bovine Serum “Gold”   
Nutrient Mixture F12 HAM  
Panserin
TM
 401 
LB Broth 
PAA 
 
Sigma-Aldrich 
Pan Biotech 
Formedium 
Pasching, Austria 
 
Missouri, USA 
Aidenbach, Germany 
Norfolk, UK 
 
 
Table 3-3 Reagents for Cell & Bacteria Culture 
Reagents for Cell & Bacteria Culture Company City, Country 
Ampicillin 
Dexamethasone 
Dimethyl-sulfoxide 
Kanamycine disulfate salt 
Sigma-Aldrich 
 
 
 
Steinheim, Germany 
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Polyethyleneimine (PEI) Missouri, USA 
Lipofectamine Invitrogen  
Matrigel Self made  
Penecillin/Streptomycin 
Trypsin – EDTA 
PAA 
 
Pasching, Austria 
 
 
Table 3-4 Molecular Biologically Reagents 
Molecular Biologically Reagents and Kits Company City, Country 
Restriction & Cloning Enzymes   
EcoRI 
BamHI 
HindIII 
NheI 
PstI 
XhoI 
Antarctic Phosphatase 
T4-Ligase with 10×buffer  
New England Biolabs England 
   
Kits Company City, Country 
Gel extraction and PCR purification Kit 
Mini and Midi Plasmid preparation Kit 
RNeasy Protect Mini Kit 
Quant-iT dsDNA BR Assay Kit 
Quant-iT RNA Assay Kit 
Macherey-Nagel 
 
Quiagen 
Molecular 
Probes/Invitrogen 
Düren, Germany 
 
Hilden, Germany 
Eugene, USA 
 
   
PCR and reverse Transcription Company City, Country 
DNAse 
dNTP’s 
KOD DNA Polymerase with 10×buffer and 
dNTP’s 
Reverse Transcriptase MMLV 10×buffer 
RNAse Block MMLV 
RNAse 
Tag DNA Polymerase with 10×buffe 
New England Biolabs 
 
 
Novagen, Merck 
New England  
 
Biolabs 
England 
 
 
 
Darmstadt, Germany 
 
 
England 
   
Protease Inhibitors Company City, Country 
Foy-305 
Phenymethylsulfonyl-fluoride 
Trasylol 
Sanol - Schwarz 
Sigma - Aldrich 
Bayer 
Reichelsheim, Germany 
Steinheim, Germany 
Leverkusen, Germany 
Protein & DNA Marker & Loading dye Company City, Country 
Kaleidoscop
TM
 Protein Marker Bio Rad California, USA 
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O´GeneRuler
TM
 DNA Ladder Mix 
6×Orange Loading Dye 
RNA Loading buffer 
Fermentas 
 
Sigma-Aldrich 
France 
 
Germany 
 
 
Table 3-5 Antibodies 
Primary Antibodies 
Dilution in 
WB 
Dilution in 
IF 
Source Country 
Actin (mouse mc) 1:3000  
Prof. Brigitte M. 
Jockusch 
University of 
Braunschweig, 
Germany 
Amylase (rabbit pc) 1:2000 1:200 Sigma-Aldrich Missouri, USA 
APP (22C11) (mouse mc) 1:200 1:50 
Prof. Odete da Cruz e 
Silva 
University of 
Aveiro, Portugal 
Carboxypeptidase A (rabbit pc) 1:800 1:800 
Rockland, 
Immunochemicals 
Gilbertsville, PA, 
USA 
Chymase DEAE (pc goat) 1:1000  
LB Schwarz, Dep. of 
Internal Medicine 
Virginia 
Commonwealth 
University, USA 
CEL (pc chicken) 1:88  
Isolated from egg 
yolk (Borta, Aroso et 
al. 2010) 
Marburg, Germany 
Chymotrypsin (pc sheep) 1:2000 1:400 
Inst. for Cytobiology 
& Cytopathology 
Marburg, Germany 
Endolyn78 502 (mc mouse)  1:100 
Gudrun Ihrke, Dep. of 
Cell Biology & 
Anatomy 
Johns Hopkins 
University, 
Baltimore, USA 
GFP (pc rabbit)  1:200 
Invitrogen, Molecular 
Probes 
Eugene, Oregon, 
USA 
GP2 (4A9 mouse mc) 1:2000  A. Lowe Stanford, USA 
MAP2 (pc chicken)  1:5000 
Prof. Ana L. Carvalho, 
Univ. Coimbra 
Abcam, Cambridge, 
England 
Myc (mc mouse)  1:200 
Santa Cruz 
Biotechnology 
Heidelberg, 
Germany 
p115 (mc mouse)  1:200 
Transduction 
Laboratories 
http://www.labom
e.com/ 
PDI R-707 (pc rabbit)  1:500 
HD Sölling, MPI for 
Biophysical 
Chemistry 
Göttingen, 
Germany 
Phalloidin Tritc  1:50 Sigma-Aldrich Missouri, USA 
Piccolo (pc rabbit) 1:2500 1:200 Abcam Cambridge, England 
Piccolo (pc rabbit) 1:2500 1:200 Synaptic Systems 
Göttingen, 
Germany 
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PpiB (pc rabbit) 1:1000 1:600 Abcam Cambridge, England 
PSD95 (mc mouse)  1:200 
Prof. Ana L. Carvalho, 
Univ. Coimbra 
Millipore, 
California, USA 
RNaseA (pc rabbit) 1:1000  Sigma-Aldrich Missouri, USA 
Synaptojanin 1 (pc rabbit)  1:200 Synaptic Systems 
Göttingen, 
Germany 
Synaptophysin (mc mouse) 1:10000  
Prof. Ana L. Carvalho, 
Univ. Coimbra 
Sigma, Missouri, UA 
TGN38 (gp)(works only in rat)  1:200 H. F. Kern Marburg, Germany 
VGlut (pc guinea pig)  1:5000 
Prof. Ana L. Carvalho, 
Univ. Coimbra 
Millipore, 
California, USA 
ZG16p full length (pc rabbit) 1:5000 1:400 A. Lowe Stanford, USA 
ZG16p N1d1 (pc rabbit) 1:2000 1:200 
Cronshagen, Voland 
et al.  1994 
Inst. for 
Cytobiology & 
Cytopathology, MR, 
Germany 1994 
Secondary Antibodies WB IF Company Country 
TRITC Donkey anti Mouse  1:100 
Dianova Germany TRITC Donkey anti Rabbit  1:100 
TRITC Donkey anti Sheep  1:400 
Alexa 488 Donkey anti Rabbit  1:500 
Invitrogen/ 
Molecular Probes 
Leiden, 
Netherlands 
Alexa 488 Goat anti Mouse  1:500 
Alexa 488 Goat anti Rabbit  1:500 
Alexa 647 Goat anti Guinea Pig  1:500 
Prof. Ana L. Carvalho, 
Univ. Coimbra 
 
AMCA Rabbit anti Chicken  1:200 
Prof. Ana L. Carvalho, 
Univ. Coimbra 
Jackson Immuno 
Research, USA 
Hoechst-dye  1:2000 Polysciences, Inc. 
Eppelheim, 
Germany 
HRP Rabbit anti Chicken 1:2000  
Sigma-Aldrich 
Dianova 
Bio Rad 
 
St. Louis, USA 
Heidelb., Germany 
California, USA 
 
HRP Donkey anti Goat  1:2000  
HRP Goat anti Mouse  1:5000  
HRP Goat anti Rabbit  1:5000  
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3.3 Oligonucleotides (Primers) 
 
All primers were synthesised by Eurofins MWG|Operon (Ebersberg, Germany). Cleavage sites for 
restriction enzymes are in italic. All cloning and sequencing primers were designed for genes in 
Rattus norvegicus unless it is noted otherwise. 
 
Table 3-6 Oligonucleotides 
Primer Primer sequence 
Gene Name  & 
Accession number  
Amplified 
area 
Cloning Sequence (5´to 3´)  NCBI Pubmed Fragment 
Amylase-Myc up 
/BamHI 
tt ggatcc atg aag ttc gtt ctg ctg ct  
Amylase 2, pancreatic 
(Amy2), mRNA 
NM_031502 
bp 16 – 1539 
Fragment size 
1523 bp 
Amylase-Myc 
down/Hind III 
 tt aagctt caa ctt tga gtc ggc atg ga  
Amylase-YFP up 
/NheI 
tt gctagc cat gaa gtt cgt tct gct gct  
Amylase-YFP down 
/PstI 
 tt ctgcag caa ctt tga gtc ggc atg ga  
Chymase-Myc up 
/BamHI 
tt ggatcc atg cag gcc cta cta ttc c 
 
mast cell protease 1 
precursor, or chymase 
(RMCP-1) mRNA 
U67915.1 
 
bp 27 – 807 
Fragment size 
780 bp 
Chymase-Myc 
down /EcoRI 
tt gaattc gct tgg aga ctc tga ctc g 
Chymase-YFP up 
/EcoRI 
tt gaattc cca tgc agg ccc tac tat tcc 
Chymase-YFP down 
/BamHI 
tt ggatcc ccg ctt gga gac tct gac tcg 
Trypsinogen-Myc 
up /BamHI 
tt ggatcc atg aag gcc tta att ttc ctt  
 
protease serine 3, or 
cationic trypsinogen 
(Prss3), mRNA 
NM_0173127 
 
bp 1 – 741 
Fragment size 
741 bp 
Trypsinogen-Myc 
down/HindIII 
tt aagctt gtt ggc agc gac ggt ctg ctg    
Trypsinogen-YFP 
up/NheI 
tt gctagc cat gaa ggc ctt aat ttt cct t   
Trypsinogen-YFP 
down/PstI 
tt ctgcag gtt ggc agc gac ggt ctg ctg 
Sequencing and RT-PCR    
Amylase PCR up 
 
Amylase PCR down 
gcc ttc tgg atc ttg cac tc 
 
agt gct tga caa agc cca gt 
Amylase 2, pancreatic 
(Amy2), mRNA 
NM_031502 
bp 542 – 1368 
Fragment size 
827 
Carboxypeptidase 
up 
Carboxypeptidase 
down 
tt ggatcc atg aag aga cta ctg att ctg ag 
 
tt gatatc gta ggg gat gat ctg gga gg 
Carboxypeptidase A1 
(cba1), mRNA  
NM_016998. 
bp 309-1501 
Fragment size 
 1192 bp 
GAPDH1_control 
 
GAPDH2_control 
cca gtg agc ttc ccg ttc agc 
 
 acg acc cct tca ttg acc 
Glyceraldehyde-3-
phosphate 
dehydrogenase, mRNA 
bp 95 – 663 
Fragment size 
589 bp 
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NM_017008.3 
GP2 up 
 
GP2 down 
tt ggatcc atg gtg gct tgt gac ctg ctg 
 
tt gaattc tca gaa cag cca ggc cag gag g 
Pancreatic secretory 
granule membrane 
major glycoprotein, 
mRNA NM_134418.1 
bp 102 - 1694 
Fragment size 
1593 bp 
Piccolo up1 bp121 
Piccolo down1 
bp562 
gga cgg cta cgg gct tct gca 
 tct ttc aag atg atc gtg gac 
 
piccolo (presynaptic 
cytomatrix protein) 
(Pclo), transcript 
variant 2, mRNA. 
NM_001110797 
 
Primer Pair1: 
440 bp, 
Primer Pair2: 
640 bp, 
Primer Pair3: 
750 bp 
Piccolo up2 bp4429 
Piccolo down2 bp 
5070 
gaa agt tag tcc aaa aaa gga 
gtc ttt ttc tga gag gat tct 
Piccolo up3 
bp13921 
Piccolo down3 
bp14650 
 gtc agt cgt gga gaa agg gtc 
  
cgg aga tgg cct tca gat gat 
rFlZG16fwnosta 
 
rFlZG16rvsto 
ctc gag taa tgt tgg cca ttg ccc tct tag  
 
 tat cta gat ctc aac aag tgt tgc agt ggc t 
zymogen granule 
protein 16 (Zg16), rat 
mRNA 
NM_134409.2 
bp 36-566 
Fragment size  
531 bp 
 
3.4 Vectors and Plasmids 
 
For the cloning of C-terminal Myc tagged constructs like Amylase-Myc, Chymase-Myc and 
Trypsinogen-Myc the pCMV-Tag 5A vector from Stratagene, USA was used. For the cloning of C-
terminal GFP tagged constructs like Amylase-GFP, Chymase-GFP and Trypsinogen-GFP the pEYFP-
N1 vector from Clontech, Saint-Germain-en-Laye, France (Glebov and Nichols 2004) was used. For 
verification and as controls the following plasmids were used: YFP-ER (kindly provided by R. Jacob, 
University of Marburg, Germany), ER-Myc-∆SP-ZG16, cloned by M. Gómez-Lázaro and M. Aroso 
form our Laboratory, Carboxypeptidase-Myc and Carboxypeptidase untagged both in pCMV-Tag 
5A and GP2 in pcDNA3 were cloned by H. Borta and F. Faust from our Laboratory and APP-GFP 
(kindly provided by Prof. Odete da Cruz e Silva, University of Aveiro, Portugal).  
 
3.5 Molecular Biology Methods 
 
3.5.1 Extraction of total RNA from Tissue and Cells 
The isolation of mRNA from cultured cells and animal tissue was generally used for 
transcription into cDNA. The obtained cDNA served two different purposes: on one hand, for the 
amplification of a specific gene by PCR and subsequent cloning into an expression vector using the 
RNeasy Protect Mini Kit (Table 3-4) and on the other hand, for the determination of mRNA 
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expression levels by RT-PCR in diverse tissues and cell lines using the Trifast extraction method 
(3.5.1).  
 For isolation using the RNeasy Protect Mini Kit, cultured cells harvested by trypsination 
(3.6) were immediately frozen in liquid nitrogen and stored at –80°C or used directly. Cells were 
homogenized in a 1 mL syringe with a 20 G needle in 1 mL of the provided buffer then following 
the fabricants protocol. Elution was performed using two times 30 µl RNase-free water. Samples 
were measured and directly transcribed into cDNA. 
 For isolation using Trifast, tissue samples of 50 – 100 mg and cells grown in 6 or 10ø cm 
dishes, harvested by trypsination, were directly frozen in liquid nitrogen and either stored at -80°C 
or homogenized directly in 1 mL Trifast with a homogenizer (see section 3.1) for tissue and with a 
1 mL syringe with a 20 G needle for cells. Following the manufactures protocol, lysates of tissue 
and cells were incubated at RT for 5 min before 200 µL of chloroform (CHCl3) were added. 
Samples were shacked vigorously for approximately 15 seconds and kept at RT for 5 – 10 min. 
During centrifugation at 12000×g for 5 – 15 min the mixtures separated into three phases. The 
upper colorless aqueous phase contained RNA, the white interphase DNA and the lower red 
phenol phase proteins. If the upper phase appeared milky, the separation was not completed and 
the samples were re-centrifuged until a complete separation occurred. The upper aqueous phase, 
reassembling approximately 60% of the total volume, was transferred into a new 2 mL reaction 
tube without touching the interphase. RNA was precipitated by adding 1/10 volume of 3 M 
sodium acetate (pH 4.5) and three volumes of absolute ethanol followed by a 30 min to 1 h 
incubation at -20°C. From now on all steps occurred on ice. The RNA was spun down for 10 min at 
12000×g, 4°C and the supernatant was removed carefully. The pellet was washed twice with 1 mL 
ice cold 75% ethanol by vortexing and subsequent centrifugation for 8 min at 7500×g. The RNA 
was air-dried 10 -15 min at RT and dissolved in 30 – 80 µL RNAse free water. RNA concentration 
was determined as described in section (3.5.6). 
 
 
3.5.2 RNA Quality Control by Denaturing Agarose Gel Electrophoresis 
 Prior to the preparation of RNA gels, work space and equipment were cleaned with 70% 
(v/v) ethanol and 10% (v/v) H2O2. For 250 mL of a 1% (w/v) agarose gel 2.5 g agarose powder were 
boiled in 240 mL 1xMOPS buffer, cooled down to 60-50°C and 3.6 µL of a 1% (10 mg/L) EtBr 
solution and 10.7 mL of a 37% (v/v) formaldehyde  solution were added. The solution was poured 
into a horizontal gel chamber and well forming combs were added. 5 µL of RNA sample were 
mixed with 15 µL RNA sample loading buffer (Table 3-4) heated for 10 min at 70°C, shortly chilled 
on ice, spun down and directly loaded onto the agarose gel. Separation occurred at 95 V for 1 h. 
Digital images were taken using the Alpha Imager HP (3.1). 
 
5xMOPS running buffer for RNA gel electrophoresis 
MOPS 100.0 mM  
Na-Acetate 45.0 mM  
EDTA 12.0 mM  
DEPC 0.1% 
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In ddH2O (MilliQ), pH 7.0 
The concentrated buffer was agitated for 4 h at 37°C and autoclaved. 1xMOPS buffer was 
prepared using DEPC water. 
 
 
3.5.3 Reverse Transcription 
 By reverse transcription the relatively instable mRNA is reverse transcribed into 
complementary DNA (cDNA) producing one molecule of cDNA per one molecule of RNA to 
provide a more stable template for subsequent PCR. Per reaction 3 µg of RNA were transcribed 
with reverse transcriptase from the Moloney Murine Leukemia Virus (MMLV) (Table 3-4) using an 
oligo dT primer annealing to the polyA tail of the RNA template during 10 min incubation at RT. 
Transcription occurred at 42°C for 60 - 90 min under softly shaking. The enzyme was inactivated 
at 65°C for 20 min, the sample was shortly cooled on ice and RNA was digested adding 1 µL RNAse 
(0.7 µg/µL). The final cDNA was stored at -80°C. 
 
Standard Reaction Mix for 30 µL 
mRNA 3 µg (x µL) 
dNTP 50×mix (10 mM each) 0.6 µL 
Oligo (dT) primer (100 µM) 2.8 µL 
MMLV-RT 10×buffer  3.0 µL 
MMLV-RT RNase block (40 U/µL) 0.5 µL 
MMLV-reverse transcriptase (200 U/µL) 0.5 µL 
DEPC or MilliQ grade water x.x µL (fill up to a final volume of 30 µL) 
 
 
3.5.4 Semi-Quantitative RT-PCR 
 Semi-quantitative RT-PCR was applied to determine the mRNA expression levels of genes 
in different cells and tissues under certain stimuli e.g. culture conditions, developmental state, 
differentiation etc. For this type of PCR generally Taq (termophilus aquaticus) polymerase with a 
low proofreading capacity was used. Before the actual semi-quantitative PCR, the exponential 
phase for each template was determined by taking samples of 10 µL during and after the PCR 
reaction at cycle 12, 18, 24, 30 and 35 (after last cycle). Samples were then separated on an 
agarose gel (3.5.5), compared to an appropriate control (GAPDH) and the optimal cycle number 
for each template was chosen. For semi-quantitative RT-PCR´s, the same quantity of cDNA (3.5.3) 
was employed (150 ng in a 50 µL reaction) for all samples. Samples belonging to one set of 
experiments were run simultaneously. To rule out eventual pipetting errors reactions were 
repeated with the same set of samples two to three times. To evaluate the sample quality at least 
three independent sets of samples per experimental approach were performed. For analysis, 
generally the entire reaction mixture was loaded on an agarose gel (3.5.5), since some templates 
exhibited very low expression levels under certain conditions. 
32 
 
Standard Reaction Mix for 50 µL 
Template cDNA  1.5 µL (150 ng) 
Primer forward (0.2 µM/µL)  1.0 µL 
Primer reverse (0.2 µM/µL) 1.0 µL 
NEB dNTP’s (2 mM each)  1.0 µL 
Taq Pol 10xBuffer  5.0 µL 
Taq DNA polymerase (5 U/µL)  0.5 µL 
ddH2O  x.x µL to fill up to a final volume of 50 µL 
 
 
Table 3-7 Programs for Semi-Quantitative RT-PCR 
Amylase CBP GAPDH GP2 ZG16 
94°C  1 min 
94°C  30 sec 
52°C  30 sec     28 
72°C  1 min 
72°C  4 min 
  4°C  hold 
94°C  1 min 
94°C  30 sec 
55°C  30 sec     28 
72°C  1 min 
72°C  4 min 
  4°C  hold 
94°C  1 min 
94°C  30 sec 
51°C  30 sec     28 
72°C  1 min 
72°C  4 min 
  4°C  hold 
94°C  1 min 
94°C  30 sec 
55°C  30 sec     28 
72°C  1 min 
72°C  4 min 
  4°C  hold 
94°C  1 min 
94°C  30 sec 
60°C  30 sec      35 
72°C  20 sec   
72°C  2 min 
  4°C  hold 
The cycle numbers to each program are written behind the brackets. 
 
 
3.5.5 Cloning and Amplification of Plasmids 
 For the cloning of plasmid constructs, gene specific primer sequences were chosen and 
used to amplify the coding sequence of selected rat genes. Cloning vectors used are listed in 
section 3.4, primers, templates; restriction enzymes and fragment size are listed in Table 3-6. For 
sequence sensitive PCR´s as required for cloning, generally the KOD DNA polymerase from 
Thermococcus kodakaraensis with increased proofreading was used. Annealing temperatures 
were adjusted to the respective primer pairs, generally 4-7 degrees under the empirical melting 
temperature of primers given by the fabricant. Elongation times were chosen depending on 
template length; respecting that the polymerase can amplify approximately 1000 bp/min, even 
thought the amplification time is as well depending on the type of polymerase. Preparative 
restriction was carried out at 37°C overnight. An analytical restriction after ligation and plasmid 
amplification from bacterial clones was completed during 4 h at 37°C. Resulting PCR and 
restriction products were separated on a 1% (w/v) agarose gel using a 1xTris-Acetate-EDTA (TAE) 
buffer. Afterwards, selected bands were purified with Gel and PCR purification Kits (Table 3-4). 
Prior to ligation, digested and purified vectors were dephosphorylated to avoid false positives 
through re-ligation. For ligation, first DNA concentrations of vector and insert were determined by 
comparing equal amounts of each to the co-migrated DNA ladder on an agarose gel. The molecule 
ratios chosen between vector and insert were mostly between 1:3 and 1:5 following the 
estimated calculation: 
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 The cDNA was cloned in frame into cloning vectors (3.4). In frame insertion of all 
constructs was verified by sequencing (MWG). Correct constructs (1 µL plasmid for reproduction 
or 10 µL ligation mix) were chemically transformed into a 100 µL aliquot of competent bacteria. 
Therefore, cells were incubated for 30 min on ice followed by a 2 min heat shock at 42°C for DNA 
uptake. After a 2 min chilling on ice, bacteria were provided with 900 µL LB medium, agitated for 
45 min at 37°C for recovery and were spread on antibiotic containing LB-agar plates (100 mg/mL 
Ampicillin or 30 µg/mL Kanamycin) for selection. Plates were incubated overnight at 37°C. For test 
cultures, colonies were inoculated in 5 mL LB containing a selective antibiotic and were grown 
overnight 37°C. Two milliliter of culture were used for plasmid purification with subsequent test 
digestion. The remaining solution was kept at 4°C for later use or stocks with 50% glycerol were 
frozen at -80°C. Plasmid isolation occurred at two different scales as mini from 2 mL of a 5 mL 
overnight culture or as midi from 200 mL overnight culture. Mini preparations for sequencing and 
midi preparations in general were done with the mini or midi plasmid purification kits from 
Macherey-Nagel (Table 3-4) following the manufactures protocol. After purification, preparations 
were air-dried and taken up in ddH2OMilliQ (35-50 µL for Mini and 400 µL for Midi). For all steps 
appropriate controls were done simultaneously. Enzymes and Kits were used according to the 
fabricants instruction. 
 
Standard PCR Reaction Mix for 50 µL 
Template DNA x.x µL mostly 0.2 µL of plasmid DNA or 1 µL of cDNA 
Primer forward (0.1 µM /µL)  0.5 µL 
Primer reverse (0.1 µM /µL) 0.5 µL 
KOD dNTP’s (2 mM each)  5.0 µL 
KOD MgSO4 (25 mM)  2.0 µL 
KOD 10xBuffer  5.0 µL 
KOD hot start DNA polymerase (1 U/µL)  1.0 µL 
ddH2O  x.x µL (to fill up to a final volume of 50 µL) 
 
 
Table 3-8 Programs for Cloning PCR 
Amylase-YFP/Myc Chymase-YFP/Myc Trypsinogen-YFP/Myc 
 
94°C  2 min 
94°C  30 sec 
56°C  30 sec          38 cycles 
72°C  1.5 min 
72°C  5 min 
  4°C  hold 
 
94°C  2 min 
94°C  30 sec 
60°C  30 sec          38 cycles 
72°C  1.5 min 
72°C  5 min 
  4°C  hold 
94°C  2 min 
94°C  30 sec 
62°C  30 sec       20 cycles 
72°C  45 sec 
94°C  30 sec 
50°C  30 sec       20 cycles 
72°C  45 sec 
72°C  4 min 
  4°C  hold 
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50xTris-Acetate-EDTA (TAE) buffer  
Tris/Base 40 mM  
Acetic Acid 20 mM  
EDTA 1 mM  
In ddH2O, pH 8.0 
 
 
3.5.6 Quantification of DNA and RNA  
 DNA concentrations were measured with the Qubit quantification kit (Table 3-4) following 
the manufactures protocol. RNA concentrations were determined using a nanodrop ND 1000 (3.1) 
first calibrated with 1 µL ddH2O (MilliQ quality) followed by subsequent measuring of 1 µL of each 
sample. 
 In between each sample, the optical lens was carefully cleaned with appropriate paper 
and MilliQ water. From time to time, a blank was measured to ascertain the lens is clean. The 
nanodrop measures the optical density at a wavelength area from 200 – 350 nm. RNA has equal 
to DNA an absorption maximum at 260 nm. As proteins absorb light at a wavelength of 280 nm, 
the ratio of the OD260/280 provides information to determine the purity of a RNA preparation. A 
clean RNA preparation should have an OD ratio 260/280 of 2.0, although depending on the pH a 
pure sample can result in values below 2.0 when resuspend in water instead of TE buffer. 
Furthermore, the OD ratio of 260/230 was determined which should be close to 2.0 as well. At 
220-230 nm, three sources of contaminations can produce peaks, these are proteins, chaotropic 
salts like guanidinium isothiocyanate and phenol coming from the isolation process. 
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3.6 Cell Culture 
 
Table 3-9 Cell Lines 
Cell line and Origin Characteristics Source 
AR42J; pancreatic exocrine tumor 
(Rattus norvegicus, Wister strain9 
 
Adherent only when plated on matrigel 
coated surfaces, can be induced with 
dexamethasone for differentiation to 
acinar like cells 
 
ATCC, Rockville/USA, 
CRL-1492 
COS-7; kidney, African green 
monkey (Ceropithecus aethiops) 
 
SV40 transformed, produce large T 
antigen, adherent, fibroblast 
morphology 
 
SH-SY5Y; brain, neuroblastoma 
taken from bone marrow 
metastasis, human (Homo 
sapiens) 
These cells grow as a mix of floating and 
adherent cells 
 
ATCC, Rockville/USA; 
CRL-2266 
PhD Miriam Fernandes-
Fernandes, Albacete, 
Spain 
 
 The most common buffer applied in cell culture (but also in immunofluorescence, 
immunoblotting etc.) was 1xPBS buffer with a pH of 7.35. 1×PBS was applied to keep cells in a 
stable, isotonic and physiological environment. 
  
10xPhosphate buffer saline (PBS) 
NaCl 1.37 M 
KCl 27 mM 
Na2HPO4 * 2H2O 80 mM 
KH2PO4 15 mM 
In dH2O, pH 7.35 
For the 1xPBS working solution the pH was readjusted to 7.35.  
 
 
3.6.1 Maintenance of Mammalian Cells in Culture 
AR42J and COS-7 cells were cultured in Dulbecco’s modified Eagle medium (DMEM) high glucose 
(4.5 g/L) supplemented with 10% (v/v) FBS, 100 U/mL Penicillin, and 100 µg/mL Streptomycin 
(Faust, Gomez-Lazaro et al. 2008).  
 
SH-SY5Y were cultured in a medium mix of 1:1 DMEM and Ham´s F12 medium supplemented with 
15% (v/v) FBS, 100 U/mL Penicillin, and 100 µg/mL Streptomycin. The DMEM usually contained 
1.5 g/L sodium bicarbonate, 2 mM L-Glutamine. 
ATCC, Rockville/USA, 
CRL-1651 
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In general, cells were cultured at 37°C, 5% CO2, and 95% humidity. Cell culture work was 
performed in a sterile laminar flow safety cabinet and all materials and solutions were sterilized 
by filtration, autoclaving or heat sterilization. Routinely, cells were grown in 10ø cm dishes and 
seeded on coverslips in 6ø cm dishes for immunofluorescence experiments. Cell number was 
determined using a Fuchs-Rosenthal counting chamber.  
 
 
3.6.2 Differentiation of AR42J Cells with Dexamethasone 
 AR42J cells were either cultured as described in section 3.6.1 (Faust, Gomez-Lazaro et al. 
2008) or 8 h after seeding cells were washed twice with PBS and the medium was exchanged to 
the serum free Panserin
TM
 401 containing 100 U/mL Penicillin, and 100 µg/mL Streptomycin. To 
improve cell adherence, culture dishes and coverslips were coated with an extract from 
Engelbreth-Holm-Swarm tumor (matrigel), (Kleinman, McGoodwin et al. 1979). For statistical 
analysis of growth & induction cells were prior to seeding washed with PBS buffer pH 7.35, 
trypsinised and counted in DMEM medium under a Leica DMIL microscope (Leitz, Wetzlar, 
Germany) with a Fuchs-Rosenthal counting chamber. Cells were seeded at a defined number of 
0.5*10
6
 cells/dish using 6ø cm dishes containing coverslips for immunofluorescence (IMF) and for 
counting in the same type of dishes without coverslips. To induce differentiation and zymogen 
granule formation, cells were incubated with 10 nM dexamethasone (Swarovsky, Steinhilber et al. 
1988) for 2-6 days added 24 h after seeding. To optimize culture conditions and maintain equal 
concentrations of dexamethasone during experiments the medium was exchanged daily and 
dexamethasone was added freshly. For time-course experiments cells for IMF were fixed at 24, 
48, 72, 96, 120 and 144 h and for cell counting cells were trypsinised at the same time points and 
counted as described before. For immunoblotting cells were seed in a defined number of 1.4*10
6
 
cells per 10ø cm and lysed (3.8.4) after 48 and 72 h, or cells were collected for RNA extraction 
(3.5.1). Medium samples from 48 and 72 h were taken from dishes in which the medium was not 
exchanged daily to achieve an enrichment of secreted proteins. 
 
 
3.6.3 Transfection of Cultured Cells 
 Several methods were applied for the transfection of mammalian cells with plasmid DNA 
to allow expression of the encoded proteins. The method of choice is depending on cell type, 
application and the plasmid DNA itself. In this study only transient transfection methods were 
performed based on different mechanisms of DNA uptake, e.g. endocytosis or membrane fusion. 
The transfection efficiency, cell mortality, and morphological alterations on the cells vary in 
between the different methods, cell types, and conditions used, thus requiring optimization of the 
transfection method for each cell line and application.   
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3.6.3.1 PEI Transfection 
 For morphological studies like immunofluorescence COS-7 cells were usually transfected 
using PEI (polyethylenimine). The cationic and branched polymer PEI binds the negatively charged 
DNA backbone which allows endocytotic uptake of the complex by the cells. Once inside the cell, 
protonation of the amines results in an influx of counter-ions and water into the vesicle thus 
lowering the osmotic potential. As a result of the osmotic swelling the vesicles burst and releases 
the PEI/DNA complex (polyplex) into the cytoplasm where it than can diffuse to the nuclei in a 
microtubule independent manner. The correct DNA/PEI ratio is crucial for optimal complex 
formation. 
 24 hours before transfection cells were seeded in 6ø cm dishes containing coverslips. 10 
µg DNA were diluted in 750 µL 150 mM sodium chloride, and 100 µL PEI (0.9-1 mg/mL in dH2O) 
were mixed with 650 µL sodium chloride solution. After 15 minutes of incubation at RT the PEI 
solution was added drop-wise to the DNA solution and the mixture was incubated for additional 
20 minutes. 500 µL of the mixture were added drop-wise to 2.5 mL pre-warmed medium into the 
cell dish and the cells were incubated for 3 to 6 h at 37°C. Afterwards, the cells were washed with 
PBS and incubated for 24 - 48 h in fresh medium before fixation and processing for 
immunofluorescence (3.7.1). 
 
 
3.6.3.2 Electroporation of AR42J and COS-7 Cells 
Electroporation is a dynamic phenomenon that depends on the local transmembrane 
voltage at each point on the cell membrane. For electroporation in a cuvette it is required to have 
cells in suspension. For some cell types electroporation results in a high mortality rate, but the 
advantage of this technique is high transfection efficiency and the possibility to transfect cells 
which are usually difficult to transfect using chemical methods. For electroporation, AR42J or 
COS-7 cells were grown to 90% confluence and harvested by trypsination, resuspend in 1 mL 
complete DMEM for AR42J, or in 1 mL HBS buffer (20 mM HEPES, 137 mM NaCl, 5 mM KCl, 6 mM 
dextrose, 0.7 mM Na2HPO4, pH 7.15, sterile) for COS-7. Then 0.5 mL of the cell suspension were 
transferred to a sterile 0.4 cm gap electroporation cuvette containing 10 μg of DNA. 
Electroporation was performed in an ECM 630 Electro Cell Manipulator (3.1) at 250 V (AR42J) 
(Faust, Gomez-Lazaro et al. 2008) or 230 V (COS-7), 1500 μF and 125 Ω. After electroporation, 
cells were immediately resuspended in complete medium, plated on cover slips, which were 
uncoated for COS-7 but coated with matrigel for AR42J. To differentiate transfected AR42J cells, 
10 nM dexamethasone was added 24 h after electroporation and cells were processed for 
immunofluorescence after 48 - 72 h. COS-7 cells were used for immunofluorescence 24 - 48 h 
after electroporation. 
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3.7 Microscopy 
  
 In this work an Olympus IX81 (inverted) microscope was used for morphological studies 
and digital images were taken with the CCD camera F-View II. For co-localization studies a 
Confocal Zeiss LSM 510 was applied together with associated software. In immunofluorescence 
(IMF) protocols applied on cells, the non-ionic detergent Triton X-100 (standard detergent) and 
the surfactant sodium dodecyl sulfate (SDS) were used for permeabilisation and compared with 
each other. Triton X-100 creates holes in the cell membrane by removing lipids without disturbing 
protein-protein interactions. In order to reveal epitopes which may be masked for antibodies SDS 
can used to induce slight denaturation of proteins in fixed cells. For washing in all 
immunofluorescence and immunohistochemical methods 1xPBS was used. 
 
Mounting medium Mowiol Stock 
Mowiol 4-88   12 g 
PBS 40 mL, stir overnight 
Glycerol 20 mL, stir overnight 
The viscous solution was centrifuged for 1 h at 27216×g (15000 rpm) at 4°C (High Speed 
Centrifuge - Avanti
TM
 J-25I from Beckman Coulter, 3.1). The supernatant was taken and 0.1% (w/v) 
sodium azide was added. The final working solution consisted of 3 parts Mowiol with 1 part n-
propyl gallate solution as bleaching protection. 
 
n-propyl-gallate Stock 
N-propyl gallate 2.5% (w/v) 
Glycerol 50% (v/v)   in PBS, pH 7.35 
Note: All further mentioned solutions for IMF and IHC were prepared in PBS. 
 
 
3.7.1 Indirect IMF with Cultured Cells 
Cells from rat primary neuronal culture were kindly provided by Prof. A.L. Carvalho and 
were prepared by S. Santos (Neurosciences, University of Coimbra, Portugal). All other cell types 
were cultured in our laboratory. All steps occurred at RT and between all steps cells were washed 
softly 3-6 times with PBS. Cells grown on glass cover-slips (1-14 days, depending on cell type) 
were fixed for 20 min with 4% (w/v) para-formaldehyde (PFA) or in the case of primary neuronal 
culture, cells were fixed for 15 min with a solution of 4% (w/v) PFA/4% (w/v) sucrose. The samples 
were permeabilised either for 10 min with 0.2% (w/v) Triton X-100, (neuronal culture with 0.25% 
Triton X-100 for 5 min), or for 5 min with 1% (w/v) SDS and blocked afterwards with 1% (w/v) BSA 
for 10 min (neuronal culture for 30 min with 10% BSA). Subsequently, coverslips were incubated 
for 1 h at RT (neuronal culture for 1-2 h at 37°C) with 30 µL primary and secondary antibodies 
prepared in 1xPBS buffer or for primary neuronal culture in 3% (w/v) BSA. Antibody dilutions were 
spun down for 5 min at maximum speed directly before use. During antibody incubation, cells 
were kept in a humid and dark environment. If several primary or secondary antibodies were 
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applied the incubation occurred simultaneously. Finally, coverslips were washed in dH2O to 
prevent crystal formation through buffer salts, drained carefully, mounted with Mowiol on glass-
slides and dried overnight before microscopic examination. For primary culture, coverslips were 
mounted on glass-slides using Dako and dried for 1 h at RT. In a final step, these coverslips were 
sealed with nail-polisher and air-dried for 15 min before microscopic examination. For dilution of 
antibodies see Table 3-5. For occasional visualization of the nuclei Hoechst dye 33528 was used in 
a concentration of 0.2 µg/mL for 2-5 min after antibody incubation. Hoechst 33528 is a 
fluorescent dye that is excitable with ultraviolet light at 359 nm and it emits light at 461 nm 
appearing blue when it is intercalated between the bases of the DNA. 
 
 
3.7.2 Quantification and Statistical Analysis of Zymogen Granule Formation in AR42J 
cells 
AR42J controls and cells stimulated for zymogen granule (ZG) formation were 
immunostained with an antibody to Carboxypeptidase A as zymogen granule marker, Nuclei were 
stained with Hoechst 33528 (Table 3-1 and 3.7.1). For evaluation after Amylase-YFP, Trypsinogen-
YFP, Carboxypeptidase-Myc, Myc-ZG16p and GP2 expression cells were co-labelled with an 
antibody directed to Chymotrypsinogen as ZG marker. For quantitative analysis of granule 
morphology in AR42J cells, 100-200 cells per coverslip were examined and categorized under the 
fluorescence microscope and on photographs as cells with ‘granular’, ‘intermediate’ or ‘vesicular’ 
structures. Analysis was done blind. Cells defined as ‘granular’ contained numerous heavily 
stained secretory granules; cells defined as ‘intermediate’ contained both granule-like/granular 
and small vesicular structures exhibiting a faint staining; cells defined as ‘vesicular’ exhibited a 
fine punctate staining pattern. Four coverslips per preparation were analyzed, and 4-6 
independent experiments were performed. Quantitative analysis of ultrastructural alterations of 
granules after different experimental treatments was performed on EM micrographs. Sections 
were randomly photographed at a magnification of 3000-12000×. The results of the quantitative 
analysis presented were from 3-4 independent experiments. Significant differences between 
experimental groups were detected by analysis of variance for unpaired variables using Microsoft 
Excel. Data are presented as means ± S.D., with an unpaired t-test used to determine statistical 
differences. P-values <0.05 are considered as significant, and p-values <0.01 are considered as 
highly significant. Data analysis and preparation of diagrams were done using Microsoft Excel 
software.  
 
 
3.7.3 Immunohistochemical Methods 
3.7.3.1 Tissue Fixation 
The isolation of mouse tissue was performed through Prof. E. Martin (Department of medical 
sciences, University of Castalia-La Mancha, Albacete, Spain) via perfusion of mice with 4% (w/v) 
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PFA. All further steps of tissue fixation until cryo-sectioning were performed under the 
observation and with help of Dr. M. Fernandez-Fernandez and Dr. M.G. Lazaro. 
For post fixation, the isolated organs were first incubated overnight at 4°C in 4% (w/v) PFA 
afterwards organs were washed several times with 1×PBS and then incubated in 15% (w/v) 
sucrose at 4°C until they sagged to the bottom of the incubation vial. In a last step the solution 
was changed to 30% (w/v) sucrose and organs were incubated again until they sagged to the 
ground. 
 
 
3.7.3.2 Tissue Freezing & Cryosectioning 
Organs were embedded in Tissue-Tek® O.C.T.™ Compound (optimal cutting temperature), 
a water soluble material consistent of resins and glycols, as follows. Organs were placed in 
disposable plastic embedding molds with approximately 5 mL O.C.T –compound until total 
covering and tissue orientations, type of tissue and date were marked on the mold. 2-
methylbutane was pre-cooled in liquid nitrogen and samples were immersed until they were 
totally frozen. Samples were then stored at -80°C. For cryosectioning frozen, O.C.T.-embedded 
specimens were taken out of the mold, glued to cryostat chucks with O.C.T - compound and 
chilled in the cryostat chamber until a temperature of -23°C was reached, approximately 1 h.  
After trimming, 15-20 µm sections were cut, mounted on acid-treated superfrost plus glass slides 
and were allowed to air dry for approximately 1 h at RT before storing at -20°C. Cryosectioning 
was performed using a Microm HM 550 Cryostat from Thermo Scientific (Walldorf, Germany). 
 
 
3.7.3.3 Immunostaining of Tissue (IHC) 
Before IHC, cryosections were taken out of -20°C and air-dried for 30 min. Tissue pieces 
placed on the same slide were surrounded with a wax pen (PAP-PEN) for separation. The entire 
protocol occurred at RT and except for antibody incubations; slides were softly agitated in all 
other steps covered with approximately 200 µL of liquid. All solutions used were prepared in 
1×PBS. For permeabilisation, samples were incubated three times for 10 min in 0.25% (v/v) Triton 
X-100 and were then blocked in a solution of 0.25% (v/v) Triton X-100 and 4% (w/v) BSA for 1 h. 
Tissue pieces were next incubated with 200 µL of primary antibodies diluted in a solution of Triton 
X-100 0.25% (v/v) and 1% (w/v) BSA for 3 h. Afterwards the specimen were incubated with 200 µL 
of secondary antibodies for 1 h diluted in 1% (w/v) BSA. Between and after antibody incubation 
samples were washed three times for 10 min with PBS. For nuclei staining the samples were 
incubated with Hoechst dye 33528 in a concentration of 0.2 µg/mL in PBS for 10 - 15 min. 
Afterwards, slides were washed once for 2 min in PBS. Finally, slides were drained carefully, 
mounted with Mowiol and dried overnight before microscopic examination. 
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3.7.3.4 Electron Microscopy with Cupromeric Blue 
Proteoglycan staining was performed according to the Cupromeronic Blue

 (CmB, 
Seikagaku Corp., Tokyo, Japan) procedure at a critical electrolyte concentration developed by 
Scott (Scott 1980; Scott 1985). Pancreatic tissue was postfixed with 1% glutaraldehyde for 30 min 
and stained overnight in 25 mM sodium acetate, pH 5.7, containing 0.5% glutaraldehyde, 0.05% 
CmB and 0.3 M MgCl2. At this electrolyte concentration highly sulfated acidic glucosaminoglycan 
side chains of proteoglycans are preferentially stained by CmB (Scott 1985). After three washes in 
acetate-MgCl2, specimens were contrasted with 0.5% sodium tungstate (Scott, Orford et al. 1981) 
in water and in 50% ethanol, dehydrated in an ascending series of ethanol and embedded in 
Epon. For routine electron microscopy (EM), pancreatic lobules were fixed according to Ito and 
Karnovsky (1968). Isolated ZGM fractions were fixed in 0.1% cacodylate buffer, pH 7.3 containing 
1% glutaraldehyde (Serva, Heidelberg, Germany). Specimens were postfixed in 1% osmium 
tetroxide and embedded in Epon according to standard procedures. Thin sections of 70 nm were 
stained with uranyl acetate/lead citrate and examined using a Zeiss EM 109 electron microscope, 
performed by B. Agricola, University of Marburg.  
 
 
3.7.3.5 Immunoelectron Microscopy 
Tissue from rat pancreas and rat tongue was fixed in 0.1 M cacodylate buffer, pH 7.35 
containing 2% paraformaldehyde and 0.1% Glutaraldehyde (Serva, Heidelberg, Germany). The 
samples were dehydrated in a graded series of alcohol, embedded in Lowicryl K4M (Polysciences 
Ltd., Eppenheim, Germany) and polymerized at 20°C and UV light (360 nm) for 48-72 h. Thin 
sections (70 nm) were incubated with polyclonal antibodies directed to Chymase (1:200-1:500) 
and visualized using a 10 nm Protein A-Gold solution (J. Slot, University of Utrecht, The 
Netherlands) at a dilution of 1:60 or 1:70, both in 0.5% BSA in PBS. Sections were stained with 
uranyl acetate/lead citrate and examined using a Zeiss EM 109 electron microscope (Oberkochen, 
Germany), performed by B. Agricola, University of Marburg. The labeling density (gold 
particles/µm
2
) on ZG and control regions was determined manually on images with the same 
magnification.  
 
 
3.8 Tissue and Cell Preparation Methods  
 
3.8.1 Isolation of Zymogen Granules  
 
Tissue samples from 200 - 300 g Wister rats were kindly provided by the Instituto de Ciências 
Biomédicas Abel Salazar (ICBAS), Porto, Portugal or the Medical Faculty and Centre for 
Neurosciences, Coimbra, Portugal. 
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Homogenisation buffer for zymogen granule isolation: 
Sucrose 250 mM  
MES, pH 6.25 0.5 mM  
MgSO4 0.1 mM in dH2O 
Protease inhibitors were added in the following final concentrations directly before use:  Trasylol 
2.5 mM, Foy-305 0.01 mM and PMSF 0.1 mM. All buffers were kept on ice and the entire protocol 
was conducted at 4°C.  
 
 For homogenization, each pancreas was minced manually in 1 mL homogenisation buffer 
with a scissor. Then homogenization buffer was added up to a final volume of approximately 10 
mL and the tissue was homogenized at 2000 rpm with a homogenizer (IKA, Jellowline OST 20 
digital, 3.1) making 15-20 strokes against the rotating Teflon-pistil. The initial homogenate was 
centrifuged at 500×g for 10 min, the resulting post nuclear supernatant (SN1) was transferred into 
a new tube and centrifuged for 10 min at 2000×g to sediment ZG resulting in (SN2) and (P2). The 
sedimentation of ZG was repeated with (SN2) resulting in (SN3) and (P3). Each time, the brownish 
layer of mitochondria on top of the pellet was separated from the white zymogen granules and 
both fractions were collected in homogenization buffer. To increase the yield SN3 was joined with 
P1 and the whole procedure starting with the homogenisation was repeated two more times. 
Since the mitochondrial layer is less compact than the ZG layer, it could easily be removed by a 
careful wash with homogenisation buffer aspirating the resuspended mitochondria. Both 
mitochondria and ZG fractions were centrifuged for 20 min at 2000×g. Finally, supernatants were 
discarded and the mitochondria and ZG layers were separated from each other via careful 
pipetting. The remaining white ZG pellet was lysed in 0.25 mL to 3 mL of 50 mM Hepes buffer (pH 
8.0), depending on the amount of ZG obtained, and was stored at -20°C. All centrifugation steps 
occurred in an Eppendorf centrifuge 5810R with a swinging bucket rotor (3.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: ZG isolation scheme 
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3.8.2 Zymogen Granule Subfractionation 
 All steps applied take place at 4°C. Zymogen granules were lysed by a freezing and 
thawing cycle in 50 mM Hepes buffer, pH 8.0. After lysis ZG content (ZGC) and ZG membranes 
(ZGM) were separated by centrifugation at 100000×g for 30 min in an Ultracentrifuge Optima
TM
 LE 
80K with a Rotor Type 80 Ti (3.1). The supernatant forming the content fraction (ZGC) was 
collected and frozen at -20°C. To remove ZGC residues from the ZGM pellet, the pellet was 
carefully washed with a small amount of Hepes buffer. Afterwards the membrane pellet was 
resuspended in 300 – 1000 µL of Hepes buffer, depending on pellet size. The membranes were 
rinsed, resuspended in Hepes buffer and treated with 150 mM Na2CO3, pH 11.5 for 2 h on ice. 
Treated membranes (ZGMwashed) were recovered by centrifugation at 100000×g for 30 min and 
thereby separated from peripheral membrane proteins (Wash). The pellet was resuspended in 50 
mM Hepes (pH 8.0) and both fractions were stored at -20°C. 
 
 
3.8.3 Synaptosome Isolation from Rat Brain Tissue 
Synaptosomes are the isolated neuronal terminals. They are easy to prepare and rich in 
synaptic vesicles thus representing an optimal source for synaptic vesicle proteins. The 
enrichment of synaptic vesicles through isolation of synaptosomes followed a protocol from the 
group of Prof. P. Gonzalvez (University of Aveiro) based on the method of (Hajos 1975). 
 
SV homogenisation buffer:  0.32 M sucrose 
pH 7.4  10 mM Hepes 
 10 mM Tris Base 
 Protease inhibitors were added in the following final concentrations directly before use:  
Trasylol 2.5 mM, Foy-305 0.01 mM and PMSF 0.1 mM. The centrifuge used for this protocol was 
an Avanti
TM
 J-25I with a fixed angle rotor JA 25.50 (3.1).  
 The brain was submerged in 10 mL SV homo buffer minced with a scissor and thereafter 
homogenized with ca. 25 strokes using a homogenizer (IKA, Jellowline OST 20 digital, 3.1). After a 
10 min centrifugation at 1500×g, the nuclear sediment was removed and the supernatant 
centrifuged at 9616×g for 20 min. While the resulting supernatant was discarded, the pellet 
fraction was resuspended in 1 mL of SV homogenisation buffer and carefully layered on top of 7.5 
mL 0.8 M sucrose in 10 mM Hepes-Tris buffer. If a different volume was used the ratio of 1:7.5 
between the brain suspension and the gradient solution was maintained. The gradient solution 
overlaid by the brain homogenate was centrifuged for 30 min at 9616×g. The resulting gradient 
had a thin brownish top layer representing myelin, a relatively big middle layer containing the 
synaptosomes and a pellet mainly consistent of mitochondria. The synaptosome fraction was 
collected carefully and a 1:1 dilution in 10 mM Hepes-Tris buffer, pH 7.4 (without sucrose) was 
prepared. Synaptosomes were pelleted in a final centrifugation step at 20000×g for 30 min. The 
supernatant was discarded while synaptosomes were resuspend in a small amount of SV 
homogenisation buffer and frozen at -20°C. 
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3.8.4 Preparation of Cell Lysates 
For the preparation of cell lysates, cells grown to confluence on 10ø cm cell culture dishes 
were washed with 5 mL PBS and placed on ice. Adding 1 mL PBS, cells were detached from the 
surface with a cell scrapper and pelleted at 500×g for 3 min at 4°C. The cell pellet was suspended 
in 250 µL lysis buffer and homogenized by 15–20 up and down strokes in a 1 mL syringe with a 26 
G x ½, 0.45 x 13 mm needle. The final solution was stored at -20°C. Alternatively, cells were quick 
lysed with SDS to obtain a whole cell lysate avoiding the degradation of protease-sensitive 
proteins. A 2% SDS solution (in dH2O) was heated up to 100°C and 1 mL of the hot solution was 
pipetted directly into a 10ø cm cell culture dish with cells grown to confluence. The cells were 
lysed immediately by pipetting the hot solution 5–6 times up and down. The sample was then 
transferred to a 1.5 mL reaction tube, boiled for 10 min at 95°C and afterwards stored at -20°C for 
later use.  
 
Lysis Buffer for cell lysates 
Tris-HCL 25 mM 
NaCl 50 mM 
Deoxycholate 0.5% (w/v) 
Triton X-100 1.5 mM (0.5%) 
In dH2O, pH 8.0 
Protease inhibitors were added in the following final concentrations directly before use:  Trasylol 
2.5 mM, Foy-305 0.01 mM and PMSF 0.1 mM. 
 
 
3.8.5 Measurement of Protein Concentrations 
Protein concentrations were determined using the Bradford assay (Bradford 1976). For 
the Bradford assay the Bio-Rad Protein Assay-Dye Reagent concentrate was used following the 
manufactures protocol. The Bradford assay can be disturbed by Triton X-100 (> 0.5%), SDS (> 
0.1%), and sodium deoxycholate (Lottspeich and Engels, 2006). For that reason, protein 
concentrations of cell lysates obtained with the quick SDS lysing method were measured with the 
Qubit quantification kit (Table 3-4) following the manufactures protocol.  
 
 
3.8.6 Protein Precipitation 
To purify samples and to diminish their volumes protein solutions were precipitated using 
either trichchloroactic acid (TCA) or chloroform-methanol (Wessel and Flugge 1984). The 
chloroform-methanol method of protein precipitation removes SDS, Triton X-100, salts and β-
mercaptoethanol from the sample. For the precipitation with chloroform-methanol, one sample 
volume was mixed with three volumes of methanol plus one volume of chloroform and vortexed 
thoroughly. Further three volumes of dH2O were added and the mixture was once more vortexed. 
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The cloudy solution was centrifuged at 10000×g at RT for 3 min until the emulsion partitioned into 
three phases. The aqueous upper phase was removed carefully without touching the interface 
containing the protein. Proteins were precipitated adding three volumes of methanol to the 
remaining phases. After mixing, a 3 min centrifugation step at 10000×g followed. The pellet was 
washed once with methanol and air-dried for 10 min. Samples were resuspend in 3×Laemmli 
buffer and used for SDS-PAGE (3.9.2). 
TCA precipitation was carried out as follows: one sample volume was mixed with one 
volume of 20% (w/v) TCA and incubated on ice for 15 - 20 min. The mix was centrifuged for 10 
min at 10000×g and 4°C and the pellet was washed one time with 5% TCA. To remove TCA from 
the pellet, the pellet was washed two times with 1 mL ice-cold acetone and centrifuged as before. 
Samples were then air-dried, resuspend in 3×Laemmli buffer and used for SDS-PAGE (3.9.2).  
 
 3xSDS-Sample buffer (Laemmli, 1970) 
1 M Tris-HCl, pH 6.8 60 mM  
Glycerol 10% (w/v)  
 SDS 2% (w/v)  
Bromphenol blue 0.005% (w/v)  
Dithiothreitol (DTT) 20 mM  
β-Mercaptoethanol 5% (v/v)  
In dH2O   
 
 
 
3.9 Biochemical Methods  
 
3.9.1 2D-Gel Electrophoresis 
The first dimension of 2D-gel electrophoresis was performed in a horizontal apparatus 
(Ettan IPGphor, GE Healthcare, San Francisco, USA). Granule subfractions were precipitated with 
20% TCA (ratio 1:1). Protein samples (300 µg) were solubilised for 30 min at 30°C in rehydration 
buffer (Rabilloud 1998). The samples were then applied onto IPG strips (11 cm, pH 3-11) and 
isoelectric focusing was conducted at 20°C with 50 µA, for a minimum of 10 h at 50 V, 1 h at 500 
V, 1 h at 1000 V and 110 min at 8000 V. The strips were afterwards incubated for 15 min in 
equilibration buffer containing 6 M urea, 75 mM Tris-HCL pH 8.8, 34.5% Glycerol (87%), 2% SDS, 
0.002% bromophenol blue and 1.5 mM DTT and then applied on top of a SDS-PAGE gel (14 cm by 
14 cm, 15%). Proteins were separated according to molecular weight in a Hoefer 600 SE RUBY 
chamber (3.1). For tryptic digestion, the SDS-PAGE were stained using colloidal Coomassie blue 
and silver staining (3.9.6 and 3.9.7). 
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3.9.2 1D-SDS Polyacrylamide Gel-Electrophoresis (SDS-PAGE) 
 Following the discontinuous tris-chloride/tris-glycine buffer systems according to 
(Laemmli 1970), proteins were separated in a running gel with a pH of 8.8.  As standard was used, 
a 12.5% running gel over layered by a 4% stacking gel with a pH of 6.8. For the separation of high 
molecular weight proteins and complexes either gradient gels with various different compositions 
from minimal 3% to maximal 16% with and without stacking gel, or low percentage gels of 5% or 
7% with a 3% stacking gels were applied (see list for gel composition down). Protein markers used 
were the pre-stained molecular weight markers Kaleidoscope (Table 3-4). The sample-running 
front was visualized by bromophenol blue contained in the sample-loading buffer. Gel 
electrophoresis in mini slap-gel chambers was conducted at 80 V until the proteins entered the 
running gel and continued at 100 V for approximately 90 min. Electrophoresis of larger gels (e.g. 
gradient gels) was performed approximately four hours. Gels were afterwards used either for 
immunoblotting (3.9.3) or isolated bands were prepared for mass spectrometry (3.10.1, 3.10.2, 
3.10.3) by Coomassie-silver staining (3.9.6 and 3.9.7). 
 
Stacking gel 5 mL (15 mL for big gels) 3%  4%   
30% PAA x.xx mL  0.63 mL 0.83 mL 
1 M Tris-HCl, pH 6.8 0.63 mL 
dH2O x.xx mL  3.63 mL 3.43 mL 
20 (w/v) % SDS 25 µL 
10% (w/v) APS 40 µL 
TEMED  5 µL 
 
 
Running gel 10 mL (30-40 mL for big gels) 3% 5% 7.5% 10% 12.5% 16%  
30% PAA x.xx mL  0.97 1.67 2.5 3.33 4.17 5.33 
2 M Tris-HCl, pH 8.8 1.86 mL 
dH2O x.xx mL  7.06 6.40 5.56 4.73 3.89 2.73 
20% (w/v) SDS 50 µL 
10% (w/v) APS 30 µL 
TEMED 5 µL 
 
 SDS-Running buffer 
Tris/Base 25 mM  
Glycin 190 mM  
SDS 0.1% (w/v)  in dH2O 
 
 
3.9.3 Immunoblotting 
 For antibody detection, proteins previously separated on a SDS-PAGE (3.9.2) were 
electrophoretically transferred (blotted) to a membrane, which could be either nitrocellulose (NC) 
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or polyvinylidene fluoride (PVDF). PVDF is more adequate for hydrophobic proteins. For blotting, 
3 mm Whatman papers and membranes were soaked in blotting buffer. PVDF membranes first 
had to be equilibrated in 100% methanol for 1 min at RT. A pile of one 3 mm Whatman paper, one 
membrane, the gel and again one 3 mm Whatman paper was prepared and embedded air was 
removed. The transfer occurred from the cathode to the anode at 12 V for 1 h in the semidry 
blotter (Trans-blot SD Semidry transfer cell, 3.1) used for proteins of 10 - 120 kDa. For high 
molecular weight proteins and complexes, a Hoefer TE22 Mini or TE42 Standard Tank blot system 
was applied see section 3.1. Wet blotting succeeded water-cooled, between 4 and 16 h 
depending on the application. Each method required its own buffer, which are listed down. The 
effectiveness of transfer was examined with Ponceau S. For washing of immunoblots 1xPBS buffer 
(section 3.7) was applied, in some cases completed to a 1xPBS-Tween buffer containing 
additionally 0.1% (v/v) Tween-20. Tween-20 is a mild non-ionic detergent used as wetting agent. 
Membranes were blocked for 1 h at RT with 5% low fat milk in PBS. Antibody dilutions were 
prepared either in PBS, PBS-Tween (PBS with 0.1% (v/v) Tween 20) or in blocking solution 
depending on the antibody. Membranes were incubated in primary antibody solution with 
agitation for 1–4 h at RT or overnight at 4°C. Then membranes were washed three times for 10 
min at RT followed by incubation in a solution of horseradish peroxidase-conjugated secondary 
antibody for 1–2 h at RT. Membranes were washed again in PBS three times for 10 min at RT. For 
the enhanced chemiluminescence (ECL) reaction, ECL 1 (containing luminol) and ECL 2 (containing 
H2O2 as enhancer) solutions were mixed in a ratio of 1:1 and membranes were incubated for 2 
minutes. Film exposure (3 to 30 minutes), development and fixation were performed in a dark 
room. For presentation and quantification films were scanned with a Bio-Rad GS-710 Calibrated 
Imaging Densitometer (3.1) and densitometric analysis for quantification was done using Bio-Rad 
Laboratories Quantity One software.   
 
Components Tank blot buffer   Semidry blot buffer  
Tris/Base 25 mM 48 mM 
Glycine 192 mM 39 mM 
Methanol 20% (v/v) 20% (v/v) 
20% SDS --------- 0.4% (w/v) 
In dH2O 
 
Ponceau S-solution  
Ponceau 0.2% (w/v) 
Acetic acid 3% (v/v)  
In dH2O 
 
 
3.9.4 Quantification of Proteins by Immunoblotting 
 To determine, if a ZG constituent is part of the ZGC or the ZGM, a dilution series with both 
fractions was performed. Samples with 1-14 µg of a ZGM fraction and 140 µg of ZCG fraction were 
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prepared and filled up with Hepes buffer to achieve an equal volume for all samples. Then, the 
same amount of 3xleammli buffer was added to all tubes and samples were heated for 5 min at 
95°C directly before loading onto a 12.5% SDS gel. On another gel with the same composition, 
samples from 0.5-12 µg of a ZGC fraction (treated as described before) were loaded together with 
140 µg of a ZGM fraction. Both gels were blotted onto nitrocellulose and incubated with 
antibodies to GP2 (ZGM marker protein), Amylase (ZGC marker protein), ZG16p and Chymase as 
described in section 3.9.3. For quantification, immunoblots were scanned and ZGC to ZGM 
concentration ratios were measured and computed by defining the band density and the 
corresponding background using a GS-710 Calibrated Densitometer together with the Quantity 
One 4.3.1 software. The distribution of total ZG proteins (approx. 95% content proteins and 5% 
membrane-bound proteins) was taken into account to calculate the ratios and percentages of 
total protein distribution between ZGC and ZGM. Results for this experiment are shown in 
Chapter 4. 
 
 
3.9.5 IgG Precipitation of Immunsera with Ammonium Sulfate 
 Serum fractions (1 mL) from antibodies were precipitated using ammonium sulfate. 
Samples were continuously kept at 4°C or on ice and sera obtained from different bleedings were 
treated separately. First, to precipitate IgG´s, one volume of serum was mixed drop by drop with 
one volume of a saturated ammonium sulfate solution (100% NH4SO4) resulting in a 50% NH4SO4 
and centrifuged for 10 min at 10000×g. The pellet was slurred with a small self made glass pestle 
and washed. Washing succeeded in 1.5 mL 40% NH4SO4 buffer followed by a 10 min centrifugation 
at 10000×g. The washing step was repeated until the resulting pellet appeared snow white. The 
pellet was solved in 400 µL sodium phosphate (Na2PO4) buffer pH 7.4 by rotation for 30 min 4°C. 
Then the sample was dialysed overnight in 1 L 10 mM Na2PO4 buffer pH 7.4. Precipitates were 
removed by a 10 min centrifugation at 10000×g. The resulting supernatant was re-dialysed for 5 h 
as before and the exact volume was defined. The protein concentration was determined and IgG´s 
were precipitated with 100% NH4SO4 in a 1:1 ratio adding the solution drop by drop. The 
precipitate was centrifuged at 10000×g for 10 min and the pellet was resuspend in 40% NH4SO4 so 
that a final concentration of 10 µg/µL protein was obtained. Aliquots were stored at 4°C. Note: It 
is important to vortex antibodies directly before use when kept in an ammonium sulfate solution! 
 
Saturated Ammonium sulfate (100% NH4SO4) buffer 
Tris-HCl, pH 8.0 20 mM  
EDTA 1 mM 
NH4SO4 ~4.1 M 
 
40% NH4SO4 buffer 
Mixture of 2.5 : 1 Tris-HCl, 1 mM EDTA, pH8.0 with 100% NH4SO4  
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Sodium phosphate (Na2PO4) buffer, pH 7.4 
10 mM Na2HPO4, pH ~9.0 
10 mM NaH2PO4, pH ~4.0  
Buffers were titrated against each other until a pH of 7.4 was reached. For 1 L of Na2PO4, pH 7.4 
approximately 810 mL Na2HPO4, pH ~9.0 were mixed with 190 mL NaH2PO4, pH ~4.0. 
 
 
3.9.6 Staining with Colloidal Coomassie Brilliant Blue G-250 
This protocol can be applied prior to silver staining for subsequent MS/MS analysis. Gels 
were fixed agitating for 1 h in 10% (v/v) acetic acid in 40% (v/v) methanol, followed by a washing 
step in distilled water. Staining was performed for 2 h in 0.12% (w/v) coomassie G250 in 20% (v/v) 
methanol. To wash out unbound Coomassie-G250 and visualize protein bands, gels were 
destained by washing in dH2O for 1-2 min followed by several times washing in destaining solution 
containing 25% (v/v) methanol. Gels were then kept in dH2O, digitalized for documentation and in 
some cases further processed for silver staining. For long term storage (2-4 weeks) gels were 
transferred into an aqueous solution containing 10% (v/v) ethanol and 20% (v/v) glycerol and 
were stored at 4°C.  
 
 
3.9.7 Subsequent Silver Staining 
 Coomassie-G250´s detection limit for proteins is around 0.2–0.5 µg while with silver 
staining less than 1 ng of protein can be detected. To visualize low abundant proteins the 
following silver staining protocol was applied to coomassie stained gels.  
 For a subsequent silver staining, gels were washed twice with dH2O and than fixed for 1 h 
in a solution of 50% (v/v) methanol, 12% (v/v) acidic acid (CH3COOH), 0.05% (v/v) formaldehyde 
(60 µL from a 37% solution in 500 mL) followed by three times 20 min washing in 50% methanol. 
A two minutes sensitizing step was carried out in a solution of 0.02% (w/v) thiosulfate (Na2S2O3), 
then gels were washed three times in dH2O. To avoid silver oxidation, from now on all work was 
performed in a dark environment. For silver staining, gels were incubated for 20 – 30 min in a 
solution of 0.2% (w/v) AgNO3 and 0.076% (v/v) formaldehyde. Formaldehyde was added freshly 
directly before use. After two times washing for 1 min in dH2O gels were developed in a solution 
of 6% (w/v) potassium carbonate (K2CO3), 0.05% (v/v) formaldehyde and 0.00004% (w/v) 
thiosulfate (Na2S2O3). To stop the staining, gels were transferred to a solution of 50% (v/v) 
methanol and 12% (v/v) acidic acid. For storage, the gels were kept in 0.1% (v/v) acidic acid 
containing 0.1% (w/v) sodium azid to avoid contamination.  
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3.10 Proteomics Methods 
 
3.10.1 Tryptic Digestion of Proteins from Coomassie-Silver Stained Gels 
 Tryptic digestion and MS/MS analysis follow the protocol from (Vitorino, Lobo et al. 
2004). To avoid contamination the working area was properly cleaned with 70% ethanol and all 
solutions applied were prepared in ddH2O. Protein bands of stained gels were excised under a 
hood and each band by itself was chopped again in smaller pieces to guarantee a better excess of 
trypsin to the proteins trapped in the gel matrix. Samples were placed in a 96 well rack with 
wholes on the bottom of each well and the position of each sample was documented. This rack 
was fixed to a bottom rack to which a vacuum could be applied. Like this, liquids were removed 
from samples and collected by applying a soft vacuum in the lower rack. Gel pieces were 
destained twice by adding 50 µL of a 50 mM sodium thiosulfate (Na2S2O3) and 15 mM potassium-
ferrocyanite (KFeCN) solution to each well and incubation for 30 min at RT. The supernatant was 
removed and gel pieces were washed three times by adding 100 µL 25 mM ammonium 
bicarbonate (NH4HCO3) in 50% acetonitrile (ACN) and incubation for 30 min at RT. Followed by a 
final washing step with 40 µL 100% ACN for 10 min at RT. Gel pieces were dried in a SpeedVac 
(Thermo Savant) for 10 – 15 min. For tryptic digestion, 25 µL of 0.01 µg/µL sequence grade 
modified porcine trypsin in 25 mM ammonium bicarbonate were added to each sample and 
incubated overnight at 37°C. By addition of 30 µL of 10% (v/v) formic acid (CH2O2) and incubation 
for 30 min at RT the digestion was stopped and peptides were extracted. To increase the peptide 
yield, gel pieces were additionally washed twice for 30 min at RT with 50 µL 10% (v/v) formic acid 
with 50% (v/v) ACN. All supernatants collected were joined and lyophilised in a SpeedVac for 4 h 
at RT. Afterwards, pellets were resuspend in 10 µL of 50% (v/v) ACN with 0.1% (v/v) trifluoroacetic 
acid (TFA) and carefully vortexed. 
 
 
3.10.2 Matrix Embedding of Samples from Tryptic Digestion for MS/MS Analysis  
 First, the MALDI target plate was washed softly in the following sequence: dH2O, 
methanol, ACN and Isopropanol, afterwards, the plate was polished. Then, samples (3.10.1) were 
mixed 1:1 with matrix solution (saturated α-cyano-4-hydroxycinnamic acid prepared in 50% 
acetonitrile with 0.1% formic acid). Two times 0.5 µL of each sample mixture were spotted onto 
the MALDI target plate. Each sample was pipetted in duplicates and their positions were 
documented. In between and after sample application the plate was allowed to dry for 5 min at 
RT. 
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3.10.3 Mass Spectrometry 
Peptide mass spectra were obtained on a MALDI-TOF/TOF mass spectrometer (4800 Proteomics 
Analyzer, Applied Biosystems, Europe, 3.1) in the positive ion reflector mode. Spectra were 
acquired in a mass range between 800 and 4500 Da with ca. 1500 laser shots. Up to six of the 
most intense ion signals per shot position (peaks) were selected excluding those coming from the 
matrix, trypsin autolysis, or acrylamide peaks. Trypsin autolysis peaks were used for internal 
calibration of the mass spectra, allowing a routine mass accuracy more than 20 ppm. 
 
 
3.10.4 Liquid Chromatography Separation and Mass Spectrometry 
For in solution digestion, 1 µg of ZGWash, ZGMwashed, or ZGM were digested using 
sequencing grade trypsin in a proportion of 1:20 and incubated overnight according to the 
manufacturer instructions. Liquid chromatography (LC) separation was performed using an 
Ultimate 3000 (Dionex/LC Packings, 3.1). Twenty microliters of each sample (corresponding to 1 
µg of protein) were injected into a Zorbax 300SB-C18 trapping column with 5 µm particle size (3.1) 
using an LcPackings Probot auto sampler (3.1). The sample was washed while bound to the 
trapping column for 3 min with 95% buffer A (ddH2O, 0.1% TFA) and 5% Buffer B (acetonitrile, 
0.1% TFA) at a flow rate of 30 μL/min. The sample was eluted into a Zorbax 300SB-C18 capillary 
analytical column with 3.5 μm particle size (3.1) by reversing the flow and at a flow rate of 0.3 
μL/min. A linear gradient of 5 to 55% Buffer B was run over a period of 35 min. Afterwards, the 
column was washed by applying a 3 min gradient from 55 to 90% Buffer B, followed by a 5 min 
hold at 90% Buffer B. The column was then re-equilibrated in 5% Buffer B prior to future analyses. 
The eluted peptides were directly deposited on 384-well MALDI plates at 20 s intervals for each 
spot using a Probot (3.1) adding 170 nL of matrix solution (prepared by diluting saturated α-
cyano-4-hydroxycinnamic acid with 70% acetonitrile and 0.1% TFA including 10 fmol of an internal 
standard). 
 
 
3.10.5 Mass Spectrometry Data Acquisition 
Spectra were processed and analysed by the Global Protein Server Workstation (Applied 
BioSystems, Foster City, CA, USA), which uses internal Mascot (Matrix Science Ltd, U.K.) software 
for searching the peptide mass fingerprints and MS/MS data. Searches were performed against 
the NCBI non-redundant protein database for Rattus norvegicus.  
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3.11 Computational Method to Compile a Phylogenetic Tree 
 
A Phylogenetic tree was compiled using BLAST pair wise alignments for proteins (BLASTP 
2.2.25+) (Altschul, Madden et al. 1997; Altschul, Wootton et al. 2005) from NCBI with the 
following parameters: tree method: neighbour joining, maximal sequence difference 0.7. The 
maximum allowed fraction of mismatched bases in the aligned region between any pair of 
sequences. If the fraction of mismatched bases for any pair of sequences was larger than this 
value, both sequences were excluded from the tree generation. The accuracy of this prediction 
decreases as the fraction of mismatched bases increases. Hence, for larger values of Max Seq 
Difference (> 0.6) sequence grouping is often accurate, but the lengths of paths between very 
dissimilar sequences can be inaccurate. Double sequences were excluded prior to the tree 
compiling. For the tree view, the BLAST tree view tool from NCBI was chosen using the fast 
minimum evolution tree method. 
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Chapter 4  Analysis of Low Abundant Membrane-Associated Proteins 
from Rat Pancreatic Zymogen Granules 
 
The exocrine pancreas served as the model that first established the role of intracellular 
compartments in the secretory pathway (Palade 1975), and ZG have been used as a model system 
to study secretory granule biogenesis and regulated secretion in general. As briefly outlined ( see 
Introduction 1.3), the molecular mechanisms required for ZG formation at the TGN, for packaging 
and sorting of cargo proteins, as well as for granule fusion and exocytosis are still poorly defined 
reviewed in (Schrader 2004; Borgonovo, Ouwendijk et al. 2006; Dikeakos and Reudelhuber 2007; 
Williams, Chen et al. 2009). According to recent models (see Introduction 1.3), part of the 
molecular machinery required for digestive enzyme sorting, granule trafficking and exocytosis is 
supposed to be associated with the granule membrane (ZGM). In addition to basic research 
interests ZG play as well important roles in pancreatic injury and disease (Gaisano and Gorelick 
2009; Husain and Thrower 2009) (see Introduction 1.1). It is well documented that mis-sorting of 
zymogens to lysosomes or the basolateral membrane domain can lead to acinar cell injury and 
pancreatic disease (e.g. to pancreatitis; see Introduction 1.1). Unravelling the molecular 
machinery that mediates the proper trafficking of potentially damaging proteases to distinct 
membrane domains by specific coat, adapter, and Rab proteins, is therefore of great biological 
and clinical importance. Thus, there is currently great interest in the identification and molecular 
characterization of ZG and ZGM components by conducting antibody screens, raft analyses as well 
as proteomics (Schmidt, Dartsch et al. 2000; Schmidt, Schrader et al. 2001; Kalus, Hodel et al. 
2002; Chen, Walker et al. 2006; Berkane, Nguyen et al. 2007; Rindler, Xu et al. 2007). 
As indicated (see Introduction 1.7), ZG are best suited for subcellular (and suborganellar) 
proteomics, as they represent abundant organelles of the exocrine pancreas, which can be easily 
isolated and purified due to their large size and density. In addition, their isolation yields large 
quantities of organelles and proteins. Furthermore, intact ZG can be lysed at pH 8 (see Figure 12 
and Methods 3.8.2) and further separated into a content (ZGC) and membrane (ZGM) fraction. 
This reflects the physiological conditions, as the ZGC proteins become soluble in the alkaline 
environment of the pancreatic duct, where bicarbonate is secreted to neutralize stomach acid in 
the small intestine. ZGM fractions can be further purified by potassium bromide and/or carbonate 
treatment at pH 11 and subsequent (gradient) centrifugation to enrich transmembrane and 
membrane-anchored proteins (ZGMwashed) or peripheral ZGM proteins (ZGWash) (Hoops and 
Rindler 1991; Schmidt, Dartsch et al. 2000; Chen, Walker et al. 2006; Chen and Andrews 2008) 
(see Figure 12, Methods 3.8.2). 
Our laboratory is applying various different proteomics approaches to identify new and 
also low abundant ZGM constituents (Figure 12). For instance, the application of doubledSDS-
PAGE, an approach optimized for the analysis of hydrophobic membrane proteins (Schagger and 
von Jagow 1991), led to the discovery of the small GTPase Rab8A at the ZGM (Faust, Gomez-
Lazaro et al. 2008). These findings were verified by immunoblotting, immunofluorescence and 
knock-down experiments, and our studies revealed that Rab8A has a role early on in ZG formation 
at the Golgi complex (Faust, Gomez-Lazaro et al. 2008).  
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In an earlier study from our group using an old-fashioned 2D-gel electrophoresis approach 
applied to the ZGWash fraction, various different acidic and basic proteins were detected, e.g. the 
serpin ZG46p, GP2, the lectin ZG16p, lipase and carboxypeptidase (Schmidt, Dartsch et al. 2000). 
We recently continued with the further analysis of the ZGWash fraction by 2D-SDS PAGE (3.9.1) in 
a team approach by applying a modern and advanced set up (see Methods 3.1). We initially 
focused on the “basic” group of peripheral ZGM proteins (pH range 6.2-11) with about 46 spots, 
among which 44 were identified and assigned to 15 unique proteins by mass spectrometry 
(3.10.3, 3.10.5, Figure 12). The separation of the ZGWash subfraction, which was obtained by a 
carbonate treatment of the ZGM, was performed by two-dimensional IEF/SDS-PAGE followed by 
Coomassie staining. For isoelectric focusing, 300 µg of protein were separated on 11 cm IPG strips 
(pH 3-11NL) and on 15% polyacrylamide gels in the 2
nd 
dimension (see Methods 3.9.2). The 
predicted intracellular distribution of the identified proteins is represented in the pie chart 
Figure 12: Methods applied by our group, for the separation of ZG and subsequent mass spectroscopic 
analysis of ZG subfractions 
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diagram of Figure 13. The 15 unique proteins (Table 4-1) were categorized in 6 groups based on 
their known subcellular localization: ZGC (n=6; 38%) and ZGM (n=6; 38%) proteins, mast cell 
proteins (n=1; 6%), ER resident proteins (n=1; 6%), and proteins with other localizations (n=2; 
12%) (Figure 13). Based on their predicted biological functions we identified 12 enzymes including 
9 digestive enzymes (usually attributed to the ZGC), 2 matrix (ZG16p, syncollin) and 3 slightly 
acidic glycoproteins (CEL, pancreatic lipase related protein 1 and 2). Based on literature and the 
Protein Knowledgebase (UniProtKB), all of the identified proteins are supposed to be soluble or 
peripheral membrane proteins, and no transmembrane proteins or membrane-anchored proteins 
have been identified in the wash fraction. Furthermore, except for two cytosolic proteins (vinculin 
(fragment), an actin-binding protein, and ubiquitin carrier protein involved in 
ubiquitination/quality control) all identified proteins are supposed to be components of the 
secretory pathway. This further confirms the applicability of the carbonate and gel-based 
proteomic approach. In addition, some classical content proteins such as amylase, elastase, 
colipase and triacylglycerol lipase were identified in the wash fraction (Table 4-1). This can be due 
to a cross-contamination of the subfractions or due to the fact that the interactions established 
between the proteins from the different subfractions are not completely disrupted in the 
separation procedure. The identification of some abundant theoretical acidic proteins within the 
“basic” group (e.g. CEL, lipase related protein 1) is likely to be a result of protein degradation 
and/or deglycosylation. 
While increased instrument sensitivity allows the identification of many more low 
abundant proteins, it also uncovers more potential contaminating proteins. Thus, it is important 
to validate the localization of proteins of interest, which in the case of ZG proteins, is mainly done 
by antibody-based technologies. Thus, some of the low abundant proteins identified in our 
approach were selected for further analysis to verify their ZG localisation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In the table, functional 
annotation and organelle 
assignments were made 
using the UniprotKB 
database, additional 
annotation was incorporated 
from literature search. The 
diagram on the next page 
illustrates the intracellular 
distribution of the identified 
proteins of the wash 
fraction. On the basis of 
published data, annotations 
in databases or predictions 
based on similarity to related 
proteins, the identified 
proteins were grouped in a 
pie chart according to their 
subcellular distribution and 
function. The Figure is taken 
from Borta, Aroso et al 2010. 
 
Table 4-1 Identified “basic”
Proteins 
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4.1 Rat Mast Cell Protease 1 (RMCP-1)/Chymase is a New ZGM Associated 
Protein 
 
The serine protease Chymase (RMCP-1), which was so far only described in mast cell 
granules (Pejler and Maccarana 1994; Pejler and Berg 1995; Pejler and Sadler 1999), was 
identified in the ZGWash fraction by suborganellar proteomics using a 2D-SDS PAGE approach 
combined with tandem mass spectrometry (Figure 12). By immunoblotting of a duplicate of the 
2D-gel using a specific antibody, Chymase was confirmed to be present in the ZGWash fraction 
(Borta, Aroso et al. 2010). Thus, the enzyme was selected for further analysis. To examine the 
distribution of Chymase among ZG subfractions, equal amounts of protein from the four 
subfractions (ZGC, ZGM, ZGMwashed and ZGWash) were separated on 12.5% acrylamide gels and 
immunoblotted using an antibody directed to Chymase (Figure 14). Furthermore, to assess a 
proper granule subfractionation, antibodies to the granule marker proteins Amylase, GP2, and 
ZG16p were used. As shown in Figure 14, immunoreactivity for Amylase was mainly found in the 
ZGC fraction, whereas GP2, a major GPI-anchored glycoprotein of ZG, was predominantly present 
in the ZGM fraction. The secretory lectin ZG16p, a peripheral ZGM protein (Cronshagen, Voland et 
al. 1994), was concentrated on isolated ZGM, and a major portion was liberated by carbonate 
treatment (Figure 14 and Figure 15 B). Interestingly, Chymase showed a very similar distribution 
pattern like ZG16p. The enzyme was associated with isolated ZGM, but barely detectable in the 
ZGC fraction. Upon carbonate-treatment, the majority of Chymase was removed from the ZGM 
and found in the ZGWash fraction indicating that the protein is a peripheral component of the 
ZGM (Figure 14). To exclude a contamination of the ZG subfractions with granules from mast cells 
(e.g. from pancreatic tissue), an antibody to Tryptase β1, a prominent mast cell marker, was 
applied. A lysate of rat tongue tissue, which is rich in mast cells containing RMCP-1, was used as a 
positive control. Both, Tryptase β1 and Chymase, were detected in lysates of rat tongue but in 
contrast to Chymase, Tryptaseβ1 was absent in ZG subfractions (Figure 14). 
 
 
Figure 13: Diagram of the intracellular distribution of the 
identified proteins of the “basic group” from the wash 
fraction. 
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In order to provide a quantitative approach, I performed dilution series of the ZGC and the ZGM 
fractions, which were analyzed by immunoblotting with specific antibodies to Chymase, Amylase, 
GP2 and ZG16p. The intensities of the corresponding signals were determined by densitometric 
measurements and the ratios of the proteins in the ZGC to ZGM fractions were calculated using 
these titration curves (Figure 15). 
A ZGC to ZGM concentration ratio of 1:46 was calculated for Chymase, indicating an 
enrichment of Chymase in the membrane fraction. Interestingly, a similar concentration ratio was 
obtained for the secretory lectin ZG16p, a peripheral membrane protein. In contrast, Amylase was 
highly enriched in the ZGC fraction (about 80:1) and GP2, a GPI-anchored protein of the ZGM, was 
highly enriched in the ZGM fraction (about 1:93.3). The calculations take into account that 
approximately 95% of the total ZG proteins are constituted by content proteins and 5% by 
membrane-bound proteins. This implicates that about 70% of total Chymase are associated with 
the ZGM fraction. In contrast, only 0.06% of total Amylase is recovered in the membrane fraction, 
and 99.94% in the content fraction. The values for the prominently membrane-associated 
proteins are presumably even higher, as the proteins are partially liberated from the membranes 
during the isolation procedure.  
 
(A) Lysed granules were separated into a content (ZGC) and membrane fraction (ZGM). In addition, isolated 
membranes were treated with Na2CO3 at pH 11.5 and separated into pellet (ZGMwashed) and supernatant 
(Wash) fractions. Equal amounts of protein (20 μg) were run on 12.5% acrylamide gels, blotted onto 
nitrocellulose membranes and incubated with antibodies to Amylase (ZGC marker protein), GP2 (ZGM 
marker protein), ZG16p (peripheral ZGM marker protein), Chymase and Tryptase β1 (mast cell control). (B) 
Densitometric quantification of immunoblots shown in (A). The distribution of the labeling density to ZGC 
and ZGM (% labeling density of total ZGC + ZGM) as well as the distribution of the labeling density to 
ZGMwashed and ZGWash (% labelling density of total ZGM) is depicted (see Figure 15). Note that the overall 
distribution of Chymase resembles that of ZG16p, a peripheral ZGM marker protein. A lysate from rat 
tongue served as control for the detection of mast cell proteins. 
Figure 14: Chymase represents a peripheral membrane protein of rat ZG. 
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More stringent conditions for the isolation and subfractionation of ZG, e.g. a high salt 
buffer, recovering of ZGM in a 0.3 M/1 M sucrose gradient to avoid pelleting, and extensive 
washing in 100 mM NaHCO3 pH 8.1, did not lead to any alteration of the distribution of Chymase 
and ZG16p. Only Amylase was more efficiently removed from the ZGM (Borta, Aroso et al. 2010). 
Thus, it can be excluded that not all of the content is solubilized and that aggregated zymogens 
might sediment with the membranes. The minor amount of amylase found in the ZGM fractions is 
as well an indicator for complete ZG lysis and solubilization of the granule content (at least of 
amylase-containing complexes). Furthermore, membrane-association of some content proteins 
was also observed by others after more stringent washing/purification conditions and gradient 
centrifugation (Chen, Walker et al. 2006; Rindler, Xu et al. 2007). 
 
 
(A) Dilution series of ZGC and ZGM subfractions were analyzed by immunoblotting. (B) ZGC to ZGM 
concentration ratios were calculated using densitometry of the corresponding signals from the 
immunoblots using a GS-710 Calibrated Densitometer together with the Quantity One 4.3.1 software. The 
distribution of total ZG proteins (approx. 95% content proteins and 5% membrane-bound proteins) was 
taken into account to calculate the ratios and percentages of total protein distribution between ZGC and 
ZGM. Note that Amylase, a classical content marker, shows 80 fold enrichment in the ZGC fraction with 
only 0.06% of total Amylase found within the ZGM fraction. 
Figure 15: Determination of the ratio between the ZGC and ZGM quantities of Chymase, ZG16p, GP2 and 
Amylase. 
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4.2 Chymase is Sorted to Secretory Granules in Pancreatic AR42J Cells 
 
 To examine if exogenously expressed Chymase is sorted to ZG, rat pancreatic AR42J cells 
were treated with the glucocorticoid dexamethasone to initiate their differentiation into acinar-
like cells and the de novo formation of electron-opaque secretory granules containing the major 
pancreatic zymogens (Logsdon, Moessner et al. 1985) (see Introduction 1.7). Granule formation 
was usually induced 24 h after plating by the addition of 10 nM dexamethasone, and cells were 
processed after 2-3 days. RT-PCR with mRNA from stimulated and control AR42J cells revealed 
that Chymase was not endogenously expressed under our experimental conditions (Figure 16 L). It 
is known that AR42J cells do not express all ZG proteins found in rat pancreas (Yu, Hao et al. 
2004). Thus, AR42J cells were transfected with a generated construct coding for a Chymase-YFP 
fusion protein (see Methods 3.5.5 and 3.6.3, Figure 16 A-C) or an YFP containing an ER-targeting 
signal (YFP-ER) (Figure 16 D-I) and stimulated for granule formation. After 2-3 days, cells were 
processed for indirect immunofluorescence (see Methods 3.7.1) using antibodies to 
Carboxypeptidase A (Figure 16 B, E). Dexamethasone-treatment resulted in the formation of 
numerous characteristic granules positive for Carboxypeptidase A. Confocal microscopy (see 
Methods 3.8) revealed that many of these granules showed a co-localization with Chymase-YFP 
(Figure 16 A, C), whereas the control YFP-ER localized mainly to the Golgi complex in AR42J cells 
(Figure 16 G-I), and not to secretory granules (Figure 16 D, F). As additional controls, a VSVG-GFP 
and YFP-GPI fusion protein were expressed in AR42J cells, but were not observed to be sorted to 
secretory granules. The fusion proteins were instead targeted to the plasma membrane in AR42J 
cells (Faust, Gomez-Lazaro et al. 2008). This shows that the YFP tag does not interfere with the 
protein targeting and sorting to the specific cellular compartments occurs unrestricted. 
Quantification by pixel-by-pixel analysis from confocal images revealed a co-localization 
coefficient of 77 ± 18% (n=6, 15 z-planes from each cell) for Chymase-YFP and Carboxypeptidase A 
(Figure 16 K). These findings demonstrate that rat mast cell Chymase enters the secretory 
pathway and is properly sorted to ZG in AR42J cells, an acinar model system. 
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AR42J cells were transfected with a Chymase-YFP construct (A), a p-EYFP-ER construct (D, G) or a p-EYFP-N1 
vector (J), stimulated for granule formation and processed for indirect immunofluorescence 72 hours after 
transfection using antibodies directed to Carboxypeptidase A (CBP) (B, E) and the Golgi marker P115 (H). 
Overlays (Merge) of the confocal images (A-B; D-E; G-H) are shown in (C, F, I). Arrows point to some 
granules showing colocalisation of Chymase-YFP and CBP. EYFP-ER localizes mainly to the Golgi complex and 
is not targeted to granules in AR42J cells. Cytosolic YFP (J) is not targeted to granules either. (K) Quantitative 
correlation analysis. Image analysis was carried out with the Zeiss LSM 510 4.0 software (Carl Zeiss 
MicroImaging, Inc.). The correlation plot describes the pixel colocalisation depending on their intensity in 
the Alexa 488 (for Chymase-YFP) and TRITC (for CBP) channels with region 3 displaying colocalising pixels, 
whereas regions 1 and 2 contain the non-colocalising pixels for each label, respectively. The signals below 
the background (indicated by the axes) in each picture were not included in the quantification of the 
colocalisation coefficients. An average value of 77% of colocalisation has been obtained measured from 6 
cells (15 z-planes from each cell) with a standard deviation of 18%. (L) RT-PCR of mRNA isolated from AR42J 
cells (treated with 10 nM dexamethasone) (a) and from rat tongue (t) (positive control for Chymase 
expression). GAPDH was used as a loading control. Note that Chymase is not endogenously expressed in 
pancreatic acinar AR42J cells. Scale bars, 10 µm. 
 
Figure 16: Chymase is targeted to zymogen granules in pancreatic acinar AR42J cells. 
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4.3 Chymase Locates to ZG in Rat Pancreatic Tissue 
 
By immunohistological and ultrastructural studies which were performed in cooperation 
with B. Agricola (University of Marburg, Germany) the localization of endogenous Chymase to ZG 
in rat pancreatic tissue could be confirmed  (Figure 17). For this approach (see Method 3.7.3.3), 
frozen sections of rat pancreas were incubated with specific antibodies directed to Chymase and 
to Carboxypeptidase A, a prominent granule marker protein (Figure 17 A, B). Chymase was 
observed to colocalize with Carboxypeptidase A over the granule region/zymogen granules 
surrounding the acinar lumen (Figure 17 C). As a negative control, sections were incubated with a 
pre-absorbed antibody and with anti-Carboxypeptidase A (Figure 17 D-F).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Since immunoelectron microscopy can reveal a more precise image of the subcellular 
localization of a protein then immunohistology, this method was applied for further verification. 
Tissue samples of rat tongue and pancreas were embedded in K4M (Figure 18 A, B), and ultrathin 
sections were stained with antibodies to Chymase and afterward with protein A-gold (see 
Methods 3.8.3.5). Rat tongue tissue served as a positive control, as it is rich in mast cells and 
Chymase-containing granules. A prominent and uniform labeling with gold particles was observed 
on cytoplasmic granules (Figure 18 A). A specific gold-labeling of ZGs in pancreatic acinar cells was 
as well observed. The staining was less prominent, but specific for ZGs (Figure 18 B) (labeling 
density on ZG: 1.16±0.1 gold particles/µm
2
, labeling density on control areas outside ZG: 0.18±0.8 
gold particles/µm
2
). This might be due to the low abundance of Chymase in ZGs and the 
regulation of its expression level (e.g. by feeding behaviour). Also, the accessibility of the protein 
might be reduced in highly condensed ZGs. 
 
Cryosections of rat pancreas were incubated with antibodies specific for Chymase (A) and Carboxypeptidase 
(CBP) (B). (C) Overlay (Merge) of (A, B). (D, E) Negative control using pre-adsorbed Chymase and anti-
Carboxypeptidase antibodies. (F) Overlay (Merge) of (D, E). Asterisks in (F) mark the nuclei of acinar cells. 
Scale bars, 10 µm.  
Figure 17: Immunofluorescence microscopy of rat pancreatic sections.  
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4.4 Sulfated Proteoglycans are Present on the Inner Surface of the Granule 
Membrane 
 
Since early electron microscopic studies revealed the existence of a fibrillar network in 
pancreatic juice as well as on the inner surface of the ZGM after freeze-fracture (Cabana, Hugon 
et al. 1981; Grondin, St-Jean et al. 1992), we examined the presence of sulfated proteoglycans in 
zymogen granules of pancreatic tissue by the Cupromeronic Blue (CmB) protocol (see Materials 
and Methods (3.7.3.4, Figure 18). This protocol has been successfully used to stain proteoglycans 
in secretory granules of leucocytes (Unger, Hokland et al. 1997). Interestingly, the formed CmB-
proteoglycan complexes mainly appeared in ultrathin pancreatic sections, fixed-stained according 
to Scott (1980), as elongated small electron-dense filaments or 'prisms' underneath the granule 
membrane with some variation between individual granules (Figure 19 A, B). CmB-proteoglycan 
complexes were also observed in the intermembrane space (Figure 19 A), presumably due to a 
staining of proteoglycans of the extracellular matrix, and in the acinar lumen (not shown). 
However, no other intracellular organelles of the acinar cells were positive for proteoglycan 
staining. These morphological observations support our previous biochemical studies (Schmidt, 
Dartsch et al. 2000; Schmidt, Schrader et al. 2001) indicating that sulfated proteoglycans are 
components of a submembranous matrix which is associated with the inner surface of ZG (see 
Introduction 1.3). 
When isolated ZGM and ZGM pre-treated with carbonate at pH 11 (which removes most 
of the peripheral components) were embedded for electron microscopy, the untreated 
membranes appeared overwhelmingly curved or curled (Figure 19 C). In contrast, most of the 
carbonate-treated membranes had a strikingly linear appearance (Figure 19 D). We assume based 
Tissue form rat tongue (A) and pancreas (B) was processed for immunogold electron microscopy, incubated 
with a polyclonal anti-Chymase antibody and visualized using 10 nm protein A gold. Arrowheads in (B) 
indicate gold particles on zymogen granules (ZG). Gr, granule of a mast cell; N, nucleus. Scale bars, 1µm. EM 
preparations were done with help and support of B. Agricola, University of Marburg. 
Figure 18: Chymase localizes to zymogen granules in acinar cells of the exocrine pancreas. 
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on the above observations that the granule matrix might have important mechanical functions 
during granule formation at the trans-Golgi network (TGN) as well as for granule stability. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.5 Discussion to Chymase as Peripheral Protein of the ZGM 
 
The ZG membrane has been the focus of recent proteomics studies (Chen, Walker et al. 
2006; Rindler, Xu et al. 2007; Chen and Andrews 2008) as their components are supposed to 
contribute – at least partially – to the sorting and packaging of digestive enzymes into ZG, their 
apical transport, membrane fusion and regulated, Ca
2+
-dependent secretion as well as to 
pancreatic and intestinal disorders. Here we report on the identification of peripheral, 
membrane-associated proteins of the ZGM by a suborganellar proteomic approach based on 
carbonate-treatment of ZGM and 2D-PAGE of the corresponding supernatant (wash) fraction. In 
this study we focused on the identification and characterization of a “basic” group of membrane-
Pancreatic tissue (A, B) was stained according to the Cupromeronic Blue (Cmb) protocol and embedded for 
electron microscopy (3.7.3.4). (A, B) Electron dense proteoglycan complexes were found to form filaments 
underneath the granule membrane in acinar cells of rat pancreas (A; asterisks). In addition, Cmb staining 
was detected within the intracellular space (A, white arrows). (B) Higher magnification view of ZG in acinar 
cells of rat pancreas after Cmb staining. Arrows in (A) and (B) point to proteoglycan complexes. (C, D) ZG 
were isolated from rat pancreas, and membrane subfractions were prepared. Isolated membranes (ZGM) 
were either left untreated (C), or incubated with sodium carbonate to remove granule matrix components 
(D) and afterwards processed for electron microscopy. Note the strong curved (arrowheads) or curled 
membranes (arrows) in (C), in contrast to their linear appearance in (D). EM preparations were done with 
help and support of B. Agricola, University of Marburg. 
Figure 19: Pancreatic ZG possess a submembranous proteoglycan skeleton, influencing membrane 
curvature. 
64 
 
associated proteins (pI range 6.2-11). As a verification of our approach, two previously reported 
peripheral (basic) ZG proteins, the secretory lectin ZG16p and Syncollin, were identified in this 
study. ZG16p is supposed to interact with the ZGM via its lectin domain, whereas Syncollin has 
been shown to interact with cholesterol and the GPI-anchored membrane glycoprotein GP2 
(Kleene, Dartsch et al. 1999; Hodel, An et al. 2001; Kalus, Hodel et al. 2002). Furthermore, no 
transmembrane proteins or classical membrane-anchored proteins were detected. Based on 
bioinformatics information and published results, almost all of the identified proteins are able to 
enter the secretory pathway, thus confirming their interaction with the luminal side of the ZGM. 
The two identified cytosolic proteins Vinculin (fragment), an actin-binding protein, and Ubiquitin 
carrier protein involved in ubiquitination/quality control may be associated with the cytosolic side 
of the ZG. A novel protein, rat mast cell Chymase A, appeared to be of low abundance in the 2D-
PAGE, and was thus selected for further validation of our approach. It is important to note that 
while increased instrument sensitivity allowed the identification of many more low abundant 
ZGM proteins; it also uncovered more contaminating proteins (Iwai and Inagami 1990). The 
confirmation of identified proteins on ZGM is thus a major and important task (Iwai and Inagami 
1990). 
By applying immunoblotting for the detection mast cell marker proteins, we were able to 
rule out that the presence of Chymase in our granule subfractions was the result of a 
contamination with mast cell granules/proteins. The distribution of Chymase in the granule 
subfractions resembled that of ZG16p, a typical peripheral ZGM marker, further confirming that 
Chymase is a genuine peripheral ZGM protein. In addition, its granule localization was for the first 
time confirmed by immunocytochemistry and morphological studies with pancreatic tissue and 
AR42J cells, an acinar cell model. In contrast to the biochemical data, membrane-association of 
Chymase appears to be less pronounced based on the ultrastructural studies. As mentioned 
before, this might be explained by restrictions in antibody binding. It is as well possible that 
Chymase interacts with membrane-associated proteoglycans which extend into the content (see 
below). Furthermore, we cannot rigorously exclude that the biochemical experiments exaggerate 
the amount of membrane-association, e.g. due to differential solubility of the ZG proteins in the 
lysis buffer. Importantly, an exogenously expressed Chymase-YFP fusion protein was targeted to 
ZG in pancreatic AR42J cells, whereas other fusion proteins (e.g. YFP-ER, Ruby-ER, VSVG-GFP, YFP-
GPI) entering the secretory pathway in AR42J cells were not observed to be targeted to ZG. It 
should be noted that Chymase was also suggested to be a potential peripheral ZGM protein based 
on a recent iTRAQ quantitative proteomic analysis (Chen and Andrews 2008). Taken together, 
these results clearly demonstrate that Chymase is a genuine peripheral ZGM proteins and no 
contaminant. 
Chymase has been identified as a major, highly basic chymotrypsin-like serine protease of 
mast cells, where it is stored in regulated secretory granules. Thus, its presence in ZGs of the 
exocrine pancreas is not that unusual at all. With respect to function, Chymase is likely to act as a 
serine protease after ZG secretion. RMCP-1 of mast cells is involved in inflammatory processes 
and tissue-remodelling (Leskinen, Lindstedt et al. 2003). Its capability to cleave proteins of the 
extracellular matrix (e.g. fibronectin) might be a reason for its low and regulated abundance in 
ZGs. 
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Interestingly, several known digestive enzymes, among them many lipid-interacting enzymes, 
were also identified in the wash subfraction. The presence of these classical content (ZGC) 
proteins in a ZGM fraction is usually interpreted as a contamination. However, it should be noted 
that these enzymes remain partially attached to the ZGM even under more stringent purification 
conditions (e.g. KBr wash before carbonate treatment) or after further purification of crude ZGM 
by gradient centrifugation (Chen, Walker et al. 2006; Rindler, Xu et al. 2007). Interestingly, many 
of the membrane-associated enzymes identified in this study in a membrane wash fraction have 
been predicted to be potential luminal ZGM proteins in a recent topology analysis of purified ZGM 
(Chen and Andrews 2008). Thus, it is very likely that the identified subset of peripheral digestive 
enzymes exhibits a more specific interaction with the ZGM than previously expected. Enzymes 
with lipid-binding properties might interact with membrane lipids to specifically associate with 
the ZGM. They might as well associate with lipid microdomains, which have been identified in 
ZGM (Schmidt, Schrader et al. 2001; Berkane, Nguyen et al. 2007). Their importance for granule 
biogenesis has been demonstrated in recent studies (Schmidt, Schrader et al. 2001; Gondre-Lewis, 
Petrache et al. 2006).  
Besides Chymase, we also detected a prominent amount of RNase A at the ZGM (1:10; 
about 33% of total RNase A compared to 0.06% of total amylase) (not shown). Interestingly, this 
interaction might be mediated by the interaction of RNase A with proteoglycans, e.g. of a 
predicted submembranous granule matrix (Scheele, Fukuoka et al. 1994; Schmidt, Dartsch et al. 
2000). We present first ultrastructural data, which reveal a submembranous localization of 
proteoglycans within zymogen granules using Cupromeronic Blue cytochemistry. Removal of the 
matrix components by carbonate treatment of granule membranes led to a loss of membrane 
curvature. 
 RNase A has been shown to interact with heparin and chondroitinsulfate (Dvorak and 
Morgan 1998; Dvorak and Morgan 1998), and based on these properties, a protein A-gold-RNase 
A technique has been developed to detect proteoglycans in cellular compartments and tissues 
(Dvorak and Morgan 1999). Protein A-gold-RNase A also labeled putative proteoglycans in ZG at 
the membrane and in the content (Dvorak and Morgan 1999). Furthermore, an interaction with 
proteoglycans has been described for Chymase (Pejler and Sadler 1999). This interaction is 
supposed to influence enzyme function (Dvorak and Morgan 1998; Pejler and Sadler 1999). The 
negatively charged proteoglycans in secretory granules of hematopoietic cells and mast cells are 
engaged in the binding of small positively charged molecules, such as histamine (Brion, Miller et 
al. 1992; Grimes and Kelly 1992; Castle and Castle 1998) and proteases (Lutzelschwab, Pejler et al. 
1997; Huang, Sali et al. 1998), and have therefore been considered to promote the efficient 
packaging and concentration of secretory products (Matsumoto, Sali et al. 1995). Similarly, 
proteoglycans within ZGs are supposed to interact electrostatically and through specific protein-
protein and carbohydrate-protein binding domains with the secretory proteins of the granule 
content (Scheele, Fukuoka et al. 1994; Schmidt, Dartsch et al. 2000; Schrader 2004). A potential 
role of Serglycin in granule formation has, however, recently been questioned (Niemann, Cowland 
et al. 2009). Interestingly, in a very recent study heparan sulfate containing proteoglycans have 
been detected in a ZGM fraction (Kumazawa-Inoue, Mimura et al. 2011). Although the core 
proteins could not be identified, the secretory lectin ZG16p (Kumazawa-Inoue, Mimura et al. 
2011), ribonuclease, Carboxypeptidase and bile-salt activated Lipase were found to bind to 
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heparin by affinity chromatography (Kumazawa-Inoue, Mimura et al. 2011), whereas amylase was 
not found to interact (Kumazawa-Inoue, Mimura et al. 2011). ZG16p was found to bind most 
strongly among the ZG proteins suggesting that ZG16p may cross-link the granule heparan sulfate 
chains via its two carbohydrate-binding sites and facilitate the formation of the submembranous 
matrix (Kumazawa-Inoue, Mimura et al. 2011).  
 It will be a great challenge for future studies to also identify and characterize high 
molecular mass components such as proteoglycans and glycoproteins in ZG fractions to unveil the 
complex architecture and putative interactions at the granule membrane and in the granule 
content. 
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Chapter 5  Similarities in Exocrine and Neuroendocrine Biogenesis and 
Secretion 
 
As mentioned in section 1.1 and Chapter 4, ZG have been used as a model system to study 
secretory granule biogenesis and regulated secretion in general. Also, they play important roles in 
pancreatic injury and disease (Gaisano and Gorelick 2009; Husain and Thrower 2009; Gomez-
Lazaro, Rinn et al. 2010). As referred in section (Introduction 1.7), ZG are optimal for 
suborganellar proteomics as they are highly abundant in the exocrine pancreas. Due to their large 
size and density, they can easily be isolated and intact ZG can be further subfractionated in ZGC 
and ZGM (Figure 12 and 3.8.2). Furthermore, several methods were reported to remove and 
enrich peripheral ZGM proteins (ZGWash) as well as to enrich transmembrane and membrane-
anchored proteins, consequently facilitating further analysis (Chapter 4, Hoops and Rindler 1991; 
Schmidt, Dartsch et al. 2000; Chen, Walker et al. 2006; Chen and Andrews 2008). Thus, significant 
progress has been made in the identification of proteins involved in ZG trafficking and regulated 
exocytosis (e.g. Rab proteins and effectors, and SNARE proteins) as well as in fusion events but 
also proton pumps, membrane channels and transporters were identified (Introduction 1.4, 
Gomez-Lazaro, Rinn et al. 2010). Newly identified proteins involved in ZG trafficking towards the 
apical plasma membrane are e.g. dynein, dynactin and myosin motor proeins (Chen, Walker et al. 
2006; Rindler, Xu et al. 2007). Furthermore, several soluble N-ethylmaleimide-sensitive factor 
activating protein receptor (SNARE) proteins, Rab GTPases and aquaporins were identified and 
are suggested to be involved in granule docking/priming, swelling and exocytosis (Chen, Edwards 
et al. 2002; Cho, Sattar et al. 2002; Riedel, Antonin et al. 2002; Chen, Li et al. 2004; Faust, Gomez-
Lazaro et al. 2008; Williams, Chen et al. 2009; Gomez-Lazaro, Rinn et al. 2010). In addition, 
proteins known to be localized in other organelles or cell types as presenillins and Chymase were 
identified (Chen, Walker et al. 2006; Rindler, Xu et al. 2007; Borta, Aroso et al. 2010). 
Interestingly, many of the proteins identified by recent proteomics approaches are also known to 
be involved in neuroendocrine vesicle trafficking and exocytosis. It is known that exocrine and 
neuroendocrine regulated secretion share some characteristics. Indeed, secretory proteins are 
sorted into the secretory/zymogen granules in a pH dependent manner; the membrane 
components of the TGN/SG/ZG are involved in the sorting process, the granules mature through 
the removal of non-secretory proteins in a clathrin-dependent manner and are transported to the 
apical plasma membrane along microtubules (Introduction 1.2). The secretion occurs in both 
systems upon an external stimulus and in a Ca
2+
-dependent manner. It is widely discussed to what 
extent the secretion machineries of both systems may overlap. 
This part of my work continues with the analysis of the ZGM and ZGWash subfraction, 
focusing on the identification and confirmation of low abundant, high-molecular mass and 
hydrophobic proteins, which possibly constitute members of exocrine and neuroendocrine 
secretion systems. In order to determine the proteome overlap, I started with the comparison of 
proteomics results of the ZG, ZGM, ZGWash and synaptic vesicles (SV) obtained during the last 
few years including our own results and listed the proteins found in Table 5-1. The table provides 
some auxiliary information about the putative functions, the type of the identified protein, the 
method of detection in ZG and the corresponding publication. It may as well facilitate the 
development of experimental approaches exploiting the information about the protein 
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characteristics. Thus, the table was used as a criterion for the selection of proteins for further 
analysis such as APP. In total, 72 proteins were found to be shared by both systems and are listed 
in the table, from which six are membrane channels and transporters and 12 are membrane 
associated proteins most likely all attached to the cytosolic side including APP, SNARE and motor 
proteins (e.g. SNAP 23 and Dynactin). Furthermore, 43 proteins are listed as being involved in 
trafficking, including 24 Rab proteins, but also 3 subunits of the γ-secretase complex, 8 subunits of 
the Vacuolar H
+
-ATPase, 2 proteins which are known from the cytoplasmic active zone and one 
luminal ZG protein, which was identified in a rat brain lysate by 1D-MS/MS analysis.  
It is important to note that the overlap of both systems, described in this table, refers 
solely to proteins involved in trafficking, fusion, swelling and exocytosis of ZGs and synaptic 
vesicles. These are either membrane associated from the cytosolic side, or are transmembrane 
proteins. The overlap includes only one protein known to be attached to the luminal side which is 
suggested to be involved in ZG sorting and packaging through its interaction with the glycoprotein 
scaffold on the luminal side of the ZG membrane, which is ZG16p. These findings support the 
theory that the secretion machineries of the exocrine and neuroendocrine system may overlap. 
But for many of the newly identified proteins, their existence in the ZG of the exocrine rat 
pancreas still has to be confirmed by alternative methods such as antibody based technologies or 
PCR.   
Further, to identify new and low abundant ZGM constituents, a 2D-SDS PAGE was applied 
as shown in Chapter 4. However, the major drawback of this method is its limitation concerning 
the separation of hydrophobic membrane and high-molecular mass proteins. As alternative 
approaches to capture these special proteins, 1D-SDS-PAGE and the off gel LC-separation (3.10.4) 
methods were chosen. Samples which were prepared for 1D-SDS PAGE were loaded onto a 3-
12.5% gradient SDS-PAGE (3.9.2) and gels were subsequently stained with Coomassie and silver 
(3.9.6-3.9.7). Afterwards, selected protein bands were excised and prepared for mass 
spectrometry by tryptic digestion (3.10.1). For LC-separation, samples of 1 µg were tryptically 
digested prior to separation on a HPLC system. After peptide separation, these were directly 
applied to a Maldi target plate for mass spectrometric analysis using an integrated LcPackings 
Probot auto sampler, as depicted in Figure 12. LC-MS/MS is even more suitable for the 
identification of high-molecular mass and hydrophobic proteins since the tryptic digestion occurs 
prior to separation, facilitating the identification of peptides of very low abundant proteins. Both 
methods have the advantage of reducing the risk of protein precipitation during the separation 
since the step of isoelectric focusing is spared. The major drawback of both methods is the 
increase in the identification of false positives, contaminations which can occur during the 
isolation process. This underlines the importance of further analysis to confirm eventual new ZGM 
and ZGM associated candidates. In general, mass spectroscopic analysis succeeded with the kind 
support of Prof. F. Amado, Dr. R. Vitorino (Department of Chemistry, University of Aveiro) and M. 
Aroso from our group.  
The neuroendocrine proteins selected for further confirmation in this work are Piccolo 
and Synapotjanin-1 which were identified by the LC-MS/MS approach. APP was chosen based on 
the result obtained by the literature screen (Table 5-1) and ZG16p, which in fact represents 
known ZGM associated protein, was identified in a rat brain lysate by the 1D-SDS-PAGE approach. 
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Table 5-1 Proteins identified by proteomics approaches in exocrine ZGs and in neuroendocrine SVs. Articles about proteomics in SV used for this table: 
(Coughenour, Spaulding et al. 2004; Iwatsubo 2004; Burre, Beckhaus et al. 2006; Takamori, Holt et al. 2006; Burre and Volknandt 2007) 
Protein Name, MW, NCBI Biological process  
Newly 
localized 
Method of 
detection 
Reference 
Transporter & Channel:  
ATPase, Aminophospholipid transporter 
class I, type 8A or 8B (109499663 or 
62664531) 
Na, K-ATPase alpha-1 subunit (α1) 26.84 
kDa, (205632) 
Solute carrier family 1 member 3/Slc1a3,   
59.7 kDa, NM_019225 
Vesicle amine transport protein 1 homolog 
(VAT-1) 43.12 kDa, NM_001033683.1 
Voltage-dependent anion channel 1 (VDAC1) 
30.76 kDa, NM_031353.1 
Voltage-dependent anion channel 2 (VDAC2) 
31.75 kDa, NM_031354.1 
 
APLT: not known 
 
 
Atp1a1: not known 
 
Slc1a3: carries out Na+ dependent transport of glutamate and aspartate; 
may regulate neurotransmitter concentration in the CNS 
VAT-1:  not known 
 
VDAC1: mitochondrial outer membrane (MOM) channel, also at the plasma 
membrane, at the MOM allows diffusion of small hydrophilic molecules; in 
the plasma membrane it is involved in cell volume regulation and apoptosis. 
VDAC2: mitochondrial outer membrane channel that allows diffusion of 
small hydrophilic molecules. 
ZGM 
 
 
 
LC-MS/MS 
 
 
 
-------------- 
 
iTRAQ-LC-
MS/MS; 2D-
MS and 1D-
MS/MS 
 
Rindler et al. 
2007 
 
 
---------------- 
 
Chen et al. 
2006 
Membrane associated proteins: 
Alzheimer’s precursor protein (APP)  86.7kDa  
NP_062161.1 
Beta-actin  41.73 kDa, NM_031144.2 
Guanine nucleotide-binding protein 
G(q)α 42.14 kDa, NP_112298.1. 
Guanine nucleotide-binding protein Gβ2 35 
kDa, 71089941 
Noc2 (Rab effector), 33.4 kDa, NP_598275.1 
 
Synaptosomal-associated protein (SNAP23)     
23.2 kDa, NP_073180.1 
Synaptosomal-associated protein (SNAP29)     
29.1 kDa NP_446262.3 
Brain acid soluble protein 1 21.8 kDa, 
NP_071636.1 
Dynactin subunit 1 141.93 kDa, NP_077044.1 
 
APP: Functions as a cell surface receptor and performs physiological 
functions on the surface of neurons relevant to neurite growth, neuronal 
adhesion and axonogenesis.  
Actb: Actins are highly conserved proteins that are involved in various types 
of cell motility and are ubiquitously expressed in all eukaryotic cells.  
G(q)α: involved as modulators or transducers in various transmembrane 
signaling systems Gβ2: not known 
Noc2: zinc finger protein; may be involved in regulated exocytosis in 
endocrine and exocrine cells.  
SNAP23: Essential component of the high affinity receptor for the general 
membrane fusion machinery and an important regulator of transport vesicle 
docking and fusion. SNAP29: inhibits SNARE disassembly, implicated in 
synaptic transmission.  
Basp1: not known yet 
 
Dctn1: Required for the cytoplasmic dynein-driven retrograde movement of 
 
 
 
 
 
ZGM 
associated 
 
 
 
 
 
 
 
--------- 
 
ZGM 
 
 
 
 
 
 
LC-MS/MS 
 
 
 
 
 
 
 
---------- 
 
 
 
 
 
 
 
Rindler et 
al. 2007 
 
 
 
 
 
 
 
--------------- 
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Protein Name, MW, NCBI Biological process  
Newly 
localized 
Method of 
detection 
Reference 
 
Dynein hc 1 532.52 kDa, NP_062099.3. 
 
Myosin VIIb 241.16 kDa, IPI00208315. 
vesicles and organelles along microtubules. 
Dhc1: Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde 
motility of vesicles and organelles along microtubules. 
Myo7b: Uncharacterized protein 
associated 
on 
cytosolic 
side 
 
iTRAQ-LC-
MS/MS 
 
 
 
Chen et al. 
2008 
 
Vesicular Trafficking, Transmembrane:  
 
Ectonucleoside triphosphate 
diphosphohydrolase 1 (ENTP1, CD39) 57,4 
kDa, NP_072109.1. 
CarboxypeptidaseD (Cpd) 152, 6 kDa,  
NP_036968.1. 
Nicastrin (Ncstn) 78,4 kDa, NP_777353.1. 
Presinilin1 (PS-1) 52.8 kDa, NP_062036.2. 
Presinilin2 (PS-2) 50.05 kDa, NP_112349.2. 
Secretory carrier membrane protein 1  
(SCAMP1) 24.8 kDa AF295404 
Secretory carrier membrane protein 3 
(SCAMP3) 37.9 kDa,  NP_001094106.1. 
Vesicle-associated membrane protein 2  
(synaptobrevin2) 12.7 kDa NM_012663 
Vesicle-associated membrane protein 3    
(VAMP3) 11.5 kDa NP_476438.1  
 
Cystein string protein 22.1 kDa, no NM 
number  
Pantophysin (Synaptophysin-like protein 1),   
28.6 kDa, NP_006745.1 
Syntaxin 3 33.3 kDa, NP_112386.1 
Syntaxin 6 29.1 kDa,  NP_113853.1. 
Syntaxin 7 29.8 kDa, NP_068641.2. 
Syntaxin 16b 16.0 kDa NM_001108610.1 
Transmembrane emp24 domain-containing 
protein 10 24.9 kDa, NM_053467.1 
 
 
 
ENTP1: Hydrolyzes ATP and ADP equally well. In the nervous system, could 
hydrolyze ATP and other nucleotides to regulate purinergic 
neurotransmission. 
Cpd: metallocarboxypeptidase, serine-type carboxypeptidase 
 
Ncstn: subunit of the γ-secretase complex 
PS-1: catalytic subunit of the γ-secretase complex, hydrolase 
PS-2: catalytic subunit of the γ-secretase complex, hydrolase 
SCAMP1: Functions in post-Golgi recycling pathways. Acts as a recycling 
carrier to the cell surface. 
SCAMP3: not known 
 
VAMP2: targeting and/or fusion of transport vesicles to their target 
membrane 
VAMP3: SNARE involved in vesicular transport from the late endosomes to 
the trans-Golgi network 
 
Csp: predominantly associated with nerve endings and synaptic vesicles, but 
function is unknown  
SYPL1: not known 
Stx3: Potentially involved in docking of synaptic vesicles at  the CAZ 
Stx6: Involved in intracellular vesicle trafficking 
Stx7: Mediates the endocytic trafficking from early endosomes to late 
endosomes and lysosomes 
Stx16b: not known 
Tmed10: Involved in vesicular protein trafficking, may be involved in 
vesicular transport from endoplasmic reticulum to the Golgi 
 
 
 
 
 
 
 
 
 
 
 
 
 
ZGM 
 
 
 
 
 
 
 
 
 
 
 
 
iTRAQ-LC-
MS/MS 
     -------------- 
 
 
 
 
 
LC-MS/MS & 
iTRAQ-LC-
MS/MS 
 
 
 
 
--------------- 
 
 
 
 
 
 
 
LC-MS/MS 
 
 
 
 
Chen et al. 
2008 
------------- 
 
 
 
 
Rindler et 
al. 2007 & 
Chen et al. 
2006/8 
 
 
 
 
--------------- 
 
 
 
 
Rindler et 
al. 2007 
Stx7 also 
by Chen et 
al 2008  
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Protein Name, MW, NCBI Biological process  
Newly 
localized 
Method of 
detection 
Reference 
Vesicular Trafficking: 
Vacuolar protein sorting-associated protein 
45 (VPS45) 64.9 kDa, NP_742069.1. 
Exocyst complex component 4 (rSec8) 110.5 
kDa, NP_446327.1  
 
VPS45: expressed in brain and testis; may play a role in intracellular vesicle 
mediated transport 
rSec8: Component of the exocyst complex involved in the docking of 
exocytic vesicles with fusion sites on the plasma membrane (Golgi-to-plasma 
membrane vesicle trafficking)  
 
ZGM 
associated 
----- 
 
ZGM 
 
LC-MS/MS 
 
-------- 
iTRAQ-LC-& 
2D MS/MS  
 
Rindler et 
al. 2007 
------- 
Chen et al. 
2006 
Vesicular Trafficking-GTPases and Effectors: 
Rab-1A 22.7 kDa, NM_031090, B 20.8 kDa, 
NM_134346.3 
Rab-2A 23.5 kDa,NM_031718.1, B 24.1 kDa 
NM_001037645.1  
 
 
Rap-2b 20.5 kDa NP_596901.1. 
Rab-3A  24.97 kDa, NM_013018.2, 
Rab-4A 23.9 kDa, NM_013019.2, B 23.6 kDa, 
NP_059051.1. 
Rab-5A 23.6 kDa,NM_022692.1, B 23.6 kDa, 
NM_001079936.1, C NM_001105840.1 
Rab-7 23.5 kDa,  NM_023950.3 
Rab-8A 23.7 kDa NP_446450.2, B 23.6 kDa 
NP_695229.1  
Rab-10 22.9 kDa, NP_059055.2 
Rab-14 23.9 kDa, NP_446041.1. 
 
Rab-18 XR_086339.1 
Ral-A 23.5 kDa, NM_031093.2 
 
 
c-K-Ras2 21.7 kDa, NM_031515.3 
Rac1 21.5 kDa NM_134366.1 
 
Rab-11b 24.5 kDa, NM_032617.2 
Rab-26 28.2 kDa, NM_133580.1 
 
 
Rab-1A: Probably required for transit of protein from the ER through Golgi 
compartment. Binds GTP and GDP and possesses intrinsic GTPase activity. B: 
small GTPase; involved in antagonizing the mitogenic and transforming 
activity of Ras Rab-2A: Required for protein transport from the endoplasmic 
reticulum to the Golgi complex B: not known  
 
Rap-2b: Involved in EGFR and CHRM3 signaling pathways through 
stimulation of PLCE1. Rab-3A: Involved in exocytosis by regulating a late 
step in synaptic vesicle fusion. Rab-4A: may play a role in intracellular 
recruitment of the glucose transporter GLUT4, B: Protein transport. 
Probably involved in vesicular traffic Rab-5A: may play a role in regulation of 
vesicular transport B: plays an important role in synaptic function by 
modulating the endocytosis of synaptic vesicles C: not known Rab-7: 
Involved in late endocytic transport. Contributes to the maturation of 
phagosomes Rab-8A and B: May be involved in vesicular trafficking and 
neurotransmitter release Rab-10: Not known Rab-14: may regulate 
neurotransmitter release, Involved in membrane trafficking between the 
Golgi complex and endosomes during early embryonic development. Rab-
18: not known Ral-A: Multifunctional GTPase involved in a variety of cellular 
processes including gene expression, cell migration, cell proliferation, 
oncogenic transformation and membrane trafficking 
 
 c-K-Ras2: Ras proteins bind GDP/GTP and possess intrinsic GTPase activity. 
Rac1: In its active state, binds to a variety of effector proteins to regulate 
cellular responses such as secretory processes, phagocytosis of apoptotic 
cells, epithelial cell polarization and growth-factor induced formation of 
membrane ruffles Rab-11b: GTPase that modulates endosomal trafficking. 
Acts as a major regulator of membrane delivery during cytokinesis Rab-26: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ZGM 
 or 
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iTRAQ-LC-
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LC-MS/MS 
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2006/8 
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Protein Name, MW, NCBI Biological process  
Newly 
localized 
Method of 
detection 
Reference 
 
Rab-27b 24.6 kDa NM_053459.1 
Rab-35 23.0 kDa, NM_001013046.1 
Participates in exocrine secretion: regulates the secretion of acinar granules 
in the parotid gland Rab-27b: May be involved in targeting uroplakins to 
urothelial apical membranes Rab-35: In the process of endocytosis, 
essential rate-limiting regulator of a fast recycling pathway back to the 
plasma membrane. 
 
 
 
 
 
 
 
Vacuolar H
+
-ATPase Subunits: 
H
+
 -ATPase V0 subunit a1 96.3 kDa, 
NP_113792.2 
H
+
 -ATPase V0 subunit c 15.8 kDa, 
NM_130823.2 
H
+
 -ATPase V0 subunit d 40.3 kDa, 
NM_001011927.1 
H
+
 -ATPase V1 subunit B2 56.6 kDa 
NM_057213.2 
H
+
 -ATPase V1 subunit C1 43.9 kDa, 
NM_001011992.1 
H
+
 -ATPase V1 subunit D 28.3 kDa, 
NP_955418.1. 
H
+
 -ATPase V1 subunit E1 26.13  kDa, 
NM_198745.1 
H
+
 -ATPase V1 subunit H 50.86 kDa,  
NM_001013929.1 
 
 
V0a1: Required for assembly and activity of the vacuolar ATPase. Potential 
role in differential targeting and regulation of the enzyme for a specific 
organelle V0c: Proton-conducting pore forming subunit of the membrane 
integral V0 complex of vacuolar ATPase. V-ATPase is responsible for 
acidifying a variety of intracellular compartments in eukaryotic cells 
V1B2: Non-catalytic subunit of the peripheral V1 complex of vacuolar 
ATPase 
 
V1C1: Subunit C is necessary for the assembly of the catalytic sector of the 
enzyme 
V1D: mediates acidification of intracellular organelles for processes such as 
protein sorting and receptor-mediated endocytosis 
V1E1: Subunit of the peripheral V1 complex of vacuolar ATPase essential for 
assembly or catalytic function. 
V1H: Subunit of the peripheral V1 complex of vacuolar ATPase 
ZGM 
 or 
peripheral 
LC-MS/MS 
Rindler et 
al. 2007 
Typical ZGM associated protein newly identified in rat SV/brain 
 
ZG16p 16 kDa, NP_599236.2 
 
ZG16p: May play a role in protein trafficking, act as a linker between the 
submembranous matrix on the luminal side of ZGM and aggregated 
secretory proteins during granule formation 
newly in 
SV 
1D-MS/MS, 
IMF, WB 
Our un-
published 
results 
Typical SV associated proteins newly identified in ZG 
Cytosol & Cytomatrix: 
Piccolo (Aczonin), 552.7 kDa,   
NP_001104267.1 
Synaptojanin1 (Inositol 5-phosphatase),   
172.9 kDa , NP_445928.2 
 
Piccolo: scaffolding protein involved in the  organization of synaptic active 
zones and in synaptic vesicle trafficking 
Snj1: clathrin-mediated endocytosis in the synaptic active zone  (CAZ) 
ZGM 
associated 
LC-MS/MS 
Our 
unpublished 
results 
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5.1 The High-Molecular-Mass Cytomatrix Active Zone Proteins Piccolo and 
Synaptojanin-1 were Identified by LC-MS/MS in a ZGWash Fraction 
 
Piccolo (Aczonin) and Synaptojanin-1 (Snj-1) were both identified in a ZGWash fraction by 
LC-MS/MS analysis. Therefore, ZG were isolated and subfractionated as described in sections 
3.8.1-3.8.2. One µg of the ZGWash fraction was tryptic digested and analyzed by LC-MS/MS as 
described in sections 3.10.4-3.10.5. In the ZGWash subfraction, Piccolo was identified with a 
peptide score of 9 and a total ion score of 47, while Snj-1 was identified with a peptide score of 3 
and a total ion score of 54. Both proteins, when compared to Amylase (57.2 kDa) a highly 
abundant ZG content protein, which should appear only in miner amounts in the ZGWash fraction 
in LC-MS/MS (peptide score 7, total ion score 154), reveal values for very low abundant proteins 
or eventual contaminants. 
 Piccolo and Snj-1 are slightly acidic, multidomain proteins with a high molecular weight 
(Piccolo 552 kDa and Snj-1 173 kDa). Both proteins are known to be involved in vesicle transport 
either towards or from the apical plasma membrane in the cytomatrix active zone (CAZ) of nerve 
terminals (McPherson, Garcia et al. 1996; Wang, Kibschull et al. 1999). The CAZ is the area in 
which synaptic vesicles fuse with the presynaptic plasma membrane to undergo exocytosis. Also, 
they were found in the pancreatic β-cells as part of the endocrine secretion system (Fujimoto, 
Shibasaki et al. 2002; Hoy, Efanov et al. 2002).  
Piccolo, as a scaffold protein in the pre-synaptic active zone, forms a complex with 
Bassoon involving several other proteins (Schoch and Gundelfinger 2006). It was proven to 
interact with Rim2 in a Ca
2+
-dependent manner (Fujimoto, Shibasaki et al. 2002) and via Abp1 and 
Profilin to bind to actin organizing the exo- and endocytotic machinery (Fenster, Kessels et al. 
2003; Barclay, Morgan et al. 2005; Schoch and Gundelfinger 2006; Leal-Ortiz, Waites et al. 2008). 
In pancreatic β-cells, it was shown that Piccolo antisense oligodeoxynucleotides inhibit insulin 
secretion again involving calcium (Fujimoto, Shibasaki et al. 2002). It is known that synaptic 
transmission is initiated when an action potential triggers neurotransmitter release from a 
presynaptic nerve terminal (Katz and Kopin 1969) through the opening of Ca
2+
 channels. A 
transient Ca
2+
 increase stimulates synaptic vesicle exocytosis after which the vesicles undergo 
endocytosis, recycle and refill with neurotransmitters for a new round of exocytosis (Sudhof 
2004). ZG as well are released upon a regulated increase of intracellular Ca
2+
 concentration while 
fusing with the apical plasma membrane (Thevenod, Braun et al. 2000; Schrader 2004) but the 
calcium sensor has not been identified yet. Since Piccolo has the capacity to bind Ca
2+
 which 
induces conformational changes in the protein structure (Gerber, Garcia et al. 2001) and acts as a 
potential Ca
2+
 sensor in pancreatic β-cells (Fujimoto, Shibasaki et al. 2002), it cannot be excluded 
that this protein might also play a role in ZG exocytosis as a scaffold protein organizing ZG fusion 
with the apical membrane. 
Synaptojanin-1 (Snj-1), also known as synaptic inositol-1, 4, 5-trisphosphate 5-
phosphatase 1, is a cytosolic protein involved in clathrin-mediated endocytosis (Haffner, Takei et 
al. 1997). It is probably acting as a negative regulator for the interaction of the clathrin-coat and 
the membrane phospholipids of the vesicles, facilitating the shedding of the coat and targeting of 
the uncoated vesicle to its final destination (Robinson 1994; Damke 1996; De Camilli, Emr et al. 
1996; Tooze 1998; Harjes and Wanker 2003). In this process, Snj-1 binds to Eps15, a clathrin coat-
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associated protein, and is recruited by Endophilin to promote synaptic vesicle uncoating (Haffner, 
Takei et al. 1997; Verstreken, Koh et al. 2003). Ephrin, a chemirepulsant promotes Snj-1´s 
phosphorylation via an Ephrin receptor through which the binding to other proteins, as well as 
vesicle endocytosis, is inhibited (Hopper and O'Connor 2005; Irie, Okuno et al. 2005). Moreover, 
Snj-1s expression is not restricted to brain or pancreatic β-cells since it was also found in heart, 
liver, testis and muscle (Ramjaun and McPherson 1996; Nemoto, Arribas et al. 1997). In total, six 
different isoforms are known so far, being differently regulated throughout prenatal 
development. These isoforms split in two splice variants with the size of 145 kDa and 170-173 
kDa, having differential membrane binding properties (Ramjaun and McPherson 1996). Appealing 
is the fact that through a Ca
2+
 influx in neurons, some calcium dependent phosphatases are 
activated which in turn activate Snj-1 increasing the endocytotic turn-over (Tojima, Akiyama et al. 
2007). Hence, it is possible that Snj-1 might be involved in the clathrin-dependent removal of 
lysosomal proteins during ZG maturation or in the membrane recycling after zymogen secretion. 
Due to their roles in vesicle trafficking/recycling, both proteins were selected for further analysis 
in ZG. 
 
 
5.2 Piccolo, a Peripheral ZG Protein? A Question still not Solved 
 
By applying two commercial available antibodies directed to Piccolo in immunoblotting 
and immunofluorescence, it was not possible to obtain reliable results for Piccolo. Therefore, 
selected samples of ZG subfractions, AR42J cells and positive controls (brain lysate and SH-SY5Y 
cell lysate) were sent to the laboratory of Neurobiology of Prof. E. Gundelfinger (Leibniz Institute 
for Neurobiology, Magdeburg, Germany), a group which routinely works with Piccolo producing 
their own antibody against the protein. Here, Piccolo was detected very weakly in total ZG, ZGC 
and ZGM but not in ZGMwashed or the ZGWash fraction (Figure 20). Furthermore, it was found in 
the lysate of AR42J cells stimulated for granule formation with dexamethasone (+D) and controls 
(-D), and in positive controls (SHSY-5Y cells, rat brain), showing the characteristic antibody bands 
for Piccolo at 552 and ca. 65 kDa. Additionally, a strong band pattern from 0-50 kDa was detected 
by the antibody in ZG complete, ZGC and ZGM, probably originating from sample degradation. 
Nevertheless, with the experiments performed, it is not yet possible to confirm if Piccolo 
is a transient part of the ZGM as suggested by LC-MS/MS analysis of the ZGWash fraction and 
immunoblotting of ZG fraction, or if it is a co-purification coming from vesicles of the pancreatic β-
cells. Due to problems with the available antibodies, the work on this protein was at least 
temporally intermitted. 
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5.3 Synaptojanin-1 is Not a Peripheral Component of the ZGM  
 
To confirm the detection of Snj-1 in the ZGWash fraction, immunoblot analyses were 
conducted with a tank blot system using nitrocellulose (3.9.3). According to the data sheet of the 
antibody against Snj-1, samples were not boiled but heated for 20 min at 65°C and loaded onto a 
3-12.5% gradient gel. After immunoblotting, the antibody revealed a band at 145 kDa in the 
synaptosome fraction which was used as positive control. Only in the rat pancreatic homogenate, 
a very weak signal for Snj-1 was detected but not in any other samples loaded (Figure 21). Further 
experiments using AR42J subfractions (isolated membranes and cytosol/microsomes) and 
incubation of samples at 37°C overnight did not improve the detection of Snj-1. 
 
 
 
 
 
 
 
 
 
 
Immunofluorescence experiments using the Snj-1 antibody in AR42J cells stimulated for 
ZG formation with dexamethasone (+D) Figure 22 D-F and unstimulated controls (-D) Figure 22 A-
C exhibit a weak punctate staining pattern more at the periphery of the cells. But a co-labeling 
Lysed granules (ZG) were separated into a content 
(ZGC) and membrane fraction (ZGM). In addition, 
isolated membranes were treated with Na2CO3 at pH 
11.5 and separated into pellet (ZGMwashed) and 
supernatant (Wash) fractions. Equal amounts of 
protein (30 µg) were run on a Tris-Acetate SDS-PAGE, 
blotted overnight onto nitrocellulose and incubated 
with an antibody against Piccolo. Gel and blot were 
prepared by Dr. A. Fejtova (Magdeburg, Germany). 
Antibody specific bands appeared at approximately 
65 and 550 kDa in the positive controls (rat brain and 
SH-SY5Y cell lysate) but also in ZG complete, ZGC, 
ZGM and in AR42J cells. 
Equal amounts of protein (80 µg) were run on a 3-
12.5% gradient SDS-PAGE, blotted onto a 
nitrocellulose membrane and incubated with an 
antibody against Snj-1. The Snj-1 antibody shows 
one specific band at around 145 kDa as it is visible 
in the positive control of synaptosomes and in the 
rat pancreatic homogenate.  
Figure 20: Piccolo seems to associate to ZG and is 
expressed in pancreatic AR42J cells. 
Figure 21: Synaptojanin-1 does not localize to ZG 
subfractions. 
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with the ZG marker Chymotrypsinogen in AR42J cells revealed that the two antibodies do not 
colocalize with each other (Figure 22 A-F). Rat primary neuronal cultures served as positive 
control for Snj-1 (Figure 22 G-L). Snj-1 as a marker for endocytotic vesicles at nerve terminals 
reveals a positive staining, partially colocalising with the pre-synaptic marker protein VGlut 
(Figure 22 G, J-K) and also with the post-synaptic marker protein PSD95 (Figure 22 I, K-L). In Figure 
22 K boxed area is shown enlarged in the upper left corner of the same image. In this 
magnification, a stack like staining of the three proteins is shown which is marked by a white 
arrowhead. This stack reveals a typical staining pattern which can be found all over the neuron. In 
this stack, SNj-1 (green) is followed by Vglut (white) and then by PSD95 (red) placing the protein 
inside the cell close to the CAZ area. It can also be seen that the pre- and post-synaptic markers 
Vglut and PSD95 overlap but only at the border between pre- and post-synapse when 
fluorescence signals are difficult to separate due a limitation of resolution. 
That the antibody is able to recognize Snj-1 in AR42J cells in immunofluorescence 
experiments but not in immunoblotting may be related to the accessibility of the epitope, as 
antigen recognition appears to be sensitive to denaturation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AR42J cells stimulated for 
granule formation (D-F) and 
controls (A-C) were processed 
for indirect immunofluorescence 
after 48 h using antibodies 
directed to Synaptojanin-1 (Snj1) 
(A, C, D, F) and
Chymotrypsinogen as ZG marker 
(Chymo) (B-C, E-F). Overlays 
(Merge) of images (A-B; D-E) are 
shown in (C and F) indicating no 
significant colocalisation with 
ZG. Pictures were obtained with 
an Olympus IX81 fluorescence 
microscope. Rat primary 
neurons served as positive 
control for the Snj-1 antibody 
marking endocytotic vesicles at 
nerve terminals (H, J-L). An 
antibody to Vglut served as pre-
synaptic marker (G, J and K) an 
antibody to PSD95 as post-
synaptic marker (I, K and L). The 
overlay (Merge) of images (G-I) 
is shown in (K). The overlay of 
(G-H) is shown in (J) and the 
overlay of (H-I) in (L). Images 
were obtained on a Confocal 
Zeiss LSM 510 microscope. Scale
bars 10 µm 
Figure 22: Synaptojanin-1 does 
not localize with ZG in AR42J 
cells. 
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5.4 Exogenous Amyloid Beta A4 Protein Precursor (APP) is Sorted to Secretory 
Granules in Pancreatic AR42J Cells 
 
Recent proteomics approaches identified the Amyloid beta A4 protein precursor (APP) in 
a ZGM associated subfraction (Rindler, Xu et al. 2007; Chen and Andrews 2008) together with 
Presenilin 1, 2 and some other subunits of the γ-secretase complex (Chen and Andrews 2008). 
Interestingly, all these proteins are known to be involved in neuroendocrine secretion processes 
(Kamal, Almenar-Queralt et al. 2001). Furthermore, APP was identified in a gene atlas about the 
mouse and human protein-encoding transcriptomes, in a number of tissues amongst them total 
pancreas but with a stronger expression in the pancreatic islets (Su, Wiltshire et al. 2004). 
Although it is known to be expressed in brain, (Shioi, Pangalos et al. 1995; Sandbrink, Monning et 
al. 1997), its expression on protein level in other tissues it still not well defined. 
APP is a single-pass type 1 membrane protein known to enter the secretory pathway. In 
the precursor version a basolateral sorting signal was identified. APP undergoes various steps of 
glycosylation (Tsuchida, Shioi et al. 2001) and cleavage, especially in the endosomal-lysosomal 
pathway, where β-secretase generates the Aβ peptide. Soluble APP is then released into the 
extracellular space in a constitutive manner (Small and Gandy 2006) from where it is rapidly 
internalized via clathrin-coated pits. It was shown that some APP accumulates in secretory 
transport vesicles, leaving the late Golgi compartment returning then to the cell surface (Gandy 
and Greengard 1994; Selkoe 1996; Thinakaran and Koo 2008). APP binds to collagen which is 
inhibited by Zn
2+
. This inhibition mediates the binding to heparin and the formation of APP 
homodimers (Pangalos, Efthimiopoulos et al. 1995; Brouillet, Trembleau et al. 1999; Watanabe, 
Sukegawa et al. 1999). Furthermore, it was proposed that APP is possibly a heparan sulfate 
proteoglycan core protein (Schubert, Schroeder et al. 1988). This multifunctional protein is 
involved, amongst other functions, in synaptic vesicle recycling (Marquez-Sterling, Lo et al. 1997), 
neuronal viability, polarity (Perez, Zheng et al. 1997) and migration (LoTurco and Bai 2006; Young-
Pearse, Bai et al. 2007). It is reported that in APP knock-out mice, the SV density is reduced as well 
as the size of the CAZ, pointing towards a role in the regulation of formation and function of inter-
neuronal synapses (Yang, Gong et al. 2005). It is still under discussion if this protein is involved in 
synaptic vesicle exocytosis as a membrane anchored receptor (McLoughlin, Irving et al. 1999). As 
such, it could also play a role during the exocytosis of ZG. Besides, it does not only function as a 
membrane-anchored receptor-like molecule, but also as a secreted derivative acting upon other 
cells by binding to cytomatrix components (Milward, Papadopoulos et al. 1992; Kamal, Almenar-
Queralt et al. 2001; Young-Pearse, Chen et al. 2008). Regulated exocytosis implies the fusion of 
the vesicle membranes with the plasma membrane and the subsequent release of content to the 
extracellular space. It has been suggested that the core protein components of the intracellular 
membrane fusion machinery in the secretory granules are shared by different secretory 
organelles (Waters and Hughson 2000; Pfeffer 2007). Between these shared proteins are e.g. 
Rabs, Sec1/Munc18 and SNAREs (Rizo and Sudhof 2002; Burgoyne and Morgan 2007; Verhage and 
Toonen 2007) and eventually also APP. 
Due to the proteomics results published in recent literature, its heparan binding capacity 
and its influence on vesicle trafficking processes, it is possible that APP might play a role in ZG 
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biogenesis, maturation and/or transport as well. Based on these informations, APP was selected 
for further analysis in ZG. 
By immunoblot analysis with ZG and AR42J cell lysates from cells induced for ZG 
formation with dexamethasone (+D) and untreated controls (-D), using a specific antibody, APP 
was found weakly expressed in both AR42J cell lysate (Figure 23). However, it was neither 
detected in our isolated ZGs nor in the corresponding supernatant resulting from the ZG isolation 
(see SN3 in Figure 11, section 3.8.1). The lysates from positive controls (SH-SY5Y cells, rat brain 
and rat cortex) revealed a strong detection of APP (Figure 23). A specific antibody to Amylase was 
applied to confirm ZG enrichment and stimulation of AR42J cells.  
 
 
 
 
 
 
 
 
 
 
 
Although APP is expressed in AR42J cells, the localisation of the endogenous expressed 
protein in these cells by immunofluorescence with the specific antibody (mc mouse 22C11) was 
impaired probably due to an incompatibility with our immunofluorescence protocol. 
Nevertheless, overexpression of an APP-GFP fusion protein in AR42J cells, induced for ZG 
formation (Figure 24), revealed a partially cytosolic staining (Figure 24 A, E, M), but also a specific 
colocalisation with ER, Golgi, lysosomal and ZG marker proteins (Figure 24 A-O). AR42J cells were 
transfected with a generated APP-GFP construct, 24 h after transfection cells were induced for ZG 
formation with 10 nM dexamethasone and 72 h later, cells were processed for indirect 
immunofluorescence. Several organell marker antibodies were applied, which were directed to 
Chymotrypsinogen as ZG marker (Figure 24 B-C), Endolyn as lysosomal marker (Figure 24 F-G), PDI 
as ER marker (Figure 24 J-K), and p115 as Golgi marker (Figure 24 N-O). Dexamethasone-
treatment resulted in the formation of numerous characteristic granules positive for 
Chymotrypsinogen (Figure 24 B). Quantification, using pixel-by-pixel analysis from confocal 
images revealed a co-localization coefficient of 18.7%±13.9 for PDI (ER marker, Figure 24 L, Q), of 
29.4%±17.0 for p115 (Golgi marker, Figure 24 P, Q) and of 53.1%±21.1 for Endolyn (lysosomal 
marker, Figure 24 H, Q) with APP-GFP. The strongest colocalisation was observed with the ZG 
marker protein Chymotrypsinogen (87.9%±7.5, Figure 24 D, Q). Chymotrypsinogen and APP are 
both known to enter the secretory pathway colocalizing with ER and Golgi markers. This means 
that the actual colocalisation of APP-GFP with Chymotrypsinogen in ZG is far lower than it is 
represented by the values shown in Figure 24 Q. However, a clear colocalisation can be observed 
in ZG structures, indicating that APP-GFP is sorted to a certain extend into ZG in AR42J cells, when 
overexpressed (Figure 24 A-D). 
  
Equal amounts of protein (80 µg) were run on a 12.5% 
SDS-PAGE, wet-blotted onto a nitrocellulose membrane 
and incubated with an antibody against APP (mc mouse 
22C11). Amylase was used as control for ZG fractions. 
AR42J cell lysates were taken from cells induced for ZG 
formation for 48 h with dexamethasone (+D) and controls 
(-D). Lysates from SH-SY5Y cells, rat brain and cortex 
served as positive controls. 
Figure 23: APP is not associated with isolated ZG. 
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AR42J cells were transfected with an APP-GFP construct (A, E, I, M), stimulated for ZG formation and 
processed for indirect immunofluorescence 72 h after transfection. Cells were stained using antibodies 
directed to  Chymotrypsinogen to mark ZG (B-C), the lysosomal marker Endolyn (F-G), the ER marker PDI (J-
K) and the Golgi marker p115 (N-O). Overlays (merge) of confocal images (A-B; E-F; I-J, M-N) are shown in 
(C, G, K, and O). Arrows point to some granules, showing colocalisation of APP-GFP and Chymotrypsinogen 
(C), Endolyn (G) and p115 (O). (D, H, L and P) show the quantitative correlation analysis. Image analysis was 
carried out with the Zeiss LSM 510 4.0 software (Carl Zeiss MicroImaging, Inc.). The correlation plot 
describes the pixel colocalisation depending on their intensity in the GFP (for APP) and TRITC (for 
Chymotrypsinogen, Endolyn, PDI, and p115) channels with region 3 displaying colocalising pixels. Region 1 
and 2 contain the non-colocalising pixels for each label, respectively. The signals below the background 
(indicated by the axes) in each picture were not included in the quantification of the colocalisation 
coefficients. (Q) An average value of colocalisation has been obtained measured from six cells (7 z-planes 
from each cell) with a standard deviation given. Scale bars, 10 µm. 
Figure 24: APP-GFP is partially sorted to ZG in pancreatic AR42J cells 
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5.5 The Secretory Lectin ZG16p in Rat Brain, Still a Lot to Sort Out 
 
As mentioned in section 1.6, the secretory lectin ZG16p is expressed in several rat organs 
such as the exocrine pancreas but also in duodenum and colon, where ZG16p was found to 
localize to mucus-producing goblet cells (Cronshagen, Voland et al. 1994). However, it appears to 
be interconnected with diverse physiological processes such as apical sorting, wound healing and 
immune response (Lobler, Sass et al. 2002; Miyake, Hara et al. 2004; Kumazawa-Inoue, Mimura et 
al. 2011; Tateno, Yabe et al. 2011). ZG16p was suggested to represent a component of the 
submembranous granule matrix (a putative proteoglycan/glycoprotein scaffold at the luminal side 
of the ZGM contributing to cargo sorting, packaging and granule stability), where it was shown to 
interact with highly sulfated heparan proteoglycans (Kleene, Dartsch et al. 1999; Schmidt, Dartsch 
et al. 2000; Schrader 2004; Kumazawa-Inoue, Mimura et al. 2011). Interestingly, the protein was 
found in a cDNA hybridization array, 3 times upregulated after an induced brain lesion in the 
fornix region, during axonal regeneration, thus being associated to axonal regeneration failure 
(Kury, Abankwa et al. 2004). Additionally, I identified ZG16p in a crude rat brain lysate by 
proteomics studies using a 1D-SDS PAGE approach combined with tandem mass spectrometry in a 
band > 220 kDa (Figure 25). Since the mascot score for ZG16p in this band was 15, further 
analyses were required to confirm this result. 
In the brain, ZG16p could play a role in the secretion of extracellular matrix components, 
or enzymes, which are responsible for the degradation of the extracellular matrix, due to its 
heparan binding capacity (Kumazawa-Inoue, Mimura et al. 2011). Thus, ZG16p could fulfil 
overlapping functions in regulated exocrine and neuroendocrine secretion systems. The 
extracellular matrix consists of an interwined mesh of fibrous proteins and glycosaminoglycans 
(GAGs) (e.g. heparan and chondroitin sulfate) and its formation is essential for processes like 
growth and wound healing. As was shown in Chapter 4 the rat mast cell protease 1 (Chymase) 
associates to the submembranous matrix of ZG and it is an extracellular matrix degrading protein. 
Furthermore, this enzyme was identified in rat brain (Nelson, Siman et al. 1993). Hence, Chymase 
might be one of the proteins dependent on ZG16p´s expression in brain, to be properly packaged 
and sorted. Additionally, a role of ZG16p in immune defence in brain is possible, as it was shown 
to bind to certain fungi (Tateno, Yabe et al. 2011), even though a binding to bacteria was not 
shown yet. Encouraged by the obtained result and the findings in the literature, ZG16p was 
selected for further analysis in rat brain on mRNA and protein level by RT-PCR, immunoblotting 
and immunofluorescence. 
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5.4.1 ZG16p, a Possible New Synaptic Vesicle Constituent 
 
To confirm the result obtained by the 1D-MS/MS approach, ZG16p´s expression on 
protein level in rat brain and subfractions, obtained during a synaptic vesicle isolation, were 
analyzed (Figure 26). Equal amounts of protein (40 µg) from the different fractions (brain lysate, 
cerebellum lysate, cerebellum membrane, cortex, synaptosomes, synaptic vesicles and ZG) were 
separated on 3-12.5% gradient gels and immunoblotted using a specific antibody directed to 
ZG16p (ZG16 peptide antibody). Further, to assess synaptic vesicle enrichment, a specific antibody 
to the synaptic vesicle resident protein synaptophysin was used. As shown in Figure 26, 
immunoreactivity for synaptophysin was mainly found in the enriched SV fraction and so was 
ZG16p, too. To provide a preliminary quantitative value for the enrichment of ZG16p in the SV 
fraction, intensities of the corresponding signals from rat brain lysate and SV were determined by 
densitometric measurements and the ratios of the protein in the brain lysate to SV fractions were 
calculated. Furthermore, these values were compared to the once obtained for synaptophysin in 
the same fractions. A brain lysate to SV concentration ratio of 1:1.8 was calculated for ZG16p, 
indicating an enrichment in the SV fraction (Figure 26 A and B). Interesting, a similar 
concentration ratio was obtained for the synaptic vesicle marker protein synaptophysin (1:1.76 
enrichment in SV), confirming the enrichment of ZG16p in the SV fraction.  
 
Equal amounts of samples from rat brain lysate and ZG 
subfractions (40 µg) were incubated 20 min at 65°C in 
Laemmli buffer and run on a 3-12.5% gradient SDS-PAGE. 
After a Coomassie-silver staining (3.9.6-3.9.7) bands 
were isolated and prepared for MS/MS analysis (3.10.1-
3.10.3). The band in which ZG16p was identified in rat 
brain was far above 220 kDa. White arrows and box mark 
bands in which ZG16p was identified by mass 
spectrometry. 
Figure 25: ZG16p identified in a rat brain lysate by 1D- 
MS/MS 
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When comparing the ZG16p band in SV to ZG, it appears that the band of ZG16p in SV is 
slightly higher than in ZG (Figure 26 A). Furthermore, the antibody recognizes a band > 220 kDa in 
the SV fraction, which could arise from a cross-reaction, or corresponds to the band found by 1D-
MS/MS in the rat brain lysate (Figure 25). In previous tests performed in our laboratory, it was 
discovered that ZG16p is one of the few proteins that in their native and soluble form are trypsin 
resistent (unpublished data). This information offered the possibility to provide further proof that 
the bands (> 220 kDa and at ~16 kDa) correspond to ZG16p. For this purpose, 40 µg of isolated SV 
were digested with trypsin overnight at 37°C prior to the uptake in Laemmli buffer and were run 
on a 3-12.5% gradient SDS-PAGE together with an undigested control (Figure 26C). Through the 
trypsin digestion almost all proteins will be degraded and should disappear from the blot, and 
(A) Synaptosomes and synaptic vesicles were isolated from total rat brain homogenate by gradient 
centrifugation (3.8.3). Additionally, samples from several brain regions (cerebellum lysate, cerebellum 
membrane and cortex) obtained during SV isolation were tested for ZG16p. Equal amounts of each sample 
(40 µg) were run on a 3-12.5% gradient SDS-gel, blotted onto nitrocellulose and incubated with antibodies 
to ZG16p (peptide antibody) and Synaptophysin, positive control for synaptic vesicle (SV) isolation. The 
graph in (B) demonstrates the enrichment of ZG16p from the whole brain to SV in comparison to 
Synaptophysin. (C) Exploiting ZG16p´s trypsin resistance, 40 µg of a SV fraction were digested overnight at 
37°C and  run on a 3-12.5% gradient SDS-PAGE together with an undigested control. A higher band (above 
200 kDa), recognized by the ZG16 antibody as well as the SV positive control Synaptophysin disappeared 
after the digest, leaving only a band at ~16 kDa recognized by the ZG16 antibody, which increased in 
intensity. (D) Concentration ratios of ZG16p in SV (digested and undigested) were calculated using 
densitometric measures of the corresponding signals from the immunoblot using a GS-710 Calibrated 
Densitometer together with Quantity One 4.3.1 software.  
Figure 26: Immunoblot analysis of ZG16p´s expression in rat brain and synaptic vesicles. 
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only ZG16p should remain. By immunoblot analysis using specific antibodies directed to ZG16p 
(peptide antibody) and synaptophysin as a control for a successful digestion, the digested sample 
revealed that synaptophysin was nearly completely digested, and that the band above 220 kDa 
recognized by the ZG16p antibody disappeared (Figure 26 C). Interestingly, when compared to the 
undigested control, the ZG16p band at ~16 kDa appears more intense. The increase in intensity 
could be caused by the degradation of the higher molecular weight band above 220 kDa. In this 
band, ZG16p might be associated to a trypsin sensitive complex or high-molecular weight protein 
from which it is released after the tryptic digestion and accumulates as a monomer. But this topic 
requires further analysis in future studies. For evaluation, the intensities of the corresponding 
signals of ZG16p at the monomer level (~16 kDa) from digested and undigested SV were 
determined by densitometric measurements and the ratios of the protein bands were calculated. 
The remaining band in the digested SV sample revealed a concentration ratio of 1:1.35 when 
compared to the undigested control (Figure 26 D). 
 
 
5.4.2 ZG16´s is Differentially Expressed Throughout the Brain 
 
To further confirm the results obtained by immunoblot analysis and to specify ZG16´s expression 
in the different brain regions, RT-PCR experiments were employed. Total RNA from whole rat 
brain, different rat brain regions (hippocampus, hypothalamus, cerebellum and cortex) and 
pancreas was extracted as described in section 3.5.1. From each sample, 3 µg of RNA were 
transcribed into cDNA using MMLV reverse transcriptase (3.5.3). Equal amounts of cDNA were 
used to perform a semi-quantitative RT-PCR, as described in section (3.5.4). RT-PCR with mRNA 
from rat brain and pancreas revealed that ZG16p is expressed in rat brain, which was confirmed 
by sequencing (Figure 27 A). Sequencing results are presented in the appendix. By densitometric 
measurements of the band intensities, ZG16 mRNA revealed an approximately 2.2 fold higher 
expression level in rat pancreas when compared to total rat brain after normalization to the 
GAPDH loading control (Figure 27 A). Comparing the mRNA levels of ZG16 in the different brain 
regions (Figure 27 B), cerebellum revealed the highest level of mRNA (88.3%). In the cortex, the 
mRNA level accounted was (83.7%), in hippocampus (63.9%) and a very low level was measured in 
the hypothalamus region (43.8%). Pancreatic cDNA was used as positive control and was set to 
100%. GAPDH was applied as internal loading control to which all values were normalized.  
The differences of the ZG16 mRNA expression levels within the different brain areas can 
be related to the versatile compositions of cell types contained in the different brain 
compartments. The cerebellum consists of several types of neurons with a highly regular 
arrangement. Most important here are the Purkinje and granule cells and three types of axons 
(mossy and climbing fibers and deep nuclei). The climbing fibers represent the axons of the 
granule cells. The granule cells are densely packed along with interneurons, mainly Golgi cells but 
also with Lugaro and unipolar brush cells. The cortex is composed of the gray matter (neurons and 
unmyelinated fibers) and the white matter (myelinated axons interconnecting neurons). Further, 
it is constituted of up to six horizontal layers, each having a different connectivity and neuron 
composition. The hippocampus contains three main layers of cells having a different cell density 
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plus a varying degree of neuronal fibers, which are again dividable in at least seven subfields. The 
cell type composition is so complex that it will not be explained here. The hypothalamus is the link 
between the nervous and the endocrine system via the pituitary gland (hypophysis). It is mainly 
constituted of neurons releasing corticotrophin-releasing hormones and other hormones.  
Although some of the cells appear in all four compartments, their ratios within the 
distinguishable compartments are different from each other. Furthermore, different cell densities 
and also the regulation of gene products vary from compartment to compartment since the tasks 
for each sub-brain area are different. Through its intense and tight folding (folica cerebelli), the 
cerebellum offers a much larger surface of gray matter than the cortex region and has a much 
higher density of neurons. All this taken together could explain the relatively strong expression of 
ZG16p in the cerebellum in comparison to other brain areas.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A, B) Total RNA extracted from rat brain 
tissue and special regions was transcribed 
into cDNA (3.5.1-3.5.3). From each sample 
equal amounts of cDNA (150 ng) were used 
for a 50 µL semi-quantitative-RT-PCR (3.5.4) 
with species specific primers for ZG16. 
GAPDH served as loading control, pancreatic 
cDNA served as positive control and a 
template-free PCR mix was used as negative 
control. (A) The band from total brain was 
isolated, purified, re-amplified as described 
in 3.5.5 and send for sequencing. The graphs 
in (A and B) compare the ZG16 mRNA 
expression levels with each other after 
normalization to the GAPDH control. mRNA 
expression ratios were calculated using 
densitometric values from the corresponding 
signals from the  agarose gels using a GS-710 
Calibrated Densitometer together with 
Quantity One 4.3.1 software. 
 
Figure 27: ZG16 mRNA distribution in rat 
brain. 
85 
 
5.4.3 ZG16 Might be Sorted to RNA Granules in Rat Primary Neurons 
 
To determine the intracellular localisation of ZG16p, hippocampal neuronal primary 
cultures from rat were used in immunofluorescence experiments. After extration from rat brain, 
cells were seed on glass coverslips and cultured for 10-14 days. Cells were generally provided by 
Prof. A.L. Carvalho and Dr. S. Santos (CNC, University of Coimbra). In first immunofluorescence 
approaches with rat neuronal primary culture following the standard protocol, cells were 
permeabilised with Triton X-100. The staining, however, did not lead to a definite result due to a 
relatively strong background (Figure 28 A and B). To optimize the staining conditions, several 
antibody retrieval techniques were tested simultaneously (e.g. citrate buffer, glutaraldehyde and 
SDS). Only with SDS, a brighter staining of vesicular structure and a lower background could be 
observed (Figure 28 C and D). Briefly, SDS is an anionic tenside used in immunofluorescence to 
introduce a slight protein defolding which facilitates the access of an antibody to its antigen. It 
also reduces the background staining since badly cross-linked cytosolic proteins are easily washed 
out after the treatment. Furthermore, stained structures appeared to be the same with both 
methods, supporting the specificity of the ZG16 peptide antibody. In the modified protocol, cells 
were treated for 5 min with 1% SDS instead of 10 min with 0.2% Trition. Additional tests with both 
methods (0.2% Trition X-100 and 1% SDS) in our model cell line AR42J, stimulated for ZG 
formation, revealed that with 1% SDS the antibody recognizes the same cellular structures (ZG) as 
with Triton X-100. Additionally, no improvement in staining intensity was observed in this cell line 
(data not shown).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
After defining the conditions for immunofluorescence, localisation studies for ZG16p in rat 
neuronal primary cells were conducted (Figure 29) applying the modified immunofluorescence 
protocol for 1% SDS. Since ZG16p was found to be enriched in a SV fraction by immunoblotting 
(Figure 26), several subcellular marker antibodies were applied to neuronal cells stained with a 
ZG16p peptide antibody. 
Rat primary neuronal cells were either treated 
with 0.2% Triton X-100 for 10 min, or for 5 min 
with 1% SDS and subsequently immunostained 
with a peptide antibody against ZG16p. Cells 
treated with SDS revealed a much brighter 
staining. All images were made with a Confocal 
Zeiss LSM 510 microscope and associated 
software. Scale bars, 10 µm 
 
Figure 28: Staining of rat neuronal primary cells 
for ZG16p under different permeabilisation 
conditions. 
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(a) Neuronal cells originating from rat brain hippocampus were cultured for 10-14 days prior to 
immunofluorescence labelling. Cells were stained using antibodies to ZG16p (A, E, I and M peptide AB),
VGlut as pre-synaptic marker (B-C), PSD95 as post-synaptic marker (F, G), hRnP as a RNA granule marker (J-
K) and p115 as a Golgi marker (N-O). Overlays (merge) of confocal images (E and B; E and F; I and J, M and 
N) are shown in (C, G, K and O). Areas of colocalisation are labelled with arrowheads (B-O). (D, H and L) 
show correlation plots describing the pixel colocalisation depending on their intensity in the Alexa 488 (for
ZG16), TRITC (for PSD95 and hRnp), or for Alexa 647 (for Vglut) channels with region three displaying 
colocalising pixels in the cells. Region 1 and 2 contain the non-colocalising pixels for each label, respectively. 
The signals below the background (indicated by the axes) in each picture were not included in the 
quantification of the colocalisation coefficients. (b) Average values of colocalisation have been obtained
measured from three cells (3 z-planes from each cell) with a standard deviation given. Image analysis was 
carried out with a Confocal Zeiss LSM 510 microscope and associated software. Scale bars, 10 µm. 
 
Figure 29: Subcellular localisation of ZG16p in rat neuronal primary cells. 
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The applied antibodies were directed to the vesicular glutamate transporter (VGlut) as a pre-
synaptic marker (Figure 29a B-C), the post synaptic density protein (PSD95) as post-synaptic 
marker (Figure 29a F-G), but also to the human ribonucleoprotein (hRNP) as RNA granule marker 
(Figure 29a I-K). In all cases, the recognized structures are round or oval, distribute all along the 
cells axons and dendrites and show colocalisation with the ZG16p antibody (a staining with MAP2 
to distinguish between dentrite and axon is not shown but was routinly done). Pancreatic ZG16p 
containes an ER-targeting signal and is known to be sorted into ZG passing through the Golgi. 
However, the neuronal staining with p115, a Golgi marker, was strongly outshined by the 
additional intense nuclei staining of p115 in neurons, impairing the evalutation of the 
colocalisation coefficients in these cells. Interestingly, the Golgi marker p115 revealed a 
prominent Golgi staining in co-isolated glial cells colocalising with ZG16p as is represented in 
Figure 29a M-O. 
Quantification by pixel-by-pixel analysis from confocal images demonstrated a co-
localization coefficient of 64.5%±16.9 for hRnp (RNA granules, Figure 29a K-L and b), of 16.6%±3.8 
for Vglut (pre-synaptic marker, Figure 29a C-D and b) and of 53.1%±2.2 for PSD95 (post-synaptic 
marker, Figure 29a G-H and b) with ZG16p. PSD95 and Vglut colocalised to around 17.1%±2.8 with 
each other, which might be the result of a close proximity of post- and pre-synapses but maybe 
also due to resolution limitations as was demonstrated previously in Figure 22 K.  
 
 
5.4.4 A Full-Length and a Peptide Antibody to ZG16p Confirm Each Other 
 
 For the analyses of ZG16p in different cells and tissues, two different antibodies against 
ZG16p were available, a peptide (produced in our laboratory) and a full-length antibody. Both 
were crude serum fractions from different bleedings of rabbits. The full-length antibody was 
kindly provided by Anson Lowe, Stanford University, USA. Prior to experiments, IgG enriched 
fractions of the full-length and the peptide antibody sera were prepared as described in section 
3.9.5. All resulting ammonium salt precipitated IgG fractions were adjusted to a concentration of 
10 µg/µL to set a standard for following experiments. The aim was to characterize and compare 
both antibody types in their staining specificity for ZG16p to confirm and support previous results 
obtained with our peptide antibody. In some experiments, the peptide antibody raised questions 
about its specificity and/or ZG16p binding capacities and subcellular localisation. Both antibodies 
and appending fractions were compared to each other in immunofluorescence (Figure 30) and 
immunoblotting experiments (Figure 30). In immunofluorescence experiments with 
dexamethasone-stimulated AR42J cells, no differences in staining specificity but in staining 
intensity were observed, when comparing an IgG fraction to the corresponding crude serum of 
the antibody (not shown). After testing various antibody dilutions from 1:100 to 1:600, the IgG 
fraction of the full-length antibody and the N1d serum of the peptide antibody (Figure 30) 
revealed to be the best suited fractions for immunofluorescence experiments. Due to limitations 
in the amount, no IgG fraction could be prepared from the N1d serum of the peptide antibody. 
Furthermore, in immunofluorescence, both antibodies revealed the same staining characteristics 
in dexamethasone-stimulated AR42J cells labelling zymogen granules, as depicted in Figure 30. 
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In immunoblot analysis comparing all available serum antibodies and corresponding IgG fractions 
with each other, all recognized the ZG16p monomer at 16 kDa (Figure 31). Comparing the two 
different ZG16 antibodies with each other, both show the same band pattern but with different 
band intensities (Figure 31, yellow boxes). Furthermore, fractions belonging to the peptide 
antibody (N1a, N1b3 and N1d) revealed different immunoreactivities amongst each other. These 
variations in the immunoreactivity and band intensities are caused by different concentrations of 
the specific antibodies in the different bleedings. Interestingly, almost all fractions recognize a 
weak band appearing right on top of the 16 kDa band of approximately ~18 kDa (marked with a 
double arrow and red squared boxes), best visible with the N1a IgG fraction. It is possible, that 
this band originates from a ZG16p version before cleaving off the ER targeting signal, which would 
result in a protein with ~18 kDa. However, other possibilities such as antibody cross-reaction or 
posttranslational protein modifications can be the cause. Additionally, among the peptide 
antibody fractions, N1d resulted in the strongest staining, also showing bands at higher molecular 
weights (32 kDa, 50 kDa and 60 kDa), which are as well recognized by the full-length antibody, 
confirming each other’s specificity. It is still under discussion, if ZG16p can form dimers which 
could explain the band at 32 kDa. All other bands either derive from antibody cross-reactions, or 
are caused by strong protein complexes containing ZG16p, which did not dissolve under the 
denaturing conditions. ZG16p`s strong binding capacity, to highly sulfated heparan proteoglycans 
of ZG was shown recently (Kumazawa-Inoue, Mimura et al. 2011). According to the authors, 
ZG16p recognizes the glycosaminoglycan chains and binds most strongly to heparin. Core proteins 
of these proteoglycans revealed molecular weights of 35-40 and 66 kDa. Further, they observed 
that conformational changes in the ZG16p structure only occured under stringend conditions (5 
min, 98 in Laemmli buffer containing 5% mercaptoethanol).  
 
 
 
 
AR42J cells were induced for 
ZG formation with 
dexamethasone (+D) were 
immunostained either with the 
anti-ZG16 full-length antibody 
(1:400) (A, C) or with the anti-
ZG16 peptide antibody (1:200) 
(D, F). A co-staining with the 
ZG marker Chymotrypsinogen 
is shown in (B-C and E-F). Both 
ZG16 antibodies reveal the
same staining pattern. Images
were obtained with an 
Olympus IX81 fluorescence 
microscope. Scale bars, 10 µm 
Figure 30: ZG16 full-length 
and peptide antibodies are 
both specific for ZG16p in 
stimulated AR42J cells 
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Since both ZG16p antibodies (peptide and full-length) are able to recognize the same structures 
(ZG) and bands in immunofluorescence and immunoblot analysis respectively, the full-length 
antibody was applied to rat neuronal culture and SV vesicle fractions. This allowed us to confirm 
the results previously obtained with the peptide antibody (data not shown). 
 
 
  
Equal amounts of total ZG (10 µg) were heated for 5 min at 95°C and run on a 12.5% SDS-gel, blotted onto 
a nitrocellulose. The membrane was cut in-between lanes and each lane was incubated with a different 
primary antibody fraction under equal conditions. Blots were developed simultaneously.  
Figure 31: Immunoblot analysis of ZG16 antibody fractions 
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5.5 Discussion to Proteins Identified by Proteomics Studies in Exocrine and 
(Neuro)Endocrine Secretion Systems 
 
Some of the proteins identified by proteomics studies in exocrine and (neuro)endocrine 
secretion systems are suspected to play similar roles in both places. The scope of this part of my 
thesis was to identify further ZG membrane and matrix proteins of the rat ZG which might be 
shared by SV as well. Proteins identified by mass spectrometric methods in both systems (ZG and 
SV) were listed in Table 5-1 defining the proteomic overlap indicated by recent publications. 
Furthermore, two different approaches for the separation of ZGM and ZGM associated proteins 
were chosen; 1D gel-electrophoresis and as an off gel approach, liquid chromatography was 
applied. These approaches are better suited for the separation of hydrophobic, high-molecular-
weight and membrane constituents and were combined with the tryptic digestion of proteins 
followed mass spectrometric analysis (Figure 12). Four proteins were selected for further analysis, 
based on our proteomics results and the information given by current publications about 
proteomics studies in ZG and SV, which were Piccolo, Snj-1, APP and ZG16p. 
Nevertheless, with the experiments conducted to detect Piccolo in ZG and subfractions 
and also AR42J cells, it is not yet possible to confirm if Piccolo is a transient part of the ZGM as it 
was suggested after LC-MS/MS analysis of the ZGWash fraction. It is possible that Piccolo is a co-
purification coming from vesicles of the pancreatic β-cells where it was identified previously 
(Fujimoto, Shibasaki et al. 2002). Since further functional studies were disabled, due to problems 
with the available antibodies, the work on this protein is at least temporally intermitted and 
results are not further discussed. However, its putative role as a Ca
2+
 sensor makes it an attractive 
candidate protein in ZG secretion. 
In contrast, Snj-1 could be detected in immunoblot analysis in the positive control of 
synaptosomes and very weakly in a total lysate of rat pancreas, but not in ZG subfractions (ZGM, 
ZGMwashed, ZGWash and ZGC), or AR42J cell lysates (Figure 21). Furthermore, the Snj-1 specific 
antibody revealed a high sensitivity regarding the state of denaturation/folding of the protein 
making detection by immunoblot experiments in samples with a low Snj-1 concentration 
challenging. In immunofluorescence experiments, Snj-1 revealed its low expression in AR42J cells. 
Independent from their state of differentiation, AR42J cells show a weak punctate staining 
pattern close to the cells peripheries, not colocalising with the ZG marker protein 
Carboxypeptidase (Figure 22 A-F). Evaluating the obtained results for Snj-1, it is very unlikely that 
this protein is involved in ZG trafficking since in none of the experiment Snj-1 localized to ZG. 
Probably, Snj-1 appeared in LC-MS/MS analysis due to a co-purification, being attached to co-
isolated endocytotic vesicles or membranes from ruptured vesicles constituting an impurity in the 
ZG preparation. The very weak positive band for Snj-1 in the pancreatic homogenate from Figure 
21 is most likely caused by endosomal vesicles coming from the pancreatic β-cells in which Snj-1 
was identified previously (Hoy, Maechler et al. 2002). 
APP was identified in a ZGM associated subfraction by recent proteomics approaches 
(Rindler, Xu et al. 2007; Chen and Andrews 2008) implying a role in ZG exocytosis. In immunoblot 
analysis APP was not detected in ZG, or ZG subfractions, but in AR42J cell lysates (Figure 23). 
Probable due to an incompatibility of our immunofluorescence protocol with the APP specific 
antibody, endogenous APP could not be detected in AR42J cells. Conducting overexpression 
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experiments with an APP-GFP fusion protein in AR42J cells (Figure 24), however revealed a 
cytosolic staining for APP-GFP, but also a specific colocalisation with ER, Golgi and lysosomal 
marker proteins (Figure 24 E-O). Much more important, the strongest colocalisation was detected 
with Chymotrypsinogen as a ZG marker protein (Figure 24 A-C). APP is known to enter the 
secretory pathway due to its ER-targeting signal form where it is translocated to the trans-Golgi 
network. Hence, it is possible that very low amounts of endogenous  APP are sorted into ZG being 
to low for an antibody detection. By overexpression studies it could be proven that APP is sorted 
into ZG where it was prevously identified by proteomics studies (Rindler, Xu et al. 2007; Chen and 
Andrews 2008). If this sorting to ZG is the result of a mistargeting, or relates to some physiological 
function remains at this state of our studies unclear. To unraveal its possible function/s in ZG 
might become subject of future studies. 
ZG16p (16 kDa), a potential component of the submembranous matrix in ZG, was for the 
first time identified in a rat brain, lysate by a 1D-MS/MS approach with a very low Mascot score of 
15 in a band > 220 kDa (Figure 25). With its appearance in rat brain it became an interesting 
candidate which might be shared by exocrine and (neuro)endocrine secretion systems and thus, 
ZG16p was selected for further analyses in rat brain. By semi quantitative-RT PCR (Figure 27), 
immunoblot analysis (Figure 26) and immunofluorescence experiments (Figure 28 and Figure 29) 
the expression of ZG16p could be confirmed in rat brain. In a semi-quantitative RT-PCR testing rat 
brain tissue for ZG16 mRNA, it was found to be expressed on mRNA level after sequencing the 
characteristic ZG16 cDNA band (see Appendix, Figure 27 A). In a second, semi-quantitative RT-PCR 
approach, different brain tissue sections were tested for the expression of ZG16 mRNA (Figure 27 
B). ZG16 mRNA revealed to be expressed highest in the cerebellum but was also detected in the 
cortex, hypothalamus and hippocampus.  Through its intense and tight folding (folica cerebelli), 
the cerebellum offers a huge surface of gray matter. Furthermore, it has a much higher density 
and activity of neurons then other brain regions. The higher cell activity could explain the 
relatively strong expression of ZG16p in the cerebellum in comparison to other brain areas. In an 
immunohistochemical staining of mouse brain sections with the ZG16 antibodies, it was not 
possible to clarify which cell types are responsible for the ZG16p expression in brain (data not 
shown). In addition, the question remains under which condition/s the protein is expressed or up-
/down regulated in rat brain. In immunoblot experiments, ZG16p appeared enriched in a fraction 
of synaptic vesicles but revealed a slightly higher molecular weight (~1-2 kDa) then in ZG fractions 
from rat pancreas (Figure 26). However, its identity was indirectly confirmed by applying a tryptic 
digestion approach to a synaptic vesicle sample exploiting its protease resistance (unpublished 
data from our laboratory). The result demonstrated that only one protein band at approximately 
16 kDa remained after digestion, while the synaptophysin control was almost completely 
degraded. Even though, it remains unclear why ZG16p in SV´s appears at a sightly higher 
molecular weigth than in ZGs. In immunofluorescence experiments with rat primary neuronal 
cultures originating in the hippocampus region (Figure 29 A and B), a colocalisation coefficients 
with several subcellular marker proteins was defined. Through a pixel-by-pixel analysis, ZG16p 
revealed a strong colocalisation with the RNA granule marker hRnp and the post-synaptic marker 
PSD95, pointing to the possibility that ZG16p might be secreted into the synaptic cleft in brain. 
Further, a prominent colocalisation of a ZG16p staining with the Golgi marker p115 could be 
observed in co-isolated glia cells. These cells surround neurons and hold them in place. They are 
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responsible for the supply of nutrients and oxygen to neurons, they insulate one neuron from 
another, destroy pathogens and remove dead neurons. It is supposed that these cells play a 
crucial role in neurological diseases like Alzheimer’s disease, and it was proven that they are 
important for the regulation of neuronal repair after injury (Barres 2008). Also, it is known that 
ZG16p enters the secretory pathway colocalizing in parts with the Golgi marker p115. But it is not 
completely clear yet, if ZG16p from the exocrine pancreas is secreted into the pancreatic duct 
system, or if it remains attached to the ZGM or apical membrane during the exocytosis process 
and is recycled back via the endosomal-lysosomal pathway. In neurons, the indication points to a 
secretion into the synaptic cleft where ZG16p could be involved in the organisation of the post-
synaptic glycocalix consisting of a variety of scaffold proteins (Cheng, Hoogenraad et al. 2006; 
Chen, Winters et al. 2008), or it could be part of immunologic synapses allowing the activation of 
a unique T-cell (Sigal 2005). 
Additionally, an antibody characterisation after IgG enrichment of a full-length and a 
peptide anitbody directed to ZG16p demonstrated that both antibodies recognize ZGs in 
immunofluorescence experiments (Figure 30). In immunoblot analysis (Figure 31), both antibodies 
recognize the characteristic band for ZG16p at the monomer level (16 kDa) plus four additional 
bands at approximately 18, 32, 50 and 60 kDa in a fraction of complete zymogen granules, 
supporting the results obtained with the peptide antibody. It was recently demonstrated that 
ZG16p possesses positively-charged lysine and arginine residue cluster close to the putative sugar-
binding site specifically interacting with highly sulfated heparan sulfate chains of proteoglycans at 
the ZGM (Kanagawa, Satoh et al. 2011; Kumazawa-Inoue, Mimura et al. 2011). The core proteins 
of these proteoglycans revealed, after a heparin lyase II digestion, molecular masses of 66 and 35-
40 kDa. However, the core proteins itself have not been identified yet. Kumazawa-Inoue et al. 
(2011) also demonstrated that ZG16p changes its conformation only under stringend conditions 
(5 min, 98˚C in Laemmli buffer containing 5% mercaptoethanol). Nevertheless, in my experiment 
it remains demonstrated that ZG16p may still be bound to some HMW protein or complex under 
the denaturing conditions of the SDS-gel. A computational sequence analysis of rat ZG16p, 
searching for eventually unknown isoforms revealed that ZG16p does not have any isoforms. 
Theoretically, it is possible that both antibodies are able to recognize the ZG16p paraloge 
ZG16b/PAUF which is around 21 kDa in humans and has not been decribed yet in rat. A sequence 
alignment comparing both proteins and highlighting the binding site for the peptide antibody is 
added in the Appendix section. As a protease resistent protein, the eventual accumulation of 
ZG16p in the brain might lead to unexpected complications like in Alzheimer’s disease with 
amyloid plaques. These last findings give a new twist for the localisation of ZG16p and its eventual 
role(s) in rat brain. ZG16ps` capacity to bind highly sulphated heparan chains of proteoglycans 
with the highest specificity for heparin, in ZG (Kumazawa-Inoue, Mimura et al. 2011) might also be 
relevant for the packaging of RNA in neurons, which remains to be proven by future experiments. 
Heparan sulfate is suggested to be involved in cell-cell recognition phenomena and in the control 
of cell growth while heparin is proposed to be mainly involved in defence mechanisms against 
bacteria and other foreign material (Nader, Chavante et al. 1999).  
In very recent publications, ZG16p´s carbohydrate binding motif has been resolved and 
found to bind mannose/glucose-type glycans (Kanagawa, Satoh et al. 2011). ZG16p was found to 
bind to pathogenic fungi in the digestive system (Tateno, Yabe et al. 2011) underlining ZG16p´s 
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probable protective function. Hence, ZG16p is considered to contribute to immune defense by 
physically capturing and/or sensing pathogenic fungi (Tateno, Yabe et al. 2011). Considering the 
fact that ZG16p is an evolutionary highly conserved protein distributed from fishes to human 
(Figure 7), it might be a novel evolutionary ancient molecule required for immune defense in the 
digestive system (Tateno, Yabe et al. 2011). Still, its exact function/s in the exocrine pancreas and 
brain remain unclear and will be subject of future studies. Since ZG16p was found to be expressed 
in the exocrine pancreas (Cronshagen, Voland et al. 1994), and on mRNA level in the endocrine 
system brain (Kury, Abankwa et al. 2004), ZG16p might be the right tool to obtain new insights 
into the similarity of exocrine and neuroendocrine secretion and apical targeting. 
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Chapter 6  Modulating Zymogen Granule Formation in Pancreatic AR42J 
Cells 
 
The acinar cells of the exocrine pancreas are specialized in the synthesis, mass 
packaging/sorting, storage and regulated secretion of a complex mixture of digestive enzymes. 
The variety of pancreatic digestive enzymes is packaged in a condensed and predominantly 
inactive form into large (approx. 1 µm in diameter) secretory organelles, so called zymogen 
granules (ZG), which are released by regulated apical secretion, triggered by external stimuli. ZG 
formation is initiated at the trans-Golgi network (TGN) where the regulated secretory ZG proteins 
co-aggregate at the mildly acidic pH and high calcium levels and condensing vacuoles/immature 
secretory granules are formed (Freedman and Scheele 1993; Leblond, Viau et al. 1993; Colomer, 
Kicska et al. 1996; Dartsch, Kleene et al. 1998). They mature by further concentration of the cargo 
proteins with selective removal of components not destined for regulated secretion. The mature 
ZG are stored at the apical pole of the acinar cells and release their cargo via exocytosis in a 
calcium-dependent manner upon neuronal or hormonal stimulation into the apical lumen and the 
pancreatic duct system. The digestive enzymes are finally activated by enterokinase via 
proteolytic cleavage of trypsinogen in the small intestine (Introduction 1.1). 
Although the ZG has long been a model for the understanding of secretory granule 
biogenesis and functions, the molecular mechanisms required for ZG formation at the TGN, for 
packaging and sorting of cargo proteins, as well as for granule fusion and exocytosis are still 
poorly defined (Kleene, Dartsch et al. 1999; Schrader 2004; Dikeakos and Reudelhuber 2007; 
Gomez-Lazaro, Rinn et al. 2010). According to recent models, part of the molecular machinery 
required for digestive enzyme sorting, granule trafficking and exocytosis is supposed to be 
associated with the granule membrane (ZGM). In addition to basic research interests, ZG play 
important roles in pancreatic injury and disease (Introduction 1.1). 
The understanding of ZG biogenesis requires suitable cell culture models. Pancreatic 
AR42J cells have been used as a model system for granule formation and pancreatic exocrine 
secretion. They were originally derived from a rat pancreatic tumour following exposure to 
azaserine (Longnecker, Lilja et al. 1979). Treatment with the synthetic glucocorticoid 
dexamethasone induces the differentiation of AR42J cells into exocrine, acinar-like cells and the 
de novo formation of electron-opaque secretory granules, which contain the major pancreatic 
zymogens (Logsdon, Moessner et al. 1985). Remarkably, long-term treatment with 
dexamethasone has been shown to induce transdifferentiation to hepatocytes, and loss of the 
acinar phenotype (Shen, Slack et al. 2000). AR42J cells display stimulated secretion of amylase in 
response to cholecystokinin or acetylcholine (Logsdon 1986). However, compared to acinar cells 
from rat pancreas, stimulated secretion in AR42J cells is suboptimal (Arvan and Castle 1987), 
AR42J cells are non-polarised, do not express all rat ZG proteins, and exhibit smaller ZG (Logsdon, 
Moessner et al. 1985). 
In this chapter, we show that granule formation in AR42J cells can be modulated by 
altering the growth conditions in cell culture. Cultivation of AR42J cells in Panserin, a serum-free 
medium, resulted in enhanced induction of granule formation, expression of ZG proteins and an 
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increase in granule size compared to serum-containing DMEM. Our data indicate that this effect is 
based on the stronger stimulatory effect of Panserin on differentiation of AR42J cells. To 
investigate if an enhanced expression of ZG proteins is sufficient to initiate granule formation, we 
expressed several zymogens and ZG membrane proteins in non-stimulated AR42J cells and in 
constitutively secreting COS-7 cells. Neither single expression nor co-expression was sufficient to 
initiate granule formation in AR42J cells or granule-like structures in COS-7 cells as described for 
neuroendocrine cargo proteins. The importance of our findings for granule formation in exocrine 
cells is discussed. 
 
 
6.1 Stimulation of Granule Formation in AR42J Cells by Altered Growth 
Conditions 
 
To investigate the suitability of PaM for long term applications and its effect on 
differentiation and granule formation, AR42J cells were incubated in PaM or DMEM for 24 hours 
before granule formation was induced by the addition of 10 nM dexamethasone (3.6.1-3.6.2). 
Cells were processed for immunofluorescence after 48 and 72 hours and incubated with 
antibodies directed to carboxypeptidase A, a prominent granule marker protein (3.7.1, Figure 32) 
(Faust, Gomez-Lazaro et al. 2008). Immunofluorescence of dexamethasone-treated cells cultured 
in DMEM or PaM revealed the induction of numerous secretory granules positive for 
carboxypeptidase A under both experimental conditions (Figure 32). Interestingly, the number of 
cells containing granules appeared to be higher in PaM than in DMEM after dexamethasone-
treatment. Furthermore, the granules in many cells appeared to be larger and occasionally more 
frequent than in DMEM. Quantitative analysis of the morphological observations revealed that 
74.9 ± 4.9% of the dexamethasone-stimulated cells in PaM exhibited a prominent granular 
staining pattern compared to 62.4 ± 4.6% in DMEM (3.7.2). A stronger stimulatory activity of PaM 
on granule formation in AR42J cells was also visible in controls without dexamethasone. In DMEM 
controls, the vast majority of the cells were usually negative for carboxypeptidase, whereas about 
4-8% of the cells exhibited a strong labeling of the Golgi apparatus as well as a faint staining of 
vesicular and/or granular structures, which might represent constitutive cargo containers, 
presumably due to self-stimulation (Figure 32 C). Cultivation in PaM (without dexamethasone) 
revealed an increase in the number of cells with a Golgi-labeling and granular staining of 
carboxypeptidase A further supporting its stronger stimulatory effect on differentiation, zymogen 
induction and granule formation. It should be noted that PaM does not contain any 
glucocorticoids, which may account for a stronger induction of cellular differentiation 
(information provided by the manufacturer). Similar observations were made when antibodies to 
amylase or chymotrypsinogen were used (not shown).  
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Alterations in granule size were confirmed by ultrastructural studies (Figure 33). In 
dexamethasone-stimulated cells cultured in DMEM, electron-opaque secretory granules with a 
diameter of 0.1-0.5 µm were observed in 72 ± 6% of the cells. In stimulated cells cultured in PaM, 
secretory granules with a diameter of up to 1 µm were occasionally observed in addition to 
smaller ones (0.1-0.5 µm). In unstimulated controls electron-dense granular structures were 
mainly absent (4 ± 2% of the cells in DMEM; 12 ± 6% of the cells in PaM), but when detected were 
similar in size to those observed in DMEM containing dexamethasone (not shown). 
 
 
 
 
 
 
 
AR42J cells were cultured in DMEM (A, B) or 
PaM (C, D) and stimulated for granule 
formation with dexamethasone (B, D), (A, C) 
show untreated controls. After 72 h cells 
were processed for immunofluorescence 
using an antibody directed to 
carboxypeptidase A. Images were acquired 
on an Olympus IX81 fluorescence 
microscope. (E) Quantitative evaluation of 
granule formation under the different 
culture conditions after 72 h. Data are from 
3-4 independent experiments and are 
presented as means ± S.D. (*p<0.01, 
#p<0.05, when compared to controls). Bar, 
10 µm. 
 
Figure 32: AR42J cells reveal a stronger ZG 
induction in PaM then in DMEM medium 
98 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.2 Stimulation of Differentiation of AR42J Cells by Altered Growth 
Conditions 
 
We next analyzed cellular growth, morphology and mitotic index of AR42J cells cultured in 
DMEM and PaM with and without dexamethasone. Cellular growth rates under the different 
experimental conditions were determined by cell counting over a period of 7 days. AR42J cells 
grown in DMEM or PaM in the absence of dexamethasone exhibited a similar growth pattern: 
after a phase of adaptation, cell numbers started to increased after approximately 72 hours 
reaching a maximum after 144 hours (Figure 34). However, cells grown in DMEM showed slightly 
higher growth rates compared to PaM. In contrast, cells grown in DMEM or PaM in the presence 
of dexamethasone showed only a slight increase in cell number due to their differentiation into 
acinar-like cells (Figure 34). In line with this, the mitotic index of DMEM grown control cells was 
slightly higher than the one of PaM grown controls (Figure 34, Pam-D). In contrast, the mitotic 
index of dexamethasone-induced cells was reduced to around 1% in both DMEM and PaM 
indicating differentiation of the cultures. 
 
 
 
 
 
 
 
Electron micrograph of granules in AR42J cells which were cultured in PaM (A) or DMEM (B) and induced for 
granule formation with dexamethasone for 72 h before being processed for electron microscopy.  
Arrowheads in (A and B) indicate zymogen granules. Granules in (A) have a diameter of up to 1 µm, while 
diameters of granules in (B) are between 0.1 – 0.5 µm. M, mitochondria. EM preparations were performed 
with help and support of B. Agricola, University of Marburg. Magnification of images, 1:7500.  
Figure 33: Stimulated AR42J cells form up to 10 times bigger granules when cultured in Panserin than in 
DMEM 
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Interestingly, differentiation into acinar-like cells in the presence of dexamethasone was 
accompanied by alterations of cell morphology. Whereas in the absence of dexamethasone the 
majority of the cells grown in DMEM or PaM exhibited a spindle-like morphology, treatment with 
dexamethasone resulted in a prominent increase in cell size and establishment of a hexagonal, 
cobble-stone-like morphology (Figure 35). Cells grown in PaM plus dexamethasone appeared to 
be larger than the ones grown in DMEM plus dexamethasone. Furthermore, a higher percentage 
of apoptotic cells was observed in PaM after 72 hours of dexamethasone-stimulation. Taken 
together, these observations support the notion that PaM (plus dexamethasone) exerts a stronger 
stimulatory effect on the differentiation of AR42J cells into exocrine, acinar-like cells than 
stimulation in DMEM. 
 
 
 
 
 
 
In (A) the cellular growth rates of AR42J 
cells cultured under different conditions 
(DMEM and Panserin, induced for ZG 
formation with dexamethasone (+D) and 
untreated controls (-D)) were determined 
by cell counting over a period of 144 h. In 
(B) the mitotic index of AR42J cells was 
determined after 72 h. The results of the 
quantitative analysis presented originate 
from 3-4 independent experiments and 
are presented as means ± S.D. (*p<0.01). 
Figure 34: Growth rates and mitotic 
index of AR42J cells under different 
experimental conditions.  
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6.3 Enhanced Expression of ZG Membrane Proteins by Altered Growth 
Conditions 
 
To investigate whether the enhanced differentiation and granule formation of AR42J cells 
in PaM medium was as well accompanied by an increase in the expression levels of ZG granule 
constituents, we performed RT-PCR and immunoblotting experiments (Figure 36). We first 
analyzed the mRNA expression levels of ZG markers by RT-PCR in AR42J cells grown in DMEM or 
PaM in the absence and presence of dexamethasone (Figure 36). The administration of 
dexamethasone induced the mRNA levels of typical digestive enzymes such as amylase or 
carboxypeptidase A in both DMEM and PaM in the presence of dexamethasone. mRNA levels 
were low or undetectable in the absence of dexamethasone in DMEM, but slightly increased in 
PaM. Interestingly, the mRNA levels of membrane markers appeared to be higher in PaM plus 
dexamethasone than in DMEM plus dexamethasone. The mRNA level of ZG16p, a membrane-
associated secretory lectin supposed to be involved in protein sorting/membrane attachment was 
prominently increased in PaM (plus dexamethasone). Interestingly, the mRNA for GP2, a major 
GPI-anchored membrane glycoprotein, was induced in PaM (plus dexamethasone), whereas it 
was absent in DMEM (plus dexamethasone). The latter is consistent with published results 
indicating that AR42J cells do not express high levels of GP2 after dexamethasone-stimulation (Yu, 
Michie et al. 2004). GAPDH served as a loading control. These data indicate that cultivation of 
AR42J cells in PaM plus dexamethasone can be of advantage for the expression of ZG membrane 
and membrane-associated proteins. 
The RT-PCR data were partially confirmed by immunoblotting analysis of AR42J cell lysates 
(Figure 36). The digestive enzymes amylase and carboxypeptidase A showed comparable protein 
expression levels in both DMEM and PaM in the presence of dexamethasone. Furthermore, 
ZG16p protein levels were slightly more increased in PaM plus dexamethasone than in DMEM 
plus dexamethasone. However, GP2 was barely detectable on the protein level in both PaM and 
AR42J cells were cultured under different 
conditions and examined by phase contrast 
after 72 h. Cells exhibit in the absence of 
dexamethasone in DMEM and PaM a 
spindle-like morphology (A, C). A treatment 
with dexamethasone resulted in a 
prominent increase in cell size and 
establishment of a hexagonal morphology 
(B, D). Additionally, cells grown in PaM + 
Dexa appeared to be larger than in DMEM 
+Dexa and revealed a more cobble-stone-
like morphology. Scale bar 100 µm. 
 
 
 
Figure 35: Alterations of AR42J cell 
morphology under different culture 
conditions. 
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DMEM (plus dexamethasone) indicating that it is of low abundance in cell lysates. Actin served as 
a loading control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.4 Expression of ZG Proteins is not Sufficient to Induce Granule Formation in 
AR42J Cells 
 
We assumed that an increased expression of ZG proteins as observed e.g. after 
glucocorticoid-stimulation of AR42J cells in PaM may be responsible for an increase in ZG 
formation and in ZG size. To test this hypothesis, we generated expression constructs encoding 
for amylase-YFP, trypsinogen-YFP, carboxypeptidase-Myc, GP2, and Myc-ZG16p under control of a 
CMV promoter (3.5.5). To examine if the exogenously expressed ZG proteins were properly sorted 
to ZG granules, AR42J cells were transfected by electroporation with the constructs generated 
and stimulated for granule formation in DMEM by adding dexamethasone. After 2-3 days, cells 
were processed for indirect immunofluorescence. For colocalisation studies antibodies directed to 
carboxypeptidase A, chymotrypsinogen, GP2 or the Myc-epitope were used (Figure 37). 
 
 
 
 
 
 
(A) For RT-PCR, total RNA was extracted from AR42J cells after 48 h cultured under four different culture 
conditions (see Figure 34). Total mRNA was transcribed into cDNA (3.5.1-3.5.3). Equal amounts of cDNA 
(150 ng) were used for a 50 µL semi-quantitative-RT-PCR with species specific primers for amylase, 
carboxypeptidase, ZG16 and GP2. GAPDH served as loading control. (B) for immunoblot analysis, equal 
amounts of cell lysates (20 µg) from differentially cultured AR42J cells were run on 12.5% polyacrylamide 
gels, blotted onto nitrocellulose and incubated with antibodies directed to amylase, carboxypeptidase A, 
ZG16p and GP2. An antibody to actin served as loading control.  
 
Figure 36: Expression of ZG constituents in AR42J cells under the different experimental conditions on 
transcription and translational level. 
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All exogenously expressed ZG proteins were observed to enter the secretory pathway in 
stimulated AR42J cells and were properly sorted to ZG as indicated by colocalization with 
appropriate ZG marker proteins (Figure 37 A). Furthermore, the ZG membrane protein GP2 
exhibited a strong targeting to the plasma membrane (Figure 37). Next, we investigated whether 
the exogenous expression of the ZG proteins was sufficient to induce granule formation in AR42J 
cells in the absence of dexamethasone (Figure 37 B). The ZG content proteins amylase, 
trypsinogen and carboxypeptidase were detected in the Golgi apparatus, the ZG membrane 
associated protein ZG16p was detected in the ER of AR42J cells and the ZG membrane protein 
GP2 was detected at the plasma membrane, but the formation of typical granules (as seen in 
Figure 37 A) was not observed. Similar results were obtained when two different ZG marker 
proteins were co-expressed. Neither the co-expression of regulated secretory proteins (amylase, 
trypsinogen, and carboxypeptidase) nor the co-expression of ZG membrane proteins (ZG16p, GP2) 
or a combination of both resulted in the generation of ZG granules (Table 6-1). These results 
indicate that the overexpression of one or two ZG proteins in AR42J cells is not sufficient to 
induce granule formation. 
 
AR42J cells transfected by 
electroporation with generated 
constructs (amylase-YFP, 
trypsinogen-YFP, 
carboxypeptidase-Myc, GP2 and 
Myc-ZG16p) were stimulated for 
granule formation in DMEM by 
adding dexamethasone and 
served as controls for the 
correct targeting of transfected 
constructs into ZG (A). (B) 
Represents transfected but 
unstimulated cells. After 2-3 
days, cells were processed for 
indirect immunofluorescence. 
For colocalisation studies 
antibodies directed to, 
Chymotrypsinogen (Chymo), 
GP2 or the Myc-epitope were 
used. Images were acquired on 
an Olympus IX81 fluorescence 
microscope. Scale bars, 10 µm.  
Figure 37: The expression of ZG 
constituents in AR42J cells does 
not induce or alter ZG 
formation.  
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The combinations CBP/Myc-ZG16p and CBP-Myc/GP2 could not be tested in AR42J cells due to their endogenous 
expression of carboxypeptidase and the available antibodies. The shortcut Memb. stands for plasma membrane. 
 
 
6.5 Expression of ZG Proteins is not Sufficient to Generate Granule-Like 
Structures in Constitutively Secreting COS-7 Cells 
 
As it has been demonstrated that the overexpression of (neuro)endocrine regulated cargo 
proteins in non-endocrine, constitutively secreting cells (e.g. COS-1, COS-7, NIH-3T3) is sufficient 
to initiate the formation of granule-like structures (Kim, Tao-Cheng et al. 2001; Huh, Jeon et al. 
2003; Beuret, Stettler et al. 2004; Inomoto, Umemura et al. 2007; Stettler, Beuret et al. 2009), we 
as well overexpressed the exocrine ZG marker proteins in COS-7 cells, which lack a regulated 
secretory pathway. COS-7 cells were transfected by electroporation (3.6.3.2) with the constructs 
generated (3.3, 3.4, 3.5.5) and processed for immunofluorescence (3.7.1) after 24-72 hours. All 
exogenously expressed ZG proteins were found to label the ER and Golgi, which is typical for 
secretory proteins whose rate-limiting step in secretion is folding within and exit from the ER. 
However, no additional staining of granule-like structures or protein accumulations in post-Golgi 
organelles were observed as described after expression of neuroendocrine cargo proteins 
(Beuret, Stettler et al. 2004; Inomoto, Umemura et al. 2007; Stettler, Beuret et al. 2009). Even 
ZG16p, a secretory lectin supposed to act as a linker or helper protein in ZG granule 
sorting/formation, localised to the ER and did not induce granule-like structures (Figure 38). The 
ZG membrane protein GP2 was targeted to the plasma membrane due to its GPI anchor, besides 
the staining of the Golgi (Figure 38). Similar results were obtained when two ZG proteins were co-
expressed (Table 6-1). These findings indicate that the ZG proteins tested do not possess the 
intrinsic information to induce the formation of granule-like structures in constitutively secreting 
COS-7 cells. Interestingly, this is in contrast to (neuro)endocrine cargo proteins (Beuret, Stettler et 
al. 2004; Inomoto, Umemura et al. 2007; Stettler, Beuret et al. 2009). 
 
Table 6-1 Combination of tested double transfections with ZG proteins in AR42J and COS-7 cells 
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6.6 Discussion 
 
In this study we demonstrate that granule formation in pancreatic AR42J cells can be 
modulated by growth conditions in cell culture. We show that cultivation of AR42J cells in 
Panserin 401, a serum-free medium (PaM), which includes trace elements, albumin, cholesterol, 
soya lipids and vitamins, but no growth or attachment factors or any insulin, promotes the 
induction of granule formation, the expression of ZG proteins and an increase in granule size 
compared to serum-containing conditions in DMEM, especially when granule-formation is 
stimulated by the addition of the synthetic glucocorticoid dexamethasone. These findings are 
important for the study of granule formation and biogenesis in AR42J cells, as available pancreatic 
exocrine cell models that are as well accessible to molecular manipulations are scarce. 
 Our data indicate that the enhanced granule formation (including granule size and protein 
expression) in PaM is based on its stronger stimulatory effect on the differentiation of AR42J cells 
towards an exocrine phenotype. Enhanced differentiation is reflected by the reduced growth 
rates of AR42J cells in PaM compared to DMEM, a reduction of the mitotic index, a slight increase 
in apoptotic cells and alterations of cell morphology including an increase in cell size and 
development of a hexagonal, cobble-stone-like morphology. Interestingly, secretory granules 
comparable in size to those of the rat exocrine pancreas are observed in PaM plus 
dexamethasone, whereas in DMEM plus dexamethasone they are usually smaller in size. 
Furthermore, in PaM the expression of ZG proteins (e.g. ZG16p) is increased both on the mRNA 
COS-7 cells were transfected by electroporation with the following constructs: amylase-YFP, trypsinogen-
YFP, carboxypeptidase, GP2 and Myc-ZG16p. After 24-72 h cells were processed for immunofluorescence 
using antibodies to carboryxpepetidase A, GP2 and ZG16. Images were acquired on an Olympus IX81 
fluorescence microscope. Scale bar, 10 µm. 
Figure 38: Expression of ZG proteins in constitutively secreting COS-7 cells. 
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and the protein level. Some of the proteins (e.g. GP-2) are absent or only weakly expressed in 
DMEM. 
 Treatment with glucocorticoids has long been shown to increase the expression of 
amylase in AR42J cells (Logsdon, Moessner et al. 1985), as well as ZG membrane proteins such as 
the SNARE proteins syntaxin-3 (Pevsner, Hsu et al. 1994; Gaisano, Huang et al. 1999), syntaxin-2 
or syntaxin-4, whereas VAMP-3 and syncollin remained undetectable (Gaisano, Huang et al. 1999; 
Hodel and Edwardson 2000). In their induced exocrine state, AR42J cells upregulate as well the 
pancreatitis-associated protein 1 (PAP-1) (Lim, Song et al. 2009). Moreover, AR42J cells have the 
potential to differentiate into endocrine, insulin-producing cells after treatment with activin or 
hepatocyte growth factor (Mashima, Ohnishi et al. 1996; Mashima, Shibata et al. 1996). The 
AR42J-B13 clone appeared to be more susceptible to endocrine differentiation than the parent 
AR42J line. The differentiation capacity of AR42J cells is further underlined by their 
transdifferentiation into hepatocytes through long-term treatment with dexamethasone (Shen, 
Slack et al. 2000). This conversion is associated with the induction of the transcription factor 
C/EBPβ. The hepatocytes produced by the AR42J model exhibit many of the properties of true 
hepatocytes, expressing a range of markers including albumin, glucose-6-phosphatase, 
transferrin, transthyretin and the enzymes for Phase I and II detoxification (Shen, Horb et al. 2003; 
Shen, Burke et al. 2004). Furthermore, a transient loss of constitutive WNT3a expression, 
phosphorylation and depletion of β-catenin were observed before changes into the hepatocyte-
like (B-13/H) cells became visible (Wallace, Marek et al. 2010). 
 The molecular mechanisms of ZG biogenesis and sorting of zymogens in the acinar cells of 
the exocrine pancreas are still incompletely understood (Kleene, Dartsch et al. 1999; Kleene, 
Kastner et al. 1999; Dikeakos and Reudelhuber 2007; Gomez-Lazaro, Rinn et al. 2010). It is also 
unclear how the size and the shape of the relatively large ZG (up to 1 µm in diameter) is regulated 
and maintained. Granule size might be determined by the amount of aggregated cargo proteins 
packaged into ZG, by the removal of non-regulated cargo proteins and membrane (constitutive-
like secretion) (Arvan and Castle 1987), by granule-granule fusion during maturation (Hammel, 
Lagunoff et al. 2010), and by components of the granule membrane itself, e.g. by scaffold proteins 
of a submembranous matrix which contributes to granule size, stability and sorting (Schrader 
2004) (Introduction 1.3). Secretory granule biogenesis in neuroendocrine cells is better 
understood and in contrast to exocrine ZG biogenesis, potential sorting receptors and sorting 
signals have been identified (e.g. carboxypeptidase E, secretogranin III) (Kim, Gondre-Lewis et al. 
2006; Dikeakos and Reudelhuber 2007; Park, Koshimizu et al. 2009; Hosaka and Watanabe 2010; 
Koshimizu, Kim et al. 2010). It has also been shown that granulogenic proteins such as granins 
(e.g. the chromogranins A and B, secretogranin II) and prohormones/proneuropeptides (e.g. pro-
opiomelanocortin, pro-vasopressin, pro-oxytoxin) are able to induce dense-core granule-like 
structures in various non-endocrine cell lines when overexpressed (Kim, Tao-Cheng et al. 2001; 
Huh, Jeon et al. 2003; Beuret, Stettler et al. 2004; Stettler, Beuret et al. 2009). In contrast to 
neuroendocrine cargo proteins, the expression of prominent ZG cargo and membrane proteins 
(e.g. amylase, procarboxypeptidase A, trypsinogen, ZG16p, GP2) alone or in combination was not 
sufficient to induce granule-like structures in constitutively secreting COS-7 cells. The GPI-
anchored major ZG membrane protein GP2 has been found to associate with amylase and other 
secretory proteins in vitro, suggesting a potential role in cargo packaging or sorting (Jacob, Laine 
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et al. 1992; Leblond, Viau et al. 1993; Colomer, Lal et al. 1994). Furthermore, GP2 associates with 
the secretory lectin ZG16p and syncollin in lipid rafts and has been proposed to contribute to the 
formation of a submembranous matrix that functions in ZG formation and packaging (Schmidt, 
Schrader et al. 2001; Kalus, Hodel et al. 2002; Schrader 2004). In addition, the secretory lectin 
ZG16p has been suggested to act as a linker protein between aggregated ZG cargo proteins and 
the granule membrane/submembranous matrix (Kleene, Dartsch et al. 1999). However, these ZG 
proteins mainly localized to the ER or the plasma membrane in COS-7 cells. In addition, enhanced 
expression or co-expression of these ZG proteins in AR42J cells not stimulated for differentiation 
by dexamethasone was insufficient to induce granule formation. In contrast to COS-7 cells, AR42J 
cells possess a regulated secretion machinery. Apparently, none of the ZG cargo or membrane 
proteins tested was able to trigger granule formation or the formation of granule-like structures 
in the absence or the background of a regulated secretion machinery. However, all ZG proteins 
tested were properly targeted to ZG in dexamethasone-stimulated AR42J cells. Similar 
observations were made for GP2 after adenovirus infection of AR42J cells (Yu, Michie et al. 2004). 
Our findings indicate that in contrast to neuroendocrine secretion (Introduction 1.5) additional 
components are likely to be required for proper initiation of ZG formation. These components 
might include helper proteins for cargo aggregation or additional membrane components. Thus, 
ZG biogenesis in the exocrine pancreas is likely to require a more complex machinery, which has 
to ensure the packaging of a complex mixture of cargo proteins in large transport containers. We 
propose that an exocrine gene expression programme for the regulated secretion machinery has 
to be activated in pancreatic acinar cells, as exemplified by dexamethasone-treatment of AR42J 
cells, and that multiple components besides cargo proteins are required to perform the initial 
stages of exocrine granule formation. 
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Chapter 7   Summary and Final Conclusions  
 
Regulated secretion is a complex and fundamental biological process through which 
cellular products (e.g. digestive enzymes, hormones and neurotransmitter) are released into the 
extracellular space. Digestive enzymes are synthesized, sorted and secreted by the acinar cells of 
the exocrine pancreas. Packed and stored in ZG at the apical plasma membrane, the enzymes are 
secreted into the pancreatic duct system upon a hormonal stimulus (regulated srecretion). ZG are 
formed at the TGN via the aggregation of zymogens in an acidic milieu, but little is known about 
the specific interactions of the zymogen aggregates with the TGN/ZG membranes. Under 
discussion are lipid microdomains and a submembranous matrix mainly consisting of a 
proteoglycan scaffold. A some clinical disorders derive from malfunction or interruption of this 
processes which can be caused by mutations leading to problems in sorting and interaction of 
proteins and mostly ending up in an inflammatory process known as pancreatitis. 
Organeller subfractionation, combined with various gel and non-gel based methods, 
followed by proteomis analysis of ZG´s, helped to increase the number of ZG membrane and 
membrane associated constituents. Many of these new ZGM and peripheral proteins could have 
functions in ZG biogenesis, regulated secretion, or even after secretion into the intestinal tract in 
host defence. In addition, many of these proteins were found in other cells and subcellular 
compartments, possibly executing a similar function, which indicates a multitasking of proteins, 
e.g. in the neuroendocrine secretion system of synaptic vesicles. 
One aim of my thesis was to enrich proteins of the ZG matrix (ZGWash fraction) and ZGM, 
by a subfractionation approach, and to identify new ZGM and ZGWash constituents using 
different gel electrophoretic and off-gell approches. These include 1D and 2D-SDS PAGE and liquid 
chromatography combinend with tryptic digestion and mass spectroscopy. Further, emphasis was 
put on the identification of hydrophobic, high-molecular weight (HMW) and proteoglycan binding  
proteins, as well as proteins identified by proteomics studies in the neuroendocrine secretion 
system of synaptice vesicles. Especially for the last mentioned candidates, this included a 
thorough literatur analysis, defining the overlap of proteins identified by proteomics studies in SV 
and ZG. Afterwards, the new peripheral and ZGM constituents were confirmed, localized and also 
characterize by immunoblotting, immunofluorescence and cell culture studies. This should help to 
provide new insights in their possible functions in ZG biogenesis, sorting and packaging and 
regulated secretion. Proteins selected for further confirmation were the proteoglycan binding 
protein Chymase, the HMW proteins Piccolo and Synatpojanin-1, the heparan binding protein 
APP, and the heparin binding ZGWash protein ZG16p which was identified in a reciprocal 
approach in rat brain lysate. All of them revealed low abundance in the fraction in which they 
were identified and were either new, or a clear confirmation was missing. 
As a novel result, Chymase could be confirmed to be part of the submembranous matrix 
of ZG by immunoblot experiments showing a very similar distribution like ZG16p, a protein known 
to be part of the ZG matrix. Chymase is not endogenously expressed in AR42J cells but, 
overexpression experiments with a Chymase-YFP fusion protein revealed a proper targeting to ZG 
in AR42J cells induced for ZG formation. By electron microscopic analysis it was demonstrated 
that the endogenously expressed protein locates to ZG and in comparison to mast cell granules 
Chymase exhibited low abundance. Chymase has a proteoglycan binding capacity and is likely to 
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act as a serine protease after ZG secretion. Its capability to cleave proteins of the extracellular 
matrix (e.g. fibronectin), might be a reason for its low and regulated abundance in ZGs. Piccolo 
and Synaptojanin-1 are both members of the cytoplasmic active zone (CAZ) and were identified by 
LC-MS/MS analysis in the ZGWash fraction. While the work on Piccolo is temporally intermitted, it 
could be demonstrated, by immunoblot and immunofluorescence experiments, that Snj-1 is not a 
ZG constituent. APP, a multifunctional glycoprotein involved in many neuronal processes, was 
subsequently identified twice in the ZGM by proteomics studies (Rindler, Xu et al. 2007; Chen and 
Andrews 2008). By immunoblot analysis, APP was detected in AR42J cell lysates but not in ZG or 
corresponding subfractions. In Immunofluorescence analysis, the endogenous APP could not be 
detected, probably due to a incompatibility with of our protocol with the applied antibody. By 
overexpression experiments with the APP-GFP fusion protein in AR42J cells induced for ZG 
formation, the protein revealed a cytosolic staining but also colocalized in parts with the Golgi, 
lysosomal and ZG markers. The best colocalisation value was obtained for the ZG. As a membrane 
anchored receptor, APP could play a role during the exocytosis of ZG. Besides, it does not only 
function as a membrane-anchored receptor-like molecule, but also as a secreted derivative that 
acts upon other cells, as which it could use ZG as a transport vesicle. 
The secretory lectin ZG16p, a well-known ZGM associated protein, was identified in a rat 
brain lysate by a 1D-SDS PAGE approach, followed by proteomics analysis. In subsequent RT-PCR 
analysis, its presence in rat brain could be confirmed by sequencing. Furthermore,  a higher mRNA 
expression level appeared in rat cortex and the maximum was measured in cerebellum. In the rat 
hippocampus and hypothalamus a very weak expression was detected. By immunoblot analysis, 
the protein appeared to be enriched in a SV fraction. Due to problems in immunofluorescence 
(IMF) with the antibody staining of ZG16p in neuronal culture, different protocols for hidden 
antigens were tested and a strong improvement was observed by exchanging Triton X-100 against 
SDS. In subsequent IMF analysis of rat primary culture, ZG16p colocalized best with the RNA 
granule marker hRnp and at the post-synaptic marker PSD95. In brain, ZG16p can be involved in 
processes such as the sorting, packaging and maturation of synaptic vesicles, or RNA granules. 
Since it colocalized with the post synaptic marker PSD95, it might as well have a function after 
being released into the intracellular space, e.g. in immune defense by binding to pathogens or in 
wound healing processes (tissue regeneration). Additionally, ZG16p was found in human liver and 
downregulated in hepatocarcinoma, thus suggesting medically relevant functions. However, the 
proteins exact functions in the exocrine pancreas, brain and liver remain unclear and will be 
subject of future studies. ZG16p might be the right tool to obtain new insights into the similarity 
of exocrine and neuroendocrine secretion and apical targeting. 
The results obtained by proteomics approaches revealed that the increasing sensitivity of 
proteomics methods does not only lead to the discovery of more and new ZG constituents, but 
also leads to a higher possibility of detecting contaminants caused by the method of tissue 
homogenisation, isolation of ZG and corresponding subfractions. For that reason, it is absolutly 
necessary to confirm mass spectroscopic results with further methods such as immunoblotting, 
immunofluorescence, knock-down, overexpression experiment and others. In addition, a 
thorough investigation of their biological functions is required. 
Part of the last objective was to modulate and investigate ZG formation under different 
culture conditions. It was demonstrated that the granule formation, by culturing in the serum free 
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medium Panserin is slightly increased in AR42J cells not stimulated for ZG formation. In stimulated 
cells, granules appeared bigger and the expression of typical granules proteins was upregulated. 
Unraveling the role and importance of the expression of ZG proteins in ZG biogenesis and 
formation was the last addressed point. The overexpression of content (Amylase, 
Carboxypeptidase and Trypsinogen), matrix (ZG16p) and membrane (GP2) proteins in untreated 
AR42J cells and in constitutively secreting COS-7 cells, alone or in combination, showed that these 
proteins are not sufficient to initiate granule formation in AR42J cells and also not to activate an 
eventually existing secretion machinery in COS-7 cells. In both cell types content and matrix 
proteins accumulated in the ER and Golgi, while GP2 was distributed to the plasma membrane. 
Furthermore, no alterations in granule morphology, or number were observed in dexamethasone-
stimulated AR42J cells, after overexpression of the upper mentioned ZG proteins alone or in any 
combination. 
These findings indicate that in contrast to neuroendocrine secretion, additional 
components are likely to be required for proper initiation of ZG formation. These components 
might include helper proteins for cargo aggregation or additional membrane components. Thus, 
ZG biogenesis in the exocrine pancreas is likely to require a more complex machinery, which has 
to ensure the packaging of a complex mixture of cargo proteins in large transport containers. 
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Chapter 8  Future Perspectives 
 
Besides the new insights this work provided into the composition of the ZG matrix, a 
number of new questions has raised. Since the components of the ZGM and the submembranous 
matrix (ZGWash fraction) might play important roles in the biogenesis of ZG, sorting and packing 
of zymogens, they are also important for the understanding and treatment of pathophysiological 
processes such as pancreatitis. In this context, future studies will be aimed at the further 
identification of ZG membrane and Wash proteins (matrix components), by proteomics 
approaches, and already identified new or low abundant proteins will be futher characterised by 
immunofluorescence and immunoelectron microscopy for intracellular localisation. Immuno pull 
down exeriments and siRNA knockdown studies e.g. with APP in AR42J cells and for ZG16p also in 
neuronal primary culture will help to elucidate their function and maybe also reveal further 
unkown ZG components. Additionally, the strong membrane association of some ZG content 
proteins strengthens the hypothesis of the submembranous matrix and its role in ZG formation. 
For this purpose, Chymase, ZG16p and APP expressed as recombinant wild type and 
mutated proteins, could be used for binding assays in which their affinity to specific proteoglycans 
should be identified. Moreover, by cloning a tagged version of the membrane integrated part for 
APP, it would be possible to determine in which types of membranes APP is integrated. In 
addition, using specific IMF techniques (differentiated permeabilisation e.g. with digitonin), the 
exact location of the protein (if on the luminal or cytosolic side) could be determined. 
Uptake experiments, with purified proteins, followed by life cell imaging for observing 
their pathway throughout the cell could be performed. Transcription regulation in AR42J cells 
stimulated for ZG formation and controls could help to determine if the expression levels are in 
anyway depending on the cells state of differentiation. 
The expression of mutant versions of ZG16p, in which the sugar-binding motif will be 
altered, will help to define ZG16p’s sugar binding specificity in combination with frontal affinity 
chromatography. By silencing of ZG16p in primary neuronal culture (or expression of ZG16p 
mutants), ZG16p’s relevance for synaptic vesicle formation, sorting/trafficking of cargo, or 
acquisition of polarity (such as dendrite/axon) and synapse formation (by morphological, 
biochemical studies) will be evaluated. The parallel knockdown studies in pancreatic AR42J cells 
and primary neuronal cultures will help to elucidate putative common principles in exocrine and 
neuroendocrine secretion. In another approach ZG16p´s relevance in immune defence could be 
addressed by testing its binding ability to pathogens coming from bacteria or to bacteria itself. 
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Supplementary Figure 1: Sequence alignement of ZG16p against the peptide sequence used to generate 
peptide antibody (red box) (A). (B) Sequence alignement of the ZG16p paralogue ZG16bp/PAUF against the 
peptide sequence which was used to generate the peptide antibody (red box). Due to the alignment result a 
recognition of PAUF by the peptide antibody can not be excluded. But based on a lower sequence 
agreement the recognition of PAUF is supposedly less efficient then the one of ZG16p. 
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Supplementary Figure 2: Sequence alignement of ZG16p against the ZG16p paralogue ZG16bp/PAUF 
highlighting the recognition sequence for the peptide AB in the red box. ZG16bp/PAUF is to 30% identical 
(double dots) to ZG16p, 18% of amino acids are conserved substitutes (one dot) and around 14% are semi-
conserved amino acids. 
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Supplementary Figure 3: Sequence alignment of rat pancreatic ZG16 mRNA versus the rat brain ZG16 
mRNA/cDNA sequence. Red boxes mark primer sites. 
 
 
 
 
 
 
 
137 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 4: Example of the localisation of the ZG protein constructs in unstimulated AR42J 
cells in the ER and Golgi compartment. Unstimulated AR42J cells transfected with trypsinogen-YFP, or 
Myc-ZG16p were processed for indirect immunofluorescence after 2-3 days in culture and labelled with 
antibodies directed to ZG16p, p115 as Golgi marker and PDI as ER marker. Images were acquired on an 
Olympus IX81 fluorescence microscope. Scale bars, 10 µm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 5: Example of the localisation of the ZG protein constructs in COS-7 cells in the ER 
and Golgi compartment. COS7 cells transfected with trypsinogen-YFP, or Myc-ZG16p were processed for 
indirect immunofluorescence after 1-2 days in culture and labelled with antibodies directed to ZG16p, p115 
138 
 
as Golgi marker and PDI as ER marker. Images were acquired on an Olympus IX81 fluorescence microscope. 
Scale bars, 10 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 6: Example for double transfected unstimulated AR42J and COS-7 cells. 
Unstimulated AR42J cells (A-C) and COS-7 cells (D-F) were double transfected with amylase-YFP and GP2 
and were processed for indirect immunofluorescence after 2-3 days in culture and labelled with an antibody 
directed to GP2. (G-I) show double COS-7 cells double transfected with carboxypeptidase A and GP2 and 
were processed for indirect immunofluorescence after 2-3 days in culture and labelled with antibodies 
directed to GP2 and carboxypeptidase A. Images were acquired on an Olympus IX81 fluorescence 
microscope. Scale bars, 10 µm. 
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